{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "48d2f9f4",
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import os"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "e28cf948",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "load_dotenv(\".env\")\n",
    "api_key = os.getenv(\"OPENAI_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "d5cdb83b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\ncheck what models the key has access to\\n\\ncurl https://api.openai.com/v1/models   -H \"Authorization: Bearer $OPENAI_API_KEY\"\\n\\n'"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\"\"\"\n",
    "check what models the key has access to\n",
    "\n",
    "curl https://api.openai.com/v1/models \\\n",
    "  -H \"Authorization: Bearer $OPENAI_API_KEY\"\n",
    "\n",
    "\"\"\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "a0b3a9d0",
   "metadata": {},
   "outputs": [],
   "source": [
    "#input_file = \"../csvs/baby_tests.csv\"   # contains: 'question 1'\\n'question 2'\\n...\n",
    "#output_file = \"../csvs/baby_tests.jsonl\"\n",
    "\n",
    "# all questions\n",
    "input_file = '../csvs/questions.csv'\n",
    "output_file = '../csvs/questions.jsonl'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "e53a54f6",
   "metadata": {},
   "outputs": [],
   "source": [
    "def define_general_prompt():\n",
    "    general_prompt = \"\"\"\n",
    "    \n",
    "    'Only use results from the genomic data commons in your response and provide frequencies \\\n",
    "     as a percentage in the result. Report the result in the following output JSON format, strictly using \\\n",
    "     the structure \"The final answer is: <frequency %>\", followed by top references to publications from which you \\\n",
    "     obtained your response:\n",
    "\n",
    "    {\n",
    "        result: The final answer is: <frequency %>\n",
    "        references: <list of references>\n",
    "    }\n",
    "\n",
    "    \"\"\"\n",
    "    return general_prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "3fe0fdc0",
   "metadata": {},
   "outputs": [],
   "source": [
    "general_prompt = define_general_prompt()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "c535b917",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n    \\n    \\'Only use results from the genomic data commons in your response and provide frequencies      as a percentage in the result. Report the result in the following output JSON format, strictly using      the structure \"The final answer is: <frequency %>\", followed by top references to publications from which you      obtained your response:\\n\\n    {\\n        result: The final answer is: <frequency %>\\n        references: <list of references>\\n    }\\n\\n    '"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "general_prompt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "d9574f06",
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_jsonl(input_file, output_file):\n",
    "    with open(input_file, \"r\") as infile, open(output_file, \"w\") as outfile:\n",
    "        next(infile)  # skip the header line\n",
    "        for i, line in enumerate(infile, 1):\n",
    "            question = line.strip().strip(\"'\\\"\")  # remove quotes and newline\n",
    "            jsonl = {\n",
    "                \"custom_id\": f\"request-{i}\",\n",
    "                \"method\": \"POST\",\n",
    "                \"url\": \"/v1/chat/completions\",\n",
    "                \"body\": {\n",
    "                    \"model\": \"gpt-4o-2024-08-06\",\n",
    "                    \"temperature\": 0,\n",
    "                    \"seed\": 2000,\n",
    "                    \"response_format\": {\"type\": \"json_object\"},\n",
    "                    \"messages\": [\n",
    "                        {\"role\": \"system\", \"content\": general_prompt},\n",
    "                        {\"role\": \"user\", \"content\": question}\n",
    "                    ]\n",
    "                }\n",
    "            }\n",
    "            outfile.write(json.dumps(jsonl) + \"\\n\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ad369e08",
   "metadata": {},
   "source": [
    "### process results from batch"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dab0b142",
   "metadata": {},
   "source": [
    "#### any errors from batch, reprocess them\n",
    "- look at error.jsonl and process the error queries separately\n",
    "- sometimes errors result due to the suffix \"-batch\" added to model name which doesn't exist\n",
    "- openai probably does this to get discounts in batch API\n",
    "- rerunning error queries fixes it and model name doesnt change"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "0975ed83",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "pd.set_option('display.max_colwidth', None)\n",
    "questions = pd.read_csv('../csvs/questions.csv')\n",
    "error_questions = questions.iloc[[5, 6, 24, 80, 141, 169, 238, 246, 247, 265, 272, 287, 289, 309, 311, 407, 408, 416, 458, 485, 488]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "96fdf716",
   "metadata": {},
   "outputs": [],
   "source": [
    "error_questions.to_csv('../csvs/error_questions_gpt4.csv', index=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "f3dd5418",
   "metadata": {},
   "outputs": [],
   "source": [
    "get_jsonl(input_file='../csvs/error_questions_gpt4.csv', output_file='../csvs/error_questions_gpt4.jsonl')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3667a183",
   "metadata": {},
   "source": [
    "### process results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "72adbe91",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Results:\n",
      " ['The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0.2%', 'The final answer is: 40%', 'The final answer is: 0.5%', 'The final answer is: 5.6%', 'The final answer is: 7.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 7.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 8.3%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0.2%', 'The final answer is: 3.5%', 'The final answer is: 16.1%', 'The final answer is: 28%', 'The final answer is: 21.7%', 'The final answer is: 3.5%', 'The final answer is: 16.1%', 'The final answer is: 28.6%', 'The final answer is: 21.7%', 'The final answer is: 3.5%', 'The final answer is: 16.0%', 'The final answer is: 28.6%', 'The final answer is: 21.7%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 16.0%', 'The final answer is: 28.6%', 'The final answer is: 21.7%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 48.6%', 'The final answer is: 5%', 'The final answer is: 8.5%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 36.2%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 5.6%', 'The final answer is: 5.88%', 'The final answer is: 20%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 12%', 'The final answer is: 5.6%', 'The final answer is: 18.2%', 'The final answer is: 36.4%', 'The final answer is: 20.0%', 'The final answer is: 2.5%', 'The final answer is: 18.2%', 'The final answer is: 2.5%', 'The final answer is: 13.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.0%', 'The final answer is: 5.2%', 'The final answer is: 37.5%', 'The final answer is: 32.5%', 'The final answer is: 13.5%', 'The final answer is: 39.5%', 'The final answer is: 2.5%', 'The final answer is: 25.0%', 'The final answer is: 20.5%', 'The final answer is: 7.1%', 'The final answer is: 13.5%', 'The final answer is: 37.5%', 'The final answer is: 12.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 3.7%', 'The final answer is: 0.5%', 'The final answer is: 12.5%', 'The final answer is: 8.5%', 'The final answer is: 35.5%', 'The final answer is: 8.6%', 'The final answer is: 45.6%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 16.0%', 'The final answer is: 28%', 'The final answer is: 21.7%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.0%', 'The final answer is: 1.5%', 'The final answer is: 4.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 5.88%', 'The final answer is: 0.35%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 13.3%', 'The final answer is: 13.3%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 11.2%', 'The final answer is: 5.6%', 'The final answer is: 15.2%', 'The final answer is: 15%', 'The final answer is: 7.5%', 'The final answer is: 15%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 20%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 12.3%', 'The final answer is: 33.3%', 'The final answer is: 32.5%', 'The final answer is: 13.5%', 'The final answer is: 10.0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 18.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 16.1%', 'The final answer is: 28%', 'The final answer is: 21.7%', 'The final answer is: 7.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 25%', 'The final answer is: 16.0%', 'The final answer is: 28.6%', 'The final answer is: 21.7%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 0.21%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 1.92%', 'The final answer is: 1.23%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 1.23%', 'The final answer is: 0.35%', 'The final answer is: 1.96%', 'The final answer is: 1.5%', 'The final answer is: 0.35%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.36%', 'The final answer is: 1.23%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.96%', 'The final answer is: 1.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.27%', 'The final answer is: 2.94%', 'The final answer is: 2.5%', 'The final answer is: 2.08%', 'The final answer is: 2.0%', 'The final answer is: 2.94%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.94%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.0%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.34%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 5.2%', 'The final answer is: 15%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 15%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 7.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 3.5%', 'The final answer is: 15%', 'The final answer is: 7.5%', 'The final answer is: 57.4%', 'The final answer is: 7.5%', 'The final answer is: 15%', 'The final answer is: 5.2%', 'The final answer is: 7.5%', 'The final answer is: 5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 15.38%', 'The final answer is: 15.2%', 'The final answer is: 3.3%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.94%', 'The final answer is: 5.88%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 5.2%', 'The final answer is: 9.5%', 'The final answer is: 0.36%', 'The final answer is: 5.2%', 'The final answer is: 15.2%', 'The final answer is: 57.4%', 'The final answer is: 11.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 46.0%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.21%', 'The final answer is: 0.36%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 0.21%', 'The final answer is: 5%', 'The final answer is: 16.7%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 4.5%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 8.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0.00%', 'The final answer is: 1.2%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 1.23%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.3%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.00%', 'The final answer is: 0.00%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.00%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 2.13%', 'The final answer is: 0.00%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 1.23%', 'The final answer is: 0.21%', 'The final answer is: 4.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.35%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.21%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 0.5%', 'The final answer is: 12.5%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 5.6%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 4.5%', 'The final answer is: 8.3%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 2.0%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.3%', 'The final answer is: 7.5%', 'The final answer is: 9.5%', 'The final answer is: 25%', 'The final answer is: 22.5%', 'The final answer is: 5.6%', 'The final answer is: 3.2%', 'The final answer is: 3.5%', 'The final answer is: 6.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.0%', 'The final answer is: 0.35%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.0%', 'The final answer is: 0.35%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 12.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.44%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.96%', 'The final answer is: 1.5%', 'The final answer is: 1.96%', 'The final answer is: 1.5%', 'The final answer is: 1.1%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.23%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.98%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 8.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 2.94%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 18%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 8.5%', 'The final answer is: 5%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 8.5%', 'The final answer is: 8.5%', 'The final answer is: 8.5%', 'The final answer is: 8.5%', 'The final answer is: 8.5%', 'The final answer is: 5.2%', 'The final answer is: 4.5%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 5.88%', 'The final answer is: 5.6%', 'The final answer is: 18.2%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 5.88%', 'The final answer is: 3.7%', 'The final answer is: 5.88%', 'The final answer is: 15.38%', 'The final answer is: 15%', 'The final answer is: 5.88%', 'The final answer is: 5.88%', 'The final answer is: 15.38%', 'The final answer is: 15.2%', 'The final answer is: 30.5%', 'The final answer is: 20%', 'The final answer is: 10.5%', 'The final answer is: 5.6%', 'The final answer is: 7.5%', 'The final answer is: 18.75%', 'The final answer is: 5.6%', 'The final answer is: 8.5%', 'The final answer is: 5.2%', 'The final answer is: 8.5%', 'The final answer is: 15.2%', 'The final answer is: 15.2%', 'The final answer is: 8.5%', 'The final answer is: 15.2%', 'The final answer is: 47.5%', 'The final answer is: 8.5%', 'The final answer is: 27.5%', 'The final answer is: 47.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 0.36%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.36%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.96%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.1%', 'The final answer is: 5.88%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.21%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 15%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 15%', 'The final answer is: 15.2%', 'The final answer is: 5.88%', 'The final answer is: 5.88%', 'The final answer is: 5.3%', 'The final answer is: 30.5%', 'The final answer is: 5.88%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 15.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 15%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 7.3%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 2.0%', 'The final answer is: 7.1%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 1.92%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.94%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.45%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 0.21%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0.35%', 'The final answer is: 1.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0.35%', 'The final answer is: 0.00%', 'The final answer is: 0.45%', 'The final answer is: 0.00%', 'The final answer is: 1.92%', 'The final answer is: 0.35%', 'The final answer is: 2.94%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 1.23%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.94%', 'The final answer is: 1.23%', 'The final answer is: 2.13%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.34%', 'The final answer is: 2.34%', 'The final answer is: 2.34%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.0%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.7%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0.00%', 'The final answer is: 0.36%', 'The final answer is: 0.36%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 1.23%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 1.23%', 'The final answer is: 1.96%', 'The final answer is: 1.23%', 'The final answer is: 0.35%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 18.6%', 'The final answer is: 3.0%', 'The final answer is: 3.5%', 'The final answer is: 3.0%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 48.6%', 'The final answer is: 8.6%', 'The final answer is: 45.6%', 'The final answer is: 12.5%', 'The final answer is: 5.6%', 'The final answer is: 8.3%', 'The final answer is: 3.7%', 'The final answer is: 36.5%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 71.4%', 'The final answer is: 5.6%', 'The final answer is: 5.3%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 8.33%', 'The final answer is: 8.5%', 'The final answer is: 0.0%', 'The final answer is: 8.5%', 'The final answer is: 8.5%', 'The final answer is: 12.3%', 'The final answer is: 12.5%', 'The final answer is: 13.5%', 'The final answer is: 5.88%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 7.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.36%', 'The final answer is: 0.21%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 5.8%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.35%', 'The final answer is: 1.23%', 'The final answer is: 4.5%', 'The final answer is: 1.23%', 'The final answer is: 1.23%', 'The final answer is: 13.3%', 'The final answer is: 2.5%', 'The final answer is: 13.3%', 'The final answer is: 1.5%', 'The final answer is: 3.57%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.23%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 1.6%', 'The final answer is: 0.21%', 'The final answer is: 0.12%', 'The final answer is: 0.21%', 'The final answer is: 0.22%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.22%', 'The final answer is: 1.5%', 'The final answer is: 0.12%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.35%', 'The final answer is: 0.22%', 'The final answer is: 2.5%', 'The final answer is: 10.7%', 'The final answer is: 0.45%', 'The final answer is: 0.35%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.21%', 'The final answer is: 0.22%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 70%', 'The final answer is: 5.88%', 'The final answer is: 5.88%', 'The final answer is: 12.5%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 3.5%', 'The final answer is: 12.5%', 'The final answer is: 5%', 'The final answer is: 5.6%', 'The final answer is: 15%', 'The final answer is: 15%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 15%', 'The final answer is: 12.5%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 70%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 1.5%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 1.2%', 'The final answer is: 4.5%', 'The final answer is: 0.5%', 'The final answer is: 7.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 28.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 28.5%', 'The final answer is: 5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 28.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 28.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0.35%', 'The final answer is: 0.0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 3.4%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.21%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 7.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 52.7%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 25%', 'The final answer is: 2.5%', 'The final answer is: 36.2%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 5.2%', 'The final answer is: 36.5%', 'The final answer is: 25%', 'The final answer is: 36%', 'The final answer is: 12.5%', 'The final answer is: 37.5%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 33.3%', 'The final answer is: 8.3%', 'The final answer is: 2.5%', 'The final answer is: 20.5%', 'The final answer is: 36.4%', 'The final answer is: 13.5%', 'The final answer is: 3.5%', 'The final answer is: 22.5%', 'The final answer is: 0%', 'The final answer is: 18.5%', 'The final answer is: 3.5%', 'The final answer is: 40%', 'The final answer is: 35.6%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 33.5%', 'The final answer is: 37.5%', 'The final answer is: 32.5%', 'The final answer is: 17.5%', 'The final answer is: 52.3%', 'The final answer is: 2.5%', 'The final answer is: 25.3%', 'The final answer is: 6.5%', 'The final answer is: 34.6%', 'The final answer is: 5.4%', 'The final answer is: 13.5%', 'The final answer is: 3.5%', 'The final answer is: 12.5%', 'The final answer is: 25%', 'The final answer is: 36.5%', 'The final answer is: 13.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.1%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 3.3%', 'The final answer is: 5.6%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.7%', 'The final answer is: 4.3%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.7%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.3%', 'The final answer is: 4.5%', 'The final answer is: 52%', 'The final answer is: 5.6%', 'The final answer is: 10.0%', 'The final answer is: 8.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 3.5%', 'The final answer is: 5.3%', 'The final answer is: 3.5%', 'The final answer is: 59.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 3.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 5.0%', 'The final answer is: 3.7%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 3.5%', 'The final answer is: 3.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.3%', 'The final answer is: 0%', 'The final answer is: 52.7%', 'The final answer is: 3.5%', 'The final answer is: 10.0%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.2%', 'The final answer is: 3.5%', 'The final answer is: 59.3%', 'The final answer is: 2.3%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 25%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 15%', 'The final answer is: 32%', 'The final answer is: 35%', 'The final answer is: 25%', 'The final answer is: 20%', 'The final answer is: 15%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 15%', 'The final answer is: 32%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 41.2%', 'The final answer is: 20.0%', 'The final answer is: 22.5%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 8.5%', 'The final answer is: 90.0%', 'The final answer is: 5.88%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 8.3%', 'The final answer is: 5.6%', 'The final answer is: 18.5%', 'The final answer is: 5.6%', 'The final answer is: 42.3%', 'The final answer is: 10.5%', 'The final answer is: 25.3%', 'The final answer is: 1.2%', 'The final answer is: 22.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 32%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 33.5%', 'The final answer is: 25%', 'The final answer is: 12.5%', 'The final answer is: 32%', 'The final answer is: 15%', 'The final answer is: 32%', 'The final answer is: 14.0%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 3.5%', 'The final answer is: 15%', 'The final answer is: 3.5%', 'The final answer is: 14.5%', 'The final answer is: 15%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 15.2%', 'The final answer is: 15%', 'The final answer is: 14.0%', 'The final answer is: 15%', 'The final answer is: 5.2%', 'The final answer is: 15%', 'The final answer is: 15.2%', 'The final answer is: 15%', 'The final answer is: 25.3%', 'The final answer is: 25.3%', 'The final answer is: 25%', 'The final answer is: 3.5%', 'The final answer is: 5.4%', 'The final answer is: 3.5%', 'The final answer is: 11.2%', 'The final answer is: 2.5%', 'The final answer is: 25%', 'The final answer is: 2.5%', 'The final answer is: 35%', 'The final answer is: 5%', 'The final answer is: 12.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 36.5%', 'The final answer is: 12.5%', 'The final answer is: 25%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 33.3%', 'The final answer is: 8.33%', 'The final answer is: 5.88%', 'The final answer is: 17.5%', 'The final answer is: 36.36%', 'The final answer is: 13.5%', 'The final answer is: 5.88%', 'The final answer is: 22.5%', 'The final answer is: 5.88%', 'The final answer is: 18.5%', 'The final answer is: 3.5%', 'The final answer is: 40%', 'The final answer is: 35.6%', 'The final answer is: 5.2%', 'The final answer is: 3.3%', 'The final answer is: 5.6%', 'The final answer is: 33.3%', 'The final answer is: 32.5%', 'The final answer is: 25.3%', 'The final answer is: 52.3%', 'The final answer is: 2.5%', 'The final answer is: 25.3%', 'The final answer is: 7.5%', 'The final answer is: 21.3%', 'The final answer is: 5.4%', 'The final answer is: 12.5%', 'The final answer is: 16.7%', 'The final answer is: 33.3%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 14.0%', 'The final answer is: 5%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 19.5%', 'The final answer is: 15%', 'The final answer is: 13.5%', 'The final answer is: 10.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 19.5%', 'The final answer is: 5%', 'The final answer is: 37.5%', 'The final answer is: 37.5%', 'The final answer is: 37.5%', 'The final answer is: 37.5%', 'The final answer is: 30%', 'The final answer is: 37.5%', 'The final answer is: 37.5%', 'The final answer is: 32.8%', 'The final answer is: 80%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 9.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 4.5%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 52.9%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 52.7%', 'The final answer is: 5%', 'The final answer is: 1.5%', 'The final answer is: 4.3%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.0%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.00%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5%', 'The final answer is: 0.5%', 'The final answer is: 12.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 5.0%', 'The final answer is: 5.88%', 'The final answer is: 7.5%', 'The final answer is: 2.5%', 'The final answer is: 8.3%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 5.3%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 11.5%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 8.5%', 'The final answer is: 12.5%', 'The final answer is: 15.2%', 'The final answer is: 57.1%', 'The final answer is: 11.5%', 'The final answer is: 15%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 0%', 'The final answer is: 12.5%', 'The final answer is: 0%', 'The final answer is: 15%', 'The final answer is: 12%', 'The final answer is: 15%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 15%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 15.38%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 6.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 7.5%', 'The final answer is: 3.5%', 'The final answer is: 12.5%', 'The final answer is: 7.5%', 'The final answer is: 0.5%', 'The final answer is: 8.5%', 'The final answer is: 12.5%', 'The final answer is: 15.2%', 'The final answer is: 14.0%', 'The final answer is: 57.1%', 'The final answer is: 7.5%', 'The final answer is: 9.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 6.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 6.5%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.2%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 7.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 6.25%', 'The final answer is: 0.5%', 'The final answer is: 6.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.2%', 'The final answer is: 1.2%', 'The final answer is: 6.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.2%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 7.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 3.7%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 6.7%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 12.5%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 15.2%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 5.88%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 4.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 5.3%', 'The final answer is: 5.2%', 'The final answer is: 7.5%', 'The final answer is: 5.2%', 'The final answer is: 7.5%', 'The final answer is: 5.2%', 'The final answer is: 7.5%', 'The final answer is: 5.2%', 'The final answer is: 6.5%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.36%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.35%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 50%', 'The final answer is: 46.5%', 'The final answer is: 15%', 'The final answer is: 47.5%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 33.3%', 'The final answer is: 53%', 'The final answer is: 80%', 'The final answer is: 50%', 'The final answer is: 84.6%', 'The final answer is: 90%', 'The final answer is: 50%', 'The final answer is: 46.5%', 'The final answer is: 11.1%', 'The final answer is: 75%', 'The final answer is: 27.5%', 'The final answer is: 13.3%', 'The final answer is: 60%', 'The final answer is: 44.4%', 'The final answer is: 70%', 'The final answer is: 15.5%', 'The final answer is: 90.0%', 'The final answer is: 2.5%', 'The final answer is: 32.5%', 'The final answer is: 31.5%', 'The final answer is: 74.5%', 'The final answer is: 91.3%', 'The final answer is: 31.5%', 'The final answer is: 5.6%', 'The final answer is: 33.3%', 'The final answer is: 16.7%', 'The final answer is: 50%', 'The final answer is: 33.3%', 'The final answer is: 84.3%', 'The final answer is: 60.5%', 'The final answer is: 48.5%', 'The final answer is: 91.2%', 'The final answer is: 19.8%', 'The final answer is: 47.5%', 'The final answer is: 46.5%', 'The final answer is: 72%', 'The final answer is: 46.6%', 'The final answer is: 28.3%', 'The final answer is: 81.5%', 'The final answer is: 96.7%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 8.5%', 'The final answer is: 5%', 'The final answer is: 90.0%', 'The final answer is: 37.5%', 'The final answer is: 30.5%', 'The final answer is: 30%', 'The final answer is: 46.3%', 'The final answer is: 50%', 'The final answer is: 35%', 'The final answer is: 46.7%', 'The final answer is: 81.5%', 'The final answer is: 46.7%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 0.2%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 46.2%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 3.7%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 5.3%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.3%', 'The final answer is: 3.3%', 'The final answer is: 3.5%', 'The final answer is: 1.3%', 'The final answer is: 3.3%', 'The final answer is: 5.0%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.3%', 'The final answer is: 2.5%', 'The final answer is: 6.5%', 'The final answer is: 10.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 59.8%', 'The final answer is: 2.3%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 7.5%', 'The final answer is: 1.5%', 'The final answer is: 4.5%', 'The final answer is: 1.5%', 'The final answer is: 17.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 17.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 52.3%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 52.7%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 4.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 4.5%', 'The final answer is: 8.5%', 'The final answer is: 5.2%', 'The final answer is: 13.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.33%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 6.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.35%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.21%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.33%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 15.2%', 'The final answer is: 3.5%', 'The final answer is: 28.5%', 'The final answer is: 2.5%', 'The final answer is: 15.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 5.3%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 15.2%', 'The final answer is: 0.5%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.45%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 15.2%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 1.2%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.3%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 15%', 'The final answer is: 2.5%', 'The final answer is: 28.5%', 'The final answer is: 0.5%', 'The final answer is: 15%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 40.5%', 'The final answer is: 0.35%', 'The final answer is: 15.2%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.96%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 1.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 52.3%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 14.3%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.33%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 5.6%', 'The final answer is: 5.6%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 6.5%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 6.5%', 'The final answer is: 6.5%', 'The final answer is: 6.5%', 'The final answer is: 6.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 5%', 'The final answer is: 52.7%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 14.3%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 4.5%', 'The final answer is: 0.5%', 'The final answer is: 4.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 0.36%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 15%', 'The final answer is: 13.5%', 'The final answer is: 8.5%', 'The final answer is: 5%', 'The final answer is: 15.2%', 'The final answer is: 5.6%', 'The final answer is: 15.2%', 'The final answer is: 25%', 'The final answer is: 40%', 'The final answer is: 8.5%', 'The final answer is: 0%', 'The final answer is: 15%', 'The final answer is: 15%', 'The final answer is: 8.5%', 'The final answer is: 3.5%', 'The final answer is: 15%', 'The final answer is: 15%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 8.33%', 'The final answer is: 5.6%', 'The final answer is: 18.2%', 'The final answer is: 15.38%', 'The final answer is: 15.2%', 'The final answer is: 8.5%', 'The final answer is: 20%', 'The final answer is: 15.38%', 'The final answer is: 18.5%', 'The final answer is: 5.3%', 'The final answer is: 61.54%', 'The final answer is: 4.5%', 'The final answer is: 5.6%', 'The final answer is: 16.67%', 'The final answer is: 8.5%', 'The final answer is: 27%', 'The final answer is: 8.5%', 'The final answer is: 18.5%', 'The final answer is: 15.2%', 'The final answer is: 39.5%', 'The final answer is: 17.4%', 'The final answer is: 22.5%', 'The final answer is: 18.5%', 'The final answer is: 9.5%', 'The final answer is: 15.2%', 'The final answer is: 36.5%', 'The final answer is: 15.2%', 'The final answer is: 7.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 12.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 5%', 'The final answer is: 12%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 3.45%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 8.3%', 'The final answer is: 15%', 'The final answer is: 8.3%', 'The final answer is: 3.3%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 11.5%', 'The final answer is: 4.5%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 25.3%', 'The final answer is: 2.5%', 'The final answer is: 22.5%', 'The final answer is: 5.2%', 'The final answer is: 8.5%', 'The final answer is: 11.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 6.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 5.0%', 'The final answer is: 3.7%', 'The final answer is: 15.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.7%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 4.5%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 22.5%', 'The final answer is: 5.6%', 'The final answer is: 6.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 12%', 'The final answer is: 5.6%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 6.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 8.33%', 'The final answer is: 15.2%', 'The final answer is: 7.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 15.38%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 11.5%', 'The final answer is: 25%', 'The final answer is: 2.5%', 'The final answer is: 22.5%', 'The final answer is: 5.2%', 'The final answer is: 6.5%', 'The final answer is: 8.5%', 'The final answer is: 6.5%', 'The final answer is: 11.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 1.5%', 'The final answer is: 12.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 5.88%', 'The final answer is: 5.0%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 4.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 36.5%', 'The final answer is: 45.2%', 'The final answer is: 36.5%', 'The final answer is: 36.5%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 12.5%', 'The final answer is: 12%', 'The final answer is: 25%', 'The final answer is: 25%', 'The final answer is: 25%', 'The final answer is: 37.5%', 'The final answer is: 18.5%', 'The final answer is: 12.5%', 'The final answer is: 33.3%', 'The final answer is: 8.3%', 'The final answer is: 13.3%', 'The final answer is: 25.3%', 'The final answer is: 36.36%', 'The final answer is: 21.5%', 'The final answer is: 5.88%', 'The final answer is: 13.3%', 'The final answer is: 5.88%', 'The final answer is: 18.5%', 'The final answer is: 3.5%', 'The final answer is: 40%', 'The final answer is: 35%', 'The final answer is: 5.2%', 'The final answer is: 8.33%', 'The final answer is: 5.6%', 'The final answer is: 8.3%', 'The final answer is: 37.5%', 'The final answer is: 32.5%', 'The final answer is: 25%', 'The final answer is: 52.3%', 'The final answer is: 3.5%', 'The final answer is: 25.3%', 'The final answer is: 7.5%', 'The final answer is: 34.5%', 'The final answer is: 35%', 'The final answer is: 13.5%', 'The final answer is: 16.7%', 'The final answer is: 12.5%', 'The final answer is: 25%', 'The final answer is: 5.2%', 'The final answer is: 36.1%', 'The final answer is: 12%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 5.2%', 'The final answer is: 36.5%', 'The final answer is: 25%', 'The final answer is: 36%', 'The final answer is: 25%', 'The final answer is: 37.5%', 'The final answer is: 8.5%', 'The final answer is: 25%', 'The final answer is: 33.3%', 'The final answer is: 8.33%', 'The final answer is: 5.6%', 'The final answer is: 20.5%', 'The final answer is: 36.36%', 'The final answer is: 13.5%', 'The final answer is: 5.88%', 'The final answer is: 22.5%', 'The final answer is: 5.88%', 'The final answer is: 18.5%', 'The final answer is: 3.5%', 'The final answer is: 40%', 'The final answer is: 35%', 'The final answer is: 5.6%', 'The final answer is: 6.5%', 'The final answer is: 5.6%', 'The final answer is: 8.5%', 'The final answer is: 37.5%', 'The final answer is: 32.5%', 'The final answer is: 25.3%', 'The final answer is: 52.3%', 'The final answer is: 2.5%', 'The final answer is: 25.3%', 'The final answer is: 7.5%', 'The final answer is: 37.6%', 'The final answer is: 7.5%', 'The final answer is: 13.3%', 'The final answer is: 16.7%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 32.5%', 'The final answer is: 30%', 'The final answer is: 25%', 'The final answer is: 25%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 32.5%', 'The final answer is: 20.5%', 'The final answer is: 12.5%', 'The final answer is: 5.6%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 41.2%', 'The final answer is: 20.0%', 'The final answer is: 22.5%', 'The final answer is: 8.3%', 'The final answer is: 22.2%', 'The final answer is: 5.88%', 'The final answer is: 8.5%', 'The final answer is: 90.0%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 8.3%', 'The final answer is: 20.5%', 'The final answer is: 33.3%', 'The final answer is: 5.6%', 'The final answer is: 42.4%', 'The final answer is: 21.5%', 'The final answer is: 25.3%', 'The final answer is: 1.2%', 'The final answer is: 22.5%', 'The final answer is: 3.5%', 'The final answer is: 18.6%', 'The final answer is: 32.5%', 'The final answer is: 3.2%', 'The final answer is: 15.3%', 'The final answer is: 3.5%', 'The final answer is: 96.7%', 'The final answer is: 96.7%', 'The final answer is: 47.5%', 'The final answer is: 47.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 5.6%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 4.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 47.5%', 'The final answer is: 47.3%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.3%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 27.5%', 'The final answer is: 18.5%', 'The final answer is: 11.5%', 'The final answer is: 11.5%', 'The final answer is: 11.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 27.5%', 'The final answer is: 2.5%', 'The final answer is: 16.67%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 52.3%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.3%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 36.5%', 'The final answer is: 35.3%', 'The final answer is: 36.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.0%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 4.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 5.3%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 33.3%', 'The final answer is: 25%', 'The final answer is: 12.5%', 'The final answer is: 22.2%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 12.5%', 'The final answer is: 32.5%', 'The final answer is: 30%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 32.5%', 'The final answer is: 0.5%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 41.2%', 'The final answer is: 10.0%', 'The final answer is: 22.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 5.6%', 'The final answer is: 90.0%', 'The final answer is: 5.88%', 'The final answer is: 5.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 8.3%', 'The final answer is: 5.6%', 'The final answer is: 33.3%', 'The final answer is: 5.6%', 'The final answer is: 40.0%', 'The final answer is: 21.5%', 'The final answer is: 25.3%', 'The final answer is: 1.2%', 'The final answer is: 8.5%', 'The final answer is: 3.5%', 'The final answer is: 5.9%', 'The final answer is: 32.2%', 'The final answer is: 0.5%', 'The final answer is: 3.3%', 'The final answer is: 3.5%', 'The final answer is: 25%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 30%', 'The final answer is: 25%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 41.2%', 'The final answer is: 16.7%', 'The final answer is: 22.5%', 'The final answer is: 12.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 90%', 'The final answer is: 5.88%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 5.6%', 'The final answer is: 18.5%', 'The final answer is: 5.6%', 'The final answer is: 45%', 'The final answer is: 10.5%', 'The final answer is: 25.3%', 'The final answer is: 2.5%', 'The final answer is: 22.5%', 'The final answer is: 3.5%', 'The final answer is: 18.5%', 'The final answer is: 15%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 15%', 'The final answer is: 57.5%', 'The final answer is: 0.0%', 'The final answer is: 0%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 7.5%', 'The final answer is: 12.5%', 'The final answer is: 7.5%', 'The final answer is: 8.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 12.5%', 'The final answer is: 7.5%', 'The final answer is: 0.5%', 'The final answer is: 8.5%', 'The final answer is: 15.2%', 'The final answer is: 11.5%', 'The final answer is: 12.5%', 'The final answer is: 2.5%', 'The final answer is: 7.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 12%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 7.5%', 'The final answer is: 7.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 7.5%', 'The final answer is: 2.5%', 'The final answer is: 12.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 8.5%', 'The final answer is: 12.5%', 'The final answer is: 15.2%', 'The final answer is: 57.3%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.3%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.0%', 'The final answer is: 3.7%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.3%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 10.0%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.2%', 'The final answer is: 3.5%', 'The final answer is: 59.8%', 'The final answer is: 3.0%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 28.3%', 'The final answer is: 48.5%', 'The final answer is: 47.5%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 72.9%', 'The final answer is: 72.5%', 'The final answer is: 81.6%', 'The final answer is: 84.3%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 47%', 'The final answer is: 46.5%', 'The final answer is: 37.5%', 'The final answer is: 50%', 'The final answer is: 47.5%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 47%', 'The final answer is: 50%', 'The final answer is: 87.5%', 'The final answer is: 53%', 'The final answer is: 37.5%', 'The final answer is: 30%', 'The final answer is: 50%', 'The final answer is: 84.6%', 'The final answer is: 90%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 0%', 'The final answer is: 45%', 'The final answer is: 30.5%', 'The final answer is: 20.0%', 'The final answer is: 60%', 'The final answer is: 44.4%', 'The final answer is: 72%', 'The final answer is: 15.5%', 'The final answer is: 90.0%', 'The final answer is: 91.67%', 'The final answer is: 31.25%', 'The final answer is: 47.5%', 'The final answer is: 74.5%', 'The final answer is: 91.67%', 'The final answer is: 31.5%', 'The final answer is: 46.7%', 'The final answer is: 33.3%', 'The final answer is: 16.67%', 'The final answer is: 50%', 'The final answer is: 33.3%', 'The final answer is: 84.3%', 'The final answer is: 60%', 'The final answer is: 48.5%', 'The final answer is: 91.2%', 'The final answer is: 19.8%', 'The final answer is: 44.3%', 'The final answer is: 84.6%', 'The final answer is: 81.5%', 'The final answer is: 81.6%', 'The final answer is: 96.7%', 'The final answer is: 3.5%', 'The final answer is: 12%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 33.3%', 'The final answer is: 45%', 'The final answer is: 15%', 'The final answer is: 90%', 'The final answer is: 50%', 'The final answer is: 46.5%', 'The final answer is: 5.6%', 'The final answer is: 12.5%', 'The final answer is: 23.5%', 'The final answer is: 5.6%', 'The final answer is: 60%', 'The final answer is: 33.3%', 'The final answer is: 15.5%', 'The final answer is: 90%', 'The final answer is: 91.3%', 'The final answer is: 32.5%', 'The final answer is: 31.5%', 'The final answer is: 74.5%', 'The final answer is: 91.3%', 'The final answer is: 31.5%', 'The final answer is: 4.5%', 'The final answer is: 33.3%', 'The final answer is: 16.7%', 'The final answer is: 5.6%', 'The final answer is: 33.3%', 'The final answer is: 60%', 'The final answer is: 91.2%', 'The final answer is: 8.6%', 'The final answer is: 46.5%', 'The final answer is: 46.5%', 'The final answer is: 28.3%', 'The final answer is: 50%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 35%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 30%', 'The final answer is: 53%', 'The final answer is: 15%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 53.3%', 'The final answer is: 50%', 'The final answer is: 50%', 'The final answer is: 11.1%', 'The final answer is: 12.5%', 'The final answer is: 27.5%', 'The final answer is: 5.6%', 'The final answer is: 60%', 'The final answer is: 44.4%', 'The final answer is: 72%', 'The final answer is: 15.5%', 'The final answer is: 90%', 'The final answer is: 3.7%', 'The final answer is: 32.5%', 'The final answer is: 31.5%', 'The final answer is: 74.5%', 'The final answer is: 91.67%', 'The final answer is: 31.5%', 'The final answer is: 5.6%', 'The final answer is: 13.5%', 'The final answer is: 16.7%', 'The final answer is: 9.5%', 'The final answer is: 33.3%', 'The final answer is: 84.3%', 'The final answer is: 60%', 'The final answer is: 48.5%', 'The final answer is: 91.2%', 'The final answer is: 8.5%', 'The final answer is: 46.5%', 'The final answer is: 72.6%', 'The final answer is: 46.5%', 'The final answer is: 28.3%', 'The final answer is: 81.5%', 'The final answer is: 96.4%', 'The final answer is: 3.5%', 'The final answer is: 52%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 14.3%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.7%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 5.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 7.1%', 'The final answer is: 1.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 5.88%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 7.1%', 'The final answer is: 0.36%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 7.1%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.1%', 'The final answer is: 2.5%', 'The final answer is: 7.1%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 1.23%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 3.7%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.36%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.96%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.23%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.0%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 5.3%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.7%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 5.2%', 'The final answer is: 10.0%', 'The final answer is: 9.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 8.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 9.1%', 'The final answer is: 59.3%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 17.5%', 'The final answer is: 5.2%', 'The final answer is: 5.0%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 5.88%', 'The final answer is: 17.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 12%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 5.6%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.0%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.35%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0.00%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 0.2%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.00%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 4.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 8.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 4.5%', 'The final answer is: 6.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 3.45%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 15%', 'The final answer is: 30%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 5.2%', 'The final answer is: 5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 5.0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 17.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 7.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 7.5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 21.43%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 21.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 5.6%', 'The final answer is: 5.3%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 4.5%', 'The final answer is: 0%', 'The final answer is: 12.5%', 'The final answer is: 12.5%', 'The final answer is: 20%', 'The final answer is: 37.5%', 'The final answer is: 18.2%', 'The final answer is: 20%', 'The final answer is: 33.3%', 'The final answer is: 8.3%', 'The final answer is: 13.3%', 'The final answer is: 20.5%', 'The final answer is: 36.4%', 'The final answer is: 13.5%', 'The final answer is: 8.3%', 'The final answer is: 5.88%', 'The final answer is: 18.5%', 'The final answer is: 3.5%', 'The final answer is: 40.0%', 'The final answer is: 35.5%', 'The final answer is: 5.6%', 'The final answer is: 3.7%', 'The final answer is: 5.6%', 'The final answer is: 37.5%', 'The final answer is: 32.5%', 'The final answer is: 25.3%', 'The final answer is: 52.3%', 'The final answer is: 3.5%', 'The final answer is: 25.3%', 'The final answer is: 6.5%', 'The final answer is: 18.6%', 'The final answer is: 5.2%', 'The final answer is: 12.3%', 'The final answer is: 16.7%', 'The final answer is: 11.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 2.5%', 'The final answer is: 5.6%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 2.5%', 'The final answer is: 3.3%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 17.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 5.88%', 'The final answer is: 4.5%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 5.2%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 5.0%', 'The final answer is: 5.88%', 'The final answer is: 5.2%', 'The final answer is: 3.33%', 'The final answer is: 0%', 'The final answer is: 5.88%', 'The final answer is: 3.5%', 'The final answer is: 1.2%', 'The final answer is: 5.88%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 3.5%', 'The final answer is: 5.2%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 17.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 18.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 3.5%', 'The final answer is: 2.5%', 'The final answer is: 0.0%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 0%', 'The final answer is: 1.5%', 'The final answer is: 0.2%', 'The final answer is: 1.2%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 3.33%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 1.96%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 1.2%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 1.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 0.5%', 'The final answer is: 0%', 'The final answer is: 2.5%', 'The final answer is: 1.2%', 'The final answer is: 1.5%', 'The final answer is: 1.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 3.5%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 2.5%', 'The final answer is: 0.5%', 'The final answer is: 1.5%', 'The final answer is: 3.2%', 'The final answer is: 0%', 'The final answer is: 0.5%', 'The final answer is: 2.5%', 'The final answer is: 0%', 'The final answer is: 3.5%', 'The final answer is: 0.5%']\n",
      "\n",
      "References:\n",
      " [[\"Publication 1: Smith et al., 2022, 'Microsatellite Instability in Cancer: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Characterization of Cancer: Insights from the MATCH-Z1D Project', Cancer Genomics Journal.\"], ['Genomic Data Commons, CS-MATCH-0007 Arm S1 MATCH-S1 project data', \"Publication: 'Comprehensive Genomic Characterization of a Large Set of Microsatellite Instability-High Cancers from the Genomic Data Commons', Journal of Clinical Oncology, 2023\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., et al. (2019). Genomic Analysis of Urothelial Carcinoma in Chinese Patients Identifies a Distinct Non-Muscle-Invasive Subtype with a High Frequency of FGFR3 Mutations. Nature Communications, 10(1), 1235.'], ['Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Cancer in HIV+ Patients, Journal of Oncology, 2022.', 'Publication 2: Genomic Alterations in Lung Cancer among HIV+ Individuals, Cancer Research, 2023.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], [\"Publication 1: 'Comprehensive Genomic Characterization of Microsatellite Instability in Cancer', Journal of Clinical Oncology, 2022.\", \"Publication 2: 'Microsatellite Instability in Cancer: A Review of the Data from the Genomic Data Commons', Cancer Research, 2023.\"], ['The Cancer Genome Atlas (TCGA) Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Testicular Germ Cell Tumors (TGCT) TCGA dataset in the Genomic Data Commons', 'Comprehensive molecular characterization of testicular germ cell tumors. Nature. 2018'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. New England Journal of Medicine, 2015.', 'Ceccarelli, M., et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell, 2016.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 1234.'], ['Publication 1: Comprehensive Molecular Characterization of Lung Adenocarcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network.'], ['Bell, D., Berchuck, A., Birrer, M., Chien, J., Cramer, D., Dao, F., ... & Cancer Genome Atlas Research Network. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.', 'Cancer Genome Atlas Research Network. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2018). Comprehensive genomic characterization of uterine corpus endometrial carcinoma in Chinese patients. Nature Communications, 9(1), 1-10.'], [\"Ceccarelli, M., et al. (2016). 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.' Cell, 164(3), 550-563.\", \"Cancer Genome Atlas Research Network. (2015). 'Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.' New England Journal of Medicine, 372(26), 2481-2498.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Acute Lymphoblastic Leukemia in the TARGET-ALL-P2 Project', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric ALL: Insights from the TARGET-ALL-P2 Study', Leukemia Research\"], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Alterations in ALL and Treatment Outcomes', Leukemia Research\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Microsatellite Instability in Cancer: Prevalence and Implications', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Characterization of CS-MATCH-0007 Arm S1', Cancer Research Journal.\"], ['Publication 1: Analysis of Microsatellite Instability in the MATCH-Z1D Project, Journal of Genomic Research, 2022.', 'Publication 2: Genomic Characterization of CS-MATCH-0007 Arm Z1D, Genomics and Cancer, 2023.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal, TCGA-SKCM project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in CPTAC-3 Projects', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in CPTAC-3', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM Project. https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM project data.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], ['The Cancer Genome Atlas (TCGA) Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Lung', 'https://gdc.cancer.gov/projects/CGCI-HTMCP-LC'], [\"Chen, X., et al. (2014). 'Targeting ALK, ROS1, and MET in lung cancer.' Nature Reviews Clinical Oncology.\", \"Mackintosh, C., et al. (2012). 'Targeting the ALK pathway in cancer.' Nature Reviews Cancer.\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-965.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Bergethon K, Shaw AT, Ou SH, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol. 2012 Mar 10;30(8):863-70.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Bergethon K, Shaw AT, Ou SH, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol. 2012 Mar 10;30(8):863-70.'], ['Bell, D., et al. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.', 'Cancer Genome Atlas Research Network. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.'], [\"Publication 1: Smith et al., 2020, 'Microsatellite Instability in Cancer: A Review of the Genomic Data Commons', Journal of Genomic Research.\", \"Publication 2: Johnson et al., 2021, 'Characterization of Microsatellite Instability in the MATCH-B Project', Genomics and Cancer.\", \"Publication 3: Lee et al., 2022, 'Frequency of Microsatellite Instability in Various Cancer Types', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 4;8(1):15180.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], [\"Publication 1: Smith et al., 2021, 'Microsatellite Instability in Cancer: Prevalence and Implications', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Characterization of Cancer: Insights from the MATCH-B Project', Cancer Research Journal.\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 12;8(1):15180.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], [\"Publication 1: Smith et al., 2022, 'Microsatellite Instability in Cancer: A Comprehensive Review', Journal of Genomic Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Characterization of CS-MATCH-0007 Arm B: Insights and Implications', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of Microsatellite Instability in Cancer Treatment', Oncogenomics Journal.\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 4;8(1):15180.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Genomic Data Commons, CS-MATCH-0007 Arm Z1D MATCH-Z1D project data', \"Publication: 'Comprehensive Molecular Characterization of a Large Cohort of Cancer Patients in the MATCH-Z1D Project', Journal of Clinical Oncology, 2023\"], ['Genomic Data Commons Data Portal - CS-MATCH-0007 Arm B MATCH-B Project', \"Publication: 'Comprehensive Genomic Characterization of the MATCH-B Cohort' in Journal of Clinical Oncology\"], ['Genomic Data Commons, CS-MATCH-0007 Arm S1 MATCH-S1 project dataset', \"Publication: 'Comprehensive Genomic Characterization of Cancer: The MATCH Study', Journal of Clinical Oncology, 2023\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 4;8(1):15180.', 'The Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], [\"Publication 1: Smith et al., 2021, 'Microsatellite Instability in Cancer: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Genomic Characterization of Microsatellite Instability in Various Cancer Types', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Microsatellite Instability in Cancer: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Genomic Characterization of Microsatellite Instability in Cancer', Genomics Journal.\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Nature Communications, 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'PDGFRA Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Genomic Data Commons Data Portal - CS-MATCH-0007 Arm S1 MATCH-S1 project', \"Publication: 'Comprehensive Genomic Characterization of Microsatellite Instability in Cancer' - Journal of Clinical Oncology\", \"Publication: 'Microsatellite Instability in Cancer: A Review of the Literature' - Cancer Research\"], ['Genomic Data Commons Data Portal - CS-MATCH-0007 Arm Z1D MATCH-Z1D project', \"Publication: 'Comprehensive Genomic Characterization of Microsatellite Instability in Cancer' - Journal of Clinical Oncology\", \"Publication: 'Microsatellite Instability in Cancer: A Review of the Literature' - Cancer Research\"], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Publication 1: Comprehensive molecular characterization of the brain tumor microenvironment in the CPTAC-3 project.', 'Publication 2: Genomic alterations in head and neck cancers: Insights from the CPTAC-3 project.', 'Publication 3: Kidney cancer genomics: Findings from the CPTAC-3 project.', 'Publication 4: Lung cancer genomic landscape: Data from the CPTAC-3 project.', 'Publication 5: Pancreatic cancer molecular profiling in the CPTAC-3 project.', 'Publication 6: Uterine cancer genomic alterations: CPTAC-3 project insights.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM project data.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'BRAF Mutations in Exceptional Responders: Insights from the EXCEPTIONAL_RESPONDERS-ER Project', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'Frequency and Impact of BRAF V600E in Exceptional Responders', Nature Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BRAF Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Frequency of BRAF V600E in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2021, 'BRAF Mutations in the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma, The Cancer Genome Atlas Research Network.', 'Publication 3: Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas, The Cancer Genome Atlas Research Network.'], [\"Robertson AG, et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'BRAF Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PIK3CA in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Alterations in Human Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Wilms Tumor: PIK3CA and Other Key Alterations', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in CPTAC-3 Projects', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'PIK3CA Alterations in Cancer Genomics', Cancer Genomics Journal.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations and Their Role in Lung Cancer Progression', Cancer Research Journal.\"], ['Genomic Data Commons Data Portal - HIV+ Tumor Molecular Characterization Project - Lung Cancer (CGCI-HTMCP-LC)'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project', \"Publication: 'Molecular Characterization of Cervical Cancer in HIV+ Patients' - Journal of Cancer Research\"], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS'], [\"Publication 1: Smith et al., 2020, 'Molecular Characterization of Diffuse Large B-Cell Lymphoma in HIV+ Patients', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Genomic Alterations in HIV-Associated Lymphomas', Cancer Research Journal\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers in the Cancer Genome Atlas. Nat Genet. 2017 Apr;49(4):514-522.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-25.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-28.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['CPTAC-3 Pancreatic Cancer Study, Genomic Data Commons', 'CPTAC-3 Lung Cancer Study, Genomic Data Commons', 'CPTAC-3 Kidney Cancer Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'KRAS Mutations in Cancer Models', Journal of Cancer Research\", \"Publication 2: Johnson et al., 2023, 'Genomic Data Commons: A Comprehensive Resource', Genomics Journal\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: TCGA-UCEC Project Data'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'KRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sveen A, Kopetz S, Lothe RA. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat Rev Clin Oncol. 2020 Jan;17(1):11-32.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Genomic Data Commons Data Portal. TCGA-THCA project. https://portal.gdc.cancer.gov/projects/TCGA-THCA'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma', The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of BRAF Amplification in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'BRAF Alterations in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency and Impact of BRAF Amplification in Cancer', Oncogene.\"], ['Genomic Data Commons, CS-MATCH-0007 Arm B MATCH-B project dataset', \"Publication: 'Comprehensive Genomic Characterization of Microsatellite Instability in Cancer', Journal of Clinical Oncology, 2023\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 12;8(1):15180.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of KRAS Amplification in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'KRAS Amplification in Human Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma', The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics Journal.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Lung Cancer in HIV-Positive Patients', Journal of Oncology, 2022.\", \"Publication 2: 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Research, 2023.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\", \"Publication 3: 'The Genomic Data Commons: A Platform for Precision Medicine Research', Journal of the American Medical Informatics Association, 2016.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Profiling of HIV+ DLBCL', Cancer Genomics\", \"Publication 3: Lee et al., 2019, 'KRAS Alterations in HIV-Related Lymphomas', Oncogene Research\"], ['Gillette, M. A., Satpathy, S., Cao, S., et al. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell, 182(1), 200-225.e35.', 'The Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018;33(4):721-735.e8.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Barretina J, Taylor BS, Sboner A, et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet. 2010 Jul;42(7):715-721.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2016). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 48(6), 607-612.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Wang, Y., et al. Genomic analysis of testicular germ cell tumors in the TCGA dataset. Nature Genetics. 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and clinical relevance of chromosomal aberrations in bladder cancer: a TCGA study. J Natl Cancer Inst. 2016;108(11):djw069.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2016 May;38 Suppl 1:E1674-84.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'KRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Genomic Data Commons Data Portal. TCGA-READ project data.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' by the TARGET Osteosarcoma Working Group\"], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinoma. Cell Rep. 2017.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Genomic Data Commons Data Portal: Liver Hepatocellular Carcinoma (TCGA-LIHC) project.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA-BLCA) data from the Genomic Data Commons'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'McLendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'The Cancer Genome Atlas (TCGA) - Ovarian Serous Cystadenocarcinoma (OV) dataset.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Lung Cancer: Insights from the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2021, 'Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: A CPTAC Study', Nature Genetics.\", \"Publication 3: Lee et al., 2023, 'KRAS Mutations and Amplifications in Pancreatic Cancer', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Characterization of Lung Adenocarcinoma', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Integrative Analysis of Lung Cancer Genomics', Cancer Research.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma in the APOLLO-LUAD project. Journal of Clinical Oncology.', 'Johnson, L. et al. (2023). Comprehensive analysis of KRAS alterations in lung adenocarcinoma. Cancer Research.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Publication 1: Comprehensive molecular profiling of lung cancer in HIV-positive patients, Journal of Thoracic Oncology, 2020.', 'Publication 2: EGFR alterations in HIV-associated lung cancer, Cancer Research, 2021.'], [\"Publication 1: Smith et al., 2021, 'EGFR Alterations in CPTAC-3 Projects', Journal of Genomic Data\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of EGFR in Cancer', Cancer Genomics\", \"Publication 3: Lee et al., 2023, 'EGFR Gain in Various Cancers', Genomic Research\"], [\"Publication 1: Smith et al., 2022, 'EGFR Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Genomic Profiling of Lung Adenocarcinoma: The CDDP_EAGLE-1 Study', Cancer Research.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, et al. The Genomic Data Commons: A Unified Platform for Cancer Genomics Research. Cancer Discov. 2016 Jul;6(7):818-31.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Comprehensive analysis of EGFR alterations in lung cancer. Cancer Research.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Curtis C, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012 Apr 18;486(7403):346-52.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cell Reports, 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'KIT Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency and Impact of KIT Gain in Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], [\"Publication 1: Smith et al., 2020, 'PIK3CA Mutations in Breast Cancer: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Genomic Alterations in Colon Cancer: Insights from the CPTAC-2 Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Ovarian Cancer Genomics: PIK3CA Mutations and Their Clinical Implications', Gynecologic Oncology.\"], ['Reference 1: Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', 'Reference 2: Publication on PIK3CA mutations in metastatic breast cancer from the Genomic Data Commons'], ['Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 4;499(7456):43-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in Osteosarcoma: Implications for Targeted Therapy', Cancer Genomics.\"], ['Gillette, M. A., Satpathy, S., Cao, S., et al. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell, 182(1), 200-225.e35.', 'The Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Oct 9;32(3):405-418.e12.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinoma in the TCGA dataset'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal: TCGA-MESO project.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal - TCGA-KICH project', 'The Cancer Genome Atlas Research Network publications on Kidney Chromophobe'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers in China. Nat Genet. 2019 Apr;51(4):865-874.'], ['Genomic Data Commons Data Portal - TCGA-ACC Project', 'The Cancer Genome Atlas Research Network publications on Adrenocortical Carcinoma'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Campbell, J. D., et al. (2016). 'Comprehensive analysis of lung adenocarcinoma reveals molecular subtypes and therapeutic opportunities.' Nature Communications.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Lung Cancer in HIV-Positive Patients', Journal of Oncology.\", \"Publication 2: Johnson et al., 2021, 'Molecular Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Research.\", \"Publication 3: Lee et al., 2019, 'DDR2 Amplification in Lung Cancer: A Study from the HIV+ Tumor Molecular Characterization Project', Clinical Cancer Genomics.\"], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Head and Neck Squamous Cell Carcinoma', Nature, 2015\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma', Cancer Cell, 2017\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Integrative Analysis of Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics Journal.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Hammerman PS, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['Gillette, M. A., Satpathy, S., Cao, S., et al. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell, 182(1), 200-225.e35.', 'The Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Chin L, et al. Genomic analyses of lung adenocarcinoma. N Engl J Med. 2014;371:1693-1703.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'DDR2 Alterations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in DDR2 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of DDR2 in CPTAC-3 Projects', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'DDR2 Gain in Cancer: Insights from CPTAC-3', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Hammerman PS, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Research.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Collisson EA, Campbell JD, Brooks AN, et al. Comprehensive molecular profiling of lung adenocarcinoma: The Cancer Genome Atlas Research Network. Nature. 2014 Jul 31;511(7511):543-50.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Their Clinical Implications in Lung Adenocarcinoma: Findings from the CDDP_EAGLE-1 Study', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Clinical Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Lung Cancer in HIV-Positive Patients', Journal of Oncology.\", \"Publication 2: Johnson et al., 2021, 'Molecular Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Research.\", \"Publication 3: Lee et al., 2019, 'NOTCH1 Amplification in Lung Cancer: A Study from the Genomic Data Commons', Clinical Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Microsatellite Instability in Cancer: A Comprehensive Review', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Characterization of Microsatellite Instability in Cancer', Nature Genetics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 4;8(1):15180.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', \"Publication: 'Genomic landscape of metastatic breast cancer: insights from the Metastatic Breast Cancer Project', Journal of Clinical Oncology, 2023\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Genomic Data Commons Data Portal - TCGA-COAD', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, et al. Genomic landscape of bladder cancer. Nat Genet. 2017 Nov;49(11):1633-1641.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cortes-Ciriano I, Lee S, Park WY, Kim TM, Park PJ. A molecular portrait of microsatellite instability across multiple cancers. Nat Commun. 2017 Dec 4;8(1):15180.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao, H., et al. (2013). The landscape of somatic copy-number alteration across human cancers. Nature. 497, 415421.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cell Reports, 2018\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL)'], ['Smith, J. et al. (2022). Comprehensive proteogenomic characterization of lung adenocarcinoma. Nature.', 'Johnson, L. et al. (2023). Insights into lung adenocarcinoma through proteogenomics. Cancer Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['TCGA Research Network: Comprehensive molecular characterization of esophageal carcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program: https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of NT5C2 Alterations in Cancer Models', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Pediatric ALL', Pediatric Blood & Cancer\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in acute lymphoblastic leukemia: Insights from the MP2PRT-ALL project. Journal of Hematology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling in ALL: NT5C2 and treatment response. Leukemia Research.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cao, W., et al. (2016). Integrative Analysis of MTHFR Gene in Gastric Cancer Using TCGA Data. PLoS ONE 11(3): e0152330.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Somatic Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Comprehensive Analysis of Genomic Data in the HCMI-CMDC Project', Genomics and Cancer.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer (CGCI-HTMCP-CC) dataset'], ['APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project data in the Genomic Data Commons'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Publication 1: Comprehensive Molecular Characterization of Intrahepatic and Extrahepatic Cholangiocarcinomas, The Cancer Genome Atlas Research Network.', 'Publication 2: Integrated Genomic Characterization of Cholangiocarcinoma, Nature, 2017.'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma. Nature, 2017.', 'Publication 2: Integrated genomic characterization of oesophageal carcinoma. Nature, 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive genomic characterization of uterine carcinosarcoma in the TCGA-UCS project.', 'Publication 2: Somatic alterations in uterine carcinosarcoma: Insights from the TCGA-UCS dataset.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Zhao, L., et al. (2016). Comprehensive characterization of genomic alterations in adrenocortical carcinoma. Journal of Clinical Oncology.', 'Assi, G., et al. (2014). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Grossman RL, Heath AP, Ferretti V, et al. Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016 Sep 22;375(12):1109-1112.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas (TCGA) Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-525.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Cancer Genome Atlas Research Network. The Molecular Taxonomy of Bladder Cancer: A Comprehensive Study of 412 Bladder Tumors. Cell. 2017.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang TW, Choi C, Kim KK, Kim MS, Nam KI, Kang SB, Kim HJ, Kim NG, Yoo NJ, Lee SH. GSTP1 promoter methylation and polymorphisms: association with non-small cell lung cancer risk and prognosis. J Cancer Res Clin Oncol. 2010 Apr;136(4):589-98.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Publication 1: Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Publication 2: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.'], ['Publication 1: Smith et al. (2022) - Analysis of GSTP1 in Cancer Models, Journal of Cancer Research.', 'Publication 2: Johnson et al. (2023) - Genomic Alterations in HCMI-CMDC, Cancer Genomics.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Brain, Head and Neck, Kidney, Lung, Pancreas, and Uterus Cancers' - CPTAC Consortium\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer (CGCI-HTMCP-CC)'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - TARGET Consortium\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of Lymphomas in HIV-Positive Patients.' Cancer Research Journal.\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Nature, 2016'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018 Apr 5;173(2):400-416.e11.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Kim J, Bowlby R, Mungall AJ, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive analysis of uveal melanoma. JNCI: Journal of the National Cancer Institute, 109(1).', 'Robertson, A. G., et al. (2017). Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell, 32(2), 204-220.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cheng DT, et al. Comprehensive genomic profiling of sarcomas to identify potential targetable mutations. J Clin Oncol. 2015;33(15_suppl):11054-11054.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['The Cancer Genome Atlas Research Network. (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161(7), 1681-1696.', 'Grossman, R. L., et al. (2016). Toward a Shared Vision for Cancer Genomic Data. New England Journal of Medicine, 375(12), 1109-1112.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Liu, Y., Sethi, N. S., Hinoue, T., et al. (2018). Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell, 33(4), 721-735.e8.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6(269), pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang TW, Choi C, Kim KK, Kim MS, Nam KI, Kang SB, Kim HJ, Kim NG, Yoo NJ, Lee SH. GSTP1 promoter methylation and polymorphism increase the risk of gastric cancer. Cancer. 2010 Jan 1;116(1):394-402.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature 2011.', 'Genomic Data Commons Data Portal: TCGA-OV project data.'], ['Smith, J. et al. (2020). Genomic alterations in lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2021). Comprehensive genomic profiling of lung adenocarcinoma. Cancer Research.', 'Johnson, L. et al. (2019). Somatic mutations in lung cancer: A TCGA study. Nature Genetics.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'ABCB1 Deletions in Lung Cancer: A Comprehensive Study', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'HRAS Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['TARGET Osteosarcoma (TARGET-OS) dataset, Genomic Data Commons'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of HIV-Related Lymphomas', Cancer Research Journal\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Research.'], ['TCGA-DLBC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of diffuse large B-cell lymphoma' - Nature, 2015\"], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Cancer Genome Atlas (TCGA) Program. National Cancer Institute. https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrative Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program (TCGA) - Liver Hepatocellular Carcinoma (LIHC) dataset.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2016). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 48(4), 427-437.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cheng DT, et al. Comprehensive detection of genomic alterations in lung cancer using next-generation sequencing. Clin Cancer Res. 2015 Apr 1;21(7):1611-8.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Nature. 2015 Jan 29;517(7536):576-82. doi: 10.1038/nature14105.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Analysis of Genetic Alterations in Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Comprehensive Genomic Profiling of Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['Smith, J. et al. (2021). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Doe, A. et al. (2022). Molecular profiling of Wilms Tumor: A comprehensive study. Cancer Genomics.', 'Brown, L. et al. (2023). Advances in Wilms Tumor research: The role of genomic data. Pediatric Cancer Research.'], ['https://gdc.cancer.gov/about-data/publications/CPTAC-3'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'The Role of SMO Gain in Cervical Cancer Pathogenesis', Oncogene.\"], ['TARGET Osteosarcoma (TARGET-OS) dataset, Genomic Data Commons'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Alterations in HIV-Positive DLBCL Patients.' Cancer Research Journal.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Research.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Diffuse Large B-cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lymphoid Neoplasms', Cancer Research Journal\"], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2018.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018 Apr 5;173(2):400-416.e11.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Pancreatic Adenocarcinoma in TCGA-PAAD', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Analysis of SMO Alterations in Pancreatic Cancer', Pancreatic Cancer Journal.\"], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers from the Genomic Data Commons. Nature, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project data.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular profiling of lung adenocarcinoma. Nature, 2014.', 'Genomic Data Commons Data Portal: TCGA-LUAD project data.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Bell, D., et al. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.', 'The Cancer Genome Atlas Research Network. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Brain, Head and Neck, Kidney, Lung, Pancreas, and Uterus Cancers' - CPTAC Consortium\"], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 1234.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017.', 'Publication 2: The Genomic Data Commons: A Platform for Cancer Genomics Research, Cell, 2016.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: Insights from the TARGET-OS Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'EGFR Alterations in Pediatric Osteosarcoma', Pediatric Oncology Journal.\"], ['Publication 1: Comprehensive Molecular Characterization of Cholangiocarcinoma, TCGA Network', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, TCGA Network'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['The Cancer Genome Atlas Research Network. (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine, 368(22), 2059-2074.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2018). Comprehensive genomic characterization of uterine corpus endometrial carcinoma in Chinese patients. Nature Communications, 9(1), 1-10.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2021, 'EGFR Amplification in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Genomic Data Commons Analysis of EGFR in Cancer', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of head and neck squamous cell carcinomas' - Nature, 2020\", \"Publication: 'Integrated proteogenomic characterization of human high-grade serous ovarian cancer' - Cell, 2019\"], [\"Publication 1: Smith et al., 2022, 'EGFR Amplification in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Oncology Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: A Comprehensive Analysis', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'EGFR Amplification in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Oncology.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Research Journal.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Genomic Characterization of Osteosarcoma' - Journal of Clinical Oncology\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Comprehensive analysis of EGFR alterations in lung cancer. Cancer Research.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016.', 'Davis CF, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Chudasama P, et al. Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat Commun. 2018;9(1):144.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine. 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a contemporary review of diagnostic and therapeutic implications. Virchows Archiv. 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of EGFR in bladder cancer. Oncotarget, 10(4), 431-440.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Zack TI, Schumacher SE, Carter SL, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013 Oct;45(10):1134-40.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer. 2015;121(12):1969-78.'], [\"Campbell, J. D., et al. (2016). 'Comprehensive analysis of lung adenocarcinoma reveals molecular subtypes and therapeutic opportunities.' Nature Communications.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.'], [\"Publication 1: Smith et al., 2022, 'EGFR Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Characterization of Cancer Models', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-404.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['Smith, J. et al. (2022). Molecular Profiling in Wilms Tumor: Insights from the MP2PRT-WT Project. Journal of Pediatric Oncology.', 'Doe, A. et al. (2023). Genomic Alterations in Wilms Tumor: A Comprehensive Analysis. Cancer Genomics & Proteomics.'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - TARGET Consortium\"], [\"Publication 1: Smith et al., 2020, 'EGFR Alterations in HIV+ DLBCL', Journal of Cancer Research\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of DLBCL in HIV+ Patients', Cancer Genomics\", \"Publication 3: Lee et al., 2022, 'Genomic Insights into HIV+ DLBCL', Oncogene\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A unified platform for cancer genomics research, Nature, 2016'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Chudasama P, et al. Integrative genomic and transcriptomic analysis of leiomyosarcoma. Nat Commun. 2018.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers from the Genomic Data Commons. Cancer Res. 2019 Feb 1;79(3):662-674.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 25;371(23):2189-2199.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of EGFR in bladder cancer. Journal of Clinical Oncology, 37(15_suppl), e16000-e16000.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6(269), pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang TW, et al. Genomic characterization of gastric adenocarcinoma in the TCGA database: implications for precision medicine. BMC Cancer. 2017;17:494.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer. 2015 Jun 1;121(11):1969-78.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cheng DT, Mitchell TN, Zehir A, et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. J Mol Diagn. 2015 May;17(3):251-64.'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-LC Project', \"Publication: 'Comprehensive Molecular Characterization of Lung Cancer in HIV-Positive Patients' - Journal of Cancer Research, 2022\"], [\"Chen, X., et al. (2014). 'Targeting MTOR for cancer therapy.' Cancer Research.\", \"Smith, J., et al. (2016). 'Genomic alterations in osteosarcoma: The role of MTOR.' Journal of Clinical Oncology.\"], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cheng DT, Mitchell TN, Zehir A, et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. J Mol Diagn. 2015 May;17(3):251-64.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) project.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network, NEJM, 2016.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, NEJM, 2013.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Lung Cancer in HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Alterations in HIV-Associated Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2019, 'Comprehensive Genomic Profiling of Lung Cancer in HIV-Positive Individuals', Genomics and Cancer.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['CPTAC-3 Brain Study', 'CPTAC-3 Head and Neck Study', 'CPTAC-3 Kidney Study', 'CPTAC-3 Lung Study', 'CPTAC-3 Pancreas Study', 'CPTAC-3 Uterus Study'], ['Publication 1: Smith, J. et al. (2022). Comprehensive Genomic Characterization of the Human Cancer Model Initiative. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Insights into Somatic Alterations in Cancer Models. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Genomic Data Commons: A Resource for Cancer Research. Genomics and Cancer.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['The Cancer Genome Atlas Research Network. (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161(7), 1681-1696.', 'Grossman, R. L., et al. (2016). Toward a Shared Vision for Cancer Genomic Data. New England Journal of Medicine, 375(12), 1109-1112.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Data'], ['The Cancer Genome Atlas (TCGA) Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Analysis of Genetic Alterations in Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette, M. A., Satpathy, S., Cao, S., et al. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell, 182(1), 200-225.e35.', 'The Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951821/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program (TCGA) - Liver Hepatocellular Carcinoma (LIHC) dataset.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nature Reviews Urology, 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013;45(10):1127-1133.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic Data Commons: A Unified Platform for Cancer Genomics Data. Nucleic Acids Research, 2019.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, et al. Genomic Landscape of Lung Adenocarcinoma in East Asians. Nat Genet. 2016 Feb;48(2):178-84.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Genomic Landscape and Phenotypic Profiles of Ovarian Serous Cystadenocarcinoma. Cell. 2019 Apr 4;177(1):149-166.e10.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of the Human Cancer Model Initiative', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14;374(2):135-145.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Publication 1: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Publication 2: Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014.', 'Publication 3: The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Somatic Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of VHL in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017', 'Publication 2: The Genomic Landscape of Cervical Cancer in HIV+ Patients, Journal of Clinical Oncology, 2018'], ['Genomic Data Commons Data Portal - TARGET-OS Project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543-550.'], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma, TCGA, 2015', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Diffuse Large B-cell Lymphoma, Nature, 2018'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. J Clin Invest. 2018;128(12):5518-5528.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network', 'Publication 2: Integrated Genomic Characterization of Uterine Carcinosarcoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic analysis of testicular germ cell tumors in the TCGA project. Nature Genetics, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhang W, Edwards A, Flemington EK, Zhang K. The genomic landscape of viral oncogenesis in cervical cancer. Cancer Res. 2018 Apr 1;78(7):1896-1908.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Genomic characterization of gastric adenocarcinoma in the Cancer Genome Atlas. Oncotarget. 2017 Jan 10;8(2):3924-3935.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Campbell, J. D., et al. (2016). 'Comprehensive analysis of lung adenocarcinoma reveals molecular subtypes and therapeutic opportunities.' Nature Communications.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'MET Alterations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'MET Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Study', Cancer Research.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of human lung adenocarcinoma. Cell. 2019;177(3):723-745.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, Cha SW, Aiyetan P, Woo S, Tian Y, Gritsenko MA, Clauss TR, Choi C, Monroe ME, Thomas S, Nie S, Wu C, Moore RJ, Yu KH, Tabb DL, Fenyo D, Bafna V, Wang Y, Rodriguez H, Boja ES, Hiltke T, Rivers RC, Sokoll L, Zhu H, Shih IM, Cope L, Pandey A, Zhang B, Snyder MP, Levine DA, Smith RD, Chan DW, Rodland KD. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape of bladder cancer reveals new insights into clonal evolution and heterogeneity. Nature Reviews Urology. 2017.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in ERBB3 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of ERBB3 in CPTAC-3 Projects', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'ERBB3 Gain in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of ERBB3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'ERBB3 Alterations in Human Cancer Models', Cancer Genomics.\"], ['Genomic Data Commons - TARGET-OS project data'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of MLH1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'MLH1 Alterations in Human Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer (CGCI-HTMCP-CC) dataset'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS-2018'], ['https://gdc.cancer.gov/about-data/publications/CGCI-HTMCP-DLBCL'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Data Commons Analysis of Lung Cancer', Cancer Genomics.\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'The Cancer Genome Atlas Program (TCGA) - Liver Hepatocellular Carcinoma (LIHC) dataset.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: a unified platform for cancer genomics data. Nature Biotechnology, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018 Apr 5;173(2):400-416.e11.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, et al. Comprehensive Genomic Characterization of Bladder Urothelial Carcinoma. Cell. 2019 Oct 17;179(3):684-700.e20.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom DI, Zairis S, Abate F, Liu Z, Elliott O, Shin YJ, Lee JK, Lee IH, Park WY, Eoli M, Blumberg AJ, Lasorella A, Nam DH, Finocchiaro G, Iavarone A, Rabadan R. Clonal evolution of glioblastoma under therapy. Nat Genet. 2016 Jul;48(7):768-76.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and analysis of prognostic molecular factors in bladder urothelial carcinoma. Oncotarget. 2016;7(46):75831-75841.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of MLH1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Somatic Alterations in MLH1 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Heterozygous Deletions in Cancer Genomics', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-404.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric Osteosarcoma', Pediatric Oncology Journal.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV-Related Lymphomas', Cancer Research Journal\"], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179(4):964-983.e31.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: The Genomic Data Commons: A unified platform for cancer genomics research, Grossman et al., 2016.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['Genomic Data Commons, TCGA-THYM project data', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors in The Cancer Genome Atlas, Journal of Clinical Oncology'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS project data.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Testicular Germ Cell Tumors', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2021, 'Somatic Alterations in Testicular Germ Cell Tumors', Nature Genetics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Analysis of Testicular Germ Cell Tumors', Cancer Research.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics Journal.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018;50(4):581-589.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017 Apr 10;31(4):411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget. 2016;7(6): 6552-6565.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang, H., et al. (2013). Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell, 166(3), 755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of SLCO1B1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'SLCO1B1 Alterations in Human Cancer Models', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - TCGA-BRCA project', 'Publication: Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Publication 1: Smith, J. et al. (2022). Molecular Profiling in Wilms Tumor: Insights from the MP2PRT-WT Project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in Wilms Tumor: A Comprehensive Analysis. Cancer Genomics & Proteomics.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Characterization of Cancer Driver Genes and Mutations in the Cancer Genome Atlas' - Nature, 2020\", \"Publication: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia' - New England Journal of Medicine, 2013\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Genomic Data Commons Data Portal - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project, Genomic Data Commons'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Genomic Data Commons Data Portal - TCGA-READ project'], ['Genomic Data Commons, TCGA-CHOL project data'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['TCGA-KICH project data from the Genomic Data Commons', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - TCGA-PAAD', \"Publication: Cancer Genome Atlas Research Network. 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.' Cancer Cell, 2017.\"], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature, 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Liu, J., et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell, 2018.'], ['Genomic Data Commons, TCGA-KIRP project data'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/acc_2016'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-TGCT'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Publication: The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell, 2015.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - TCGA-COAD', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Genomic Data Commons Data Portal - TCGA-STAD Project', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Gross AM, et al. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat Genet. 2014 Sep;46(9):939-43.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25;372(26):2481-98.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA-OV project data from the Genomic Data Commons', 'Publication: The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Campbell, J. D., et al. (2016). 'Comprehensive analysis of lung adenocarcinoma reveals molecular subtypes and therapeutic opportunities.' Nature Communications.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Lung Cancer in HIV-Positive Patients', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2021, 'MET Amplification in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Research.\", \"Publication 3: Lee et al., 2019, 'Molecular Alterations in HIV-Associated Lung Cancer', Nature Medicine.\"], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma', The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'MET Amplification in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179(4):964-983.e31.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Adenocarcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179(4):964-983.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Brain, Head and Neck, Kidney, Lung, Pancreas, and Uterus Cancers' - CPTAC Consortium\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], ['Gillette, M. A., Satpathy, S., Cao, S., et al. (2020). Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell, 182(1), 200-225.e35.', 'The Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['TCGA-LIHC project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma', Cell, 2017\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Wang, Y., et al. Genomic data commons: a unified platform for cancer genomics data. Nature Biotechnology. 2016.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['TCGA-CESC project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., et al. (2015). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 47(10), 1121-1130.'], ['TCGA Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal. TCGA-BLCA project data.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal: TCGA-UCEC project data.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015; 372:2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['TCGA Research Network: Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015.', 'Genomic Data Commons Data Portal: TCGA-HNSC project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Genomic Characterization of Osteosarcoma' in Nature Communications\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of PTEN Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'PTEN Gain in Human Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Wilms Tumor: PTEN Alterations and Treatment Response', Cancer Genomics.\"], [\"Smith et al., 2021, 'Comprehensive Genomic Characterization of Lung Adenocarcinoma', Journal of Thoracic Oncology\", \"Johnson et al., 2022, 'Integrative Analysis of Genomic Data in Lung Cancer', Cancer Research\"], ['https://gdc.cancer.gov/about-data/publications/TARGET-CCSK', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer (CGCI-HTMCP-LC)'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017.', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Nature Communications, 2016.'], ['TARGET Osteosarcoma (TARGET-OS) dataset from the Genomic Data Commons'], ['Genomic Data Commons Data Portal - TARGET-ALL-P2 Project', \"Publication: 'Comprehensive Genomic Characterization of Pediatric Acute Lymphoblastic Leukemia' in Nature Genetics\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Genomics.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'PTEN Alterations in Hematologic Malignancies', Blood Cancer Journal\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.e9.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic and molecular characterization of PTEN in bladder cancer: A comprehensive analysis of the Cancer Genome Atlas (TCGA) dataset. Journal of Clinical Oncology, 37(15_suppl), e16000-e16000.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ERBB2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Alterations in Human Cancer Models', Cancer Genomics.\"], ['Publication 1: Smith, J. et al. (2021). Molecular Profiling of Wilms Tumor: Insights from the MP2PRT-WT Project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2022). Genomic Alterations in Wilms Tumor: A Comprehensive Analysis. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). ERBB2 Alterations in Pediatric Tumors: Implications for Targeted Therapy. Pediatric Cancer Research.'], ['CPTAC-3 Project Data, Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma', The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Cancer in HIV+ Patients, Journal of Oncology, 2022.', 'Publication 2: Genomic Alterations in Lung Cancer from HIV+ Individuals, Cancer Research, 2023.'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - TARGET Consortium\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-DLBCL Project'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of human lung adenocarcinoma. Cell. 2019;177(3):723-745.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'ERBB2 Alterations in ALL', Cancer Genomics\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Kim J, Bowlby R, Mungall AJ, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.'], ['PubMed ID: 28874638', 'PubMed ID: 29432254'], ['TCGA Research Network: Comprehensive molecular profiling of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers in the Cancer Genome Atlas. Nature Genetics, 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology. 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney C, McConkey DJ. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014 Feb 10;25(2):152-65.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, et al. The Genomic Landscape of Lung Squamous Cell Carcinoma and Its Impact on Therapy. Nature Reviews Cancer. 2017.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sato Y, Yoshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013 Aug;45(8):860-7.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'ERBB2 Alterations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project', \"Publication: 'Comprehensive molecular characterization of cervical cancer' - Nature, 2017\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2018\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Genomic Data Commons Data Portal - TCGA-READ project'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project Data.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Nature Reviews Gastroenterology & Hepatology, 2019.'], ['Publication 1: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma, TCGA Research Network', 'Publication 2: Integrated Genomic Characterization of Adrenocortical Carcinoma, Nature Genetics'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-TGCT'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., ... & Perou, C. M. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6(269), pl1.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015 Apr 1;75(7):1783-93.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Integrative Analysis of Lung Adenocarcinoma', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research.\"], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Oct 9;32(3):405-418.e12.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal', 'TCGA-CHOL project publications'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program: https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Genomic Data Commons Data Portal, TCGA-TGCT project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. TCGA-STAD project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015; 372:2481-2498.', 'Ceccarelli, M., et al. (2016). Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell, 164(3), 550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/OV-2011'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Landscape of Acute Lymphoblastic Leukemia in the TARGET-ALL-P3 Project'. Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Mutational Analysis in Pediatric Acute Lymphoblastic Leukemia'. Leukemia Research.\"], ['https://gdc.cancer.gov/about-data/publications/target-aml'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer (CGCI-HTMCP-CC) dataset'], ['TARGET Osteosarcoma (TARGET-OS) dataset from the Genomic Data Commons'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Research.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018 Apr 5;173(2):400-416.e11.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers from Patients of Asian and Western Origins. Science. 2019 Jan 4;364(6439):80-84.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Genomic characterization of gastric adenocarcinoma in the TCGA database: implications for precision medicine. BMC Cancer. 2017;17:494.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. TCGA-LUAD project data.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Kandoth C, et al. Nature. 2013; 497(7447): 67-73.', 'The Cancer Genome Atlas Research Network. Nature. 2011; 474(7353): 609-615.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'KRAS Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-404.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2021, 'Molecular Profiling in Wilms Tumor', Journal of Pediatric Oncology\", \"Publication 2: Johnson et al., 2022, 'Genomic Alterations in Wilms Tumor', Cancer Research Journal\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], ['TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project Data.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan, W. M., Spellman, P. T., Ricketts, C. J., et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-LIHC Project'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['https://gdc.cancer.gov/about-data/publications/acc_2016'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang, H., et al. (2013). Genomic landscape and phenotypic profiles of ovarian serous cystadenocarcinoma. BMC Medical Genomics, 6, 11.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ATM Gene Alterations in Cancer', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'ATM Deletions in Cancer Models: Frequency and Implications', Oncogene.\"], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine.', 'Publication 2: Integrated Genomic Characterization of Head and Neck Squamous Cell Carcinoma. The Cancer Genome Atlas Network. Nature.', 'Publication 3: Comprehensive Molecular Profiling of Lung Adenocarcinoma. The Cancer Genome Atlas Research Network. Nature.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179(4):964-983.e31.'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.e9.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], ['Genomic Data Commons Data Portal - TCGA-READ project'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cell. 2017 Jul 27;170(3):564-577.e18.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, Kidney Renal Papillary Cell Carcinoma (TCGA-KIRP) project.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Liu, Y., et al. (2018). Comprehensive genomic characterization of cervical squamous cell carcinoma and endocervical adenocarcinoma. Cell, 173(3), 683-699.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. New England Journal of Medicine, 2015.', 'Ceccarelli, M., et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell, 2016.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2016 Feb 11;536(7615):400-404.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research.\"], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018 Apr 5;173(2):400-416.e11.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu; Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13. doi: 10.1016/j.ccell.2017.07.007. PMID: 28810144; PMCID: PMC5554569.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. PMID: 26909576; PMCID: PMC4893174.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Liu, Y., et al. (2018). Comprehensive genomic characterization of cervical squamous cell carcinoma and endocervical adenocarcinoma. Cell, 173(3), 540-556.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. TCGA-STAD project data.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA-OV project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'CTNNB1 Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of HIV+ Cervical Cancer: Findings from the Genomic Data Commons.' Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS-2020', 'https://gdc.cancer.gov/datasets/osteosarcoma'], [\"Publication 1: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Clinical Oncology, 2020.\", \"Publication 2: 'Genomic Alterations in HIV-Associated Lymphomas', Blood Advances, 2021.\"], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of human lung adenocarcinoma. Cell. 2019;177(3):723-745.'], ['TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Wright GW, et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 2020.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Nature Reviews Gastroenterology & Hepatology, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of testicular germ cell tumors. Cell Reports, 2019.'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Publication: The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25;372(26):2481-98.'], ['Kandoth C, et al. Nature. 2013; 497(7447): 67-73.', 'The Cancer Genome Atlas Research Network. Nature. 2011; 474(7353): 609-615.'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-LC Project', \"Publication: 'Comprehensive molecular characterization of lung adenocarcinoma' in Nature, 2014\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/projects/CGCI-HTMCP-CC'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2018\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Head and Neck Squamous Cell Carcinoma', Nature, 2015\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma', Cancer Cell, 2017\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PIK3CA Amplification in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Amplification in Human Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Exceptional Responders: A Comprehensive Analysis', Cancer Research.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of SMO Amplification in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Analysis of SMO Amplification in the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency and Impact of SMO Amplification in Human Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhao H, et al. Genomic and molecular profiling of a large cohort of kidney renal clear cell carcinoma. J Clin Oncol. 2016;34(15_suppl):4501-4501.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Brain, Head and Neck, Kidney, Lung, Pancreas, and Uterus Cancers' - CPTAC Consortium\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Integrative Analysis of Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency and Impact of SMO Amplification in Lung Cancer', Oncogene.\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-LC Project', \"Publication: 'Comprehensive molecular characterization of lung adenocarcinoma' in Nature, 2014\"], ['TARGET Osteosarcoma (TARGET-OS) dataset from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of osteosarcoma and its clinical implications' - Journal of Clinical Oncology\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Choi H, et al. Genomic landscape of SMO amplification in sarcomas. J Clin Oncol. 2018;36(15_suppl):11515-11515.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Testicular germ cell tumors: Pathogenesis, diagnosis and treatment. Nature Reviews Urology. 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bell, D., et al. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.', 'Cancer Genome Atlas Research Network. (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474(7353), 609-615.'], ['Genomic Data Commons, NCI Cancer Model Development for the Human Cancer Model Initiative HCMI-CMDC project'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Cancer in the HIV+ Population, Journal of Oncology, 2022.', 'Publication 2: Genomic Alterations in Lung Cancer Among HIV+ Patients, Cancer Research, 2023.'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017.', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Nature Communications, 2016.'], ['Genomic Data Commons Data Portal - TARGET-OS Project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Oct 9;32(3):405-418.e12.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'POLD1 Alterations in Lung Cancer: A Comprehensive Study', Genomic Data Commons Reports.\"], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Chen X, et al. (2014). Targeting the p53 pathway in osteosarcoma. Nature Reviews Cancer.', 'Kansara M, et al. (2014). Translational biology of osteosarcoma. Nature Reviews Cancer.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: TP53 Alterations and Treatment Response', Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS-2020', 'https://gdc.cancer.gov/datasets/osteosarcoma'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of HIV+ DLBCL. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). TP53 alterations in HIV-related lymphomas. Oncogene Research.'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of human lung adenocarcinoma. Cell. 2019;177(3):723-745.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Genomic Data Commons Data Portal, accessed October 2023.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Pathology, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and analysis of TP53 mutations in bladder cancer. Oncotarget. 2016 Apr 5;7(14):18076-18086.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of TP53 Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.', 'Zhao H, Ljungberg B, Grankvist K, et al. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med. 2006;3(1):e13.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular characterization of cervical cancer in HIV-positive patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Somatic mutations in cervical cancer: A comprehensive analysis.' Genomic Data Commons Reports.\"], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma'], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: TP53 Alterations in HIV-Associated Lymphomas, Genomic Data Commons'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Clinical Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Nature, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['Genomic Data Commons, TCGA-THYM project data'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Zhang H, et al. The genomic landscape of acute myeloid leukemia. Nat Genet. 2012 Mar 11;44(3):251-9.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Pathology. 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Phenotypic Profiles of TP53-Mutated Cancers. Cell Reports. 2018 Apr 3;23(1):213-226.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of TP53 mutations in bladder cancer. Nature Communications, 10(1), 4857.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and analysis of prognostic molecular factors in bladder urothelial carcinoma. Oncotarget. 2016;7(46):75831-75841.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Mutational Landscape of Exceptional Responders in the EXCEPTIONAL_RESPONDERS-ER Project', Nature Genetics.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'DICER1 Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell. 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project.' Journal of Cancer Research.\", \"Publication 2: Johnson, L. et al. (2021). 'Molecular Characterization of Cervical Cancer in HIV+ Patients.' Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2019). 'DICER1 Alterations in Cervical Cancer: A Study from the Genomic Data Commons.' Oncogene.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - TARGET Consortium\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of DLBCL in HIV+ Patients', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Alterations in HIV-associated DLBCL', Cancer Research\", \"Publication 3: Lee et al., 2019, 'HIV+ DLBCL Genomic Data Analysis', Oncogene\"], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of human lung adenocarcinoma. Cell. 2019;177(3):723-745.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Integrated Genomic and Molecular Characterization of Cervical Cancer. Nature. 2017.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Publication 1: TCGA Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Publication 2: Smith et al. Genomic alterations in testicular germ cell tumors: A TCGA study. Journal of Clinical Oncology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E167-74.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Johnson, L. et al. (2023). 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons'. Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2023). 'Comprehensive Analysis of Somatic Mutations in the HCMI-CMDC'. Genomics and Cancer.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell, 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell, 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - TARGET Consortium\"], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Johnson, L. et al. (2021). Somatic mutations in lymphoid neoplasms. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2022). Comprehensive analysis of DICER1 mutations in lymphomas. Genomic Medicine.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive Molecular Characterization of Cholangiocarcinoma, The Cancer Genome Atlas Research Network, 2017.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, 2013.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project data.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Adrenocortical Carcinoma', The Cancer Genome Atlas Research Network, 2016.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', The Cancer Genome Atlas Research Network, 2013.\"], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689211/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-339.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA-BLCA) dataset in the Genomic Data Commons'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal: Uterine Corpus Endometrial Carcinoma (TCGA-UCEC) dataset.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015; 372:2481-2498.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Cancer Genome Atlas (TCGA) - Lung Squamous Cell Carcinoma (LUSC) dataset.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 4;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics Journal.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Lung Cancer in HIV-Positive Patients', Journal of Oncology.\", \"Publication 2: Johnson et al., 2021, 'Molecular Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Research.\"], ['Chen X, et al. (2014). Targeting genomic alterations in cancer. Nature Reviews Cancer.', 'Kansara M, et al. (2014). Translational biology of osteosarcoma. Nature Reviews Cancer.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Litchfield, K., et al. Identification of four new susceptibility loci for testicular germ cell tumour. Nature Communications. 2015.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., et al. (2019). Genomic Analysis of BRAF in Bladder Cancer: A Comprehensive Study of the TCGA Data. Journal of Clinical Oncology, 37(15_suppl), e16000-e16000.'], [\"Ceccarelli, M., et al. (2016). 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.' Cell, 164(3), 550-563.\", \"Cancer Genome Atlas Research Network. (2015). 'Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.' New England Journal of Medicine, 372(26), 2481-2498.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Brennan, C. W., et al. (2013). The somatic genomic landscape of glioblastoma. Cell, 155(2), 462-477.', 'Verhaak, R. G., et al. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17(1), 98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Kandoth C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Bell D, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Molecular Profiling in Wilms Tumor: Insights from the MP2PRT-WT Project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in Wilms Tumor: A Comprehensive Analysis. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). BRAF Alterations in Pediatric Renal Tumors: Implications for Targeted Therapy. Pediatric Cancer Research.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-LC Project', \"Publication: 'Comprehensive molecular characterization of lung adenocarcinoma' in Nature, 2014\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'BRAF Mutations in Pediatric Osteosarcoma', Pediatric Oncology Journal.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Profiling of HIV-Positive Lymphomas.' Cancer Research Journal.\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], ['TCGA Research Network. Comprehensive genomic characterization of diffuse large B-cell lymphoma. Cell Reports, 2018.', 'Wright, G. et al. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences, 2003.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Liu, Y., Sethi, N. S., Hinoue, T., et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33, 721735.e8 (2018).'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu; Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13. doi: 10.1016/j.ccell.2017.07.007. PMID: 28810144; PMCID: PMC5554564.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. PMID: 26909576; PMCID: PMC4893174.'], ['Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Litchfield, K., et al. Identification of four new susceptibility loci for testicular germ cell tumour. Nature Communications. 2015.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cancer Genome Atlas Research Network. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6(269), pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], [\"Ceccarelli, M., et al. (2016). 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.' Cell, 164(3), 550-563.\", \"Cancer Genome Atlas Research Network. (2015). 'Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.' New England Journal of Medicine, 372(26), 2481-2498.\"], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Lung Cancer: A Study of the CDDP_EAGLE-1 Cohort', Oncogene.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cell Reports, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543-550.'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the Genomic Data Commons'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Liu, J., et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell, 2018.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-525.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E1665-78.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Genomic Data Commons, Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project, PIK3CA E542K mutation frequency data.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma, Nature, 2013.', 'Publication 3: Comprehensive molecular profiling of lung adenocarcinoma, Nature, 2014.'], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas (TCGA) - Sarcoma (SARC) Project Data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer. 2015 Jun 1;121(11):1969-78.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature 2011.', 'Genomic Data Commons Data Portal: TCGA-OV project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-525.'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of the Human Cancer Model Initiative', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Publication 1: Comprehensive Molecular Characterization of Head and Neck Squamous Cell Carcinomas, Nature, 2015.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of Lung Cancer in HIV+ Patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'Somatic Mutations in Lung Cancer: A Study from the Genomic Data Commons.' Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer', Genomic Data Commons Reports.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Alterations in HIV-Related Lymphomas.' Cancer Research Journal.\", \"Publication 3: Lee, R. et al. (2022). 'Somatic Mutations in HIV-Positive Lymphomas.' Oncogene.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA database'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Waddell, N., et al. (2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518(7540), 495-501.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-LIHC project data.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Pathology. 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.', 'The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['TCGA Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cancer Genome Atlas Research Network. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of Genetic Alterations in Cancer Models', Cancer Genomics.\"], ['Genomic Data Commons, Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project CMI-MBC project dataset'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Catenacci DV, et al. Targeting the FGFR pathway in gastric cancer. Expert Opin Investig Drugs. 2015 Mar;24(3):393-410.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'CHEK2 Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'CHEK2 Alterations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'CHEK2 Alterations in Cervical Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['TARGET Osteosarcoma (TARGET-OS) dataset from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - Nature Communications\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Research.'], ['Genomic Data Commons Data Portal - TCGA-READ project'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu, Y., Sethi, N. S., Hinoue, T., et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Chromophobe Renal Cell Carcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-KICH Project.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program (TCGA) - Liver Hepatocellular Carcinoma (LIHC) dataset.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a contemporary review of diagnostic and prognostic biomarkers. Genes, Chromosomes & Cancer, 2019.'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Publication: The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 2014'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of FLT3 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'FLT3 Alterations in Human Cancer Models: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Molecular Profiling in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Diffuse Large B-Cell Lymphoma in HIV+ Patients', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Alterations in HIV-Associated Lymphomas', Cancer Research Journal\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA dataset'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['National Cancer Institute Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network publications on Uterine Carcinosarcoma'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Publication: The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], [\"The Cancer Genome Atlas Research Network. 'Comprehensive molecular characterization of human colon and rectal cancer.' Nature 487.7407 (2012): 330-337.\", 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-OV', 'https://portal.gdc.cancer.gov/projects/TCGA-OV'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179(4):964-983.'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: The Cancer Genome Atlas Program - Comprehensive Molecular Characterization of Cholangiocarcinoma'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013;45(10):1127-1133.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['TCGA Research Network: Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015; 372:2481-2498.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature. 2011.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of KDR in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Analysis of KDR Alterations in the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency of KDR Gain in Human Cancer Models', Genomic Data Commons Reports.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2019, 'The Role of KDR in Cervical Cancer Pathogenesis', Oncogene.\"], ['TARGET Osteosarcoma (TARGET-OS) dataset from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Comprehensive analysis of genomic alterations in lung adenocarcinoma. Cancer Research.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research\"], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.', 'Genomic Data Commons Data Portal. National Cancer Institute.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of testicular germ cell tumors. Cell Reports, 2019.'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Skin Cutaneous Melanoma (TCGA, Firehose Legacy) study'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HJ, et al. Genomic characterization of gastric adenocarcinoma in the TCGA database: a focus on KDR amplification. Gastric Cancer. 2016;19(3):555-62.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Lung Cancer in HIV-Positive Patients', Journal of Oncology, 2022.\", \"Publication 2: 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Research, 2023.\"], ['TARGET Osteosarcoma (TARGET-OS) dataset from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - Journal of Clinical Oncology\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan, W. M., Spellman, P. T., Ricketts, C. J., et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology. 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith, J. et al. (2021). 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2022). 'EZH2 Amplification in Cancer Models: Insights from the HCMI-CMDC'. Cancer Genomics.\"], ['Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-965.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Clinical Oncology, 2020.\", \"Publication 2: 'Genomic Alterations in HIV-Associated Lymphomas', Blood Advances, 2021.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of PIM1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'PIM1 Alterations in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency of PIM1 Gain in HCMI-CMDC Project', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'FGFR3 Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer (CGCI-HTMCP-LC)'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' by the TARGET Osteosarcoma Working Group\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Phenotype of Esophageal Squamous Cell Carcinoma in a Chinese Population. Cancer Cell. 2018.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma: FGFR3 and Beyond', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Pancreatic Adenocarcinoma', Pancreatic Cancer Journal.\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers in the Cancer Genome Atlas. Nature Genetics, 2017.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(3), 219-222.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim P, et al. FGFR2 and FGFR3 gain-of-function mutations in gastric cancer. Oncotarget. 2014 Nov 30;5(22):10478-87.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 1234.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543-550.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016;48(6):607-616.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA, Provisional) - cBioPortal for Cancer Genomics'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas', Nature, 2020\", \"Publication: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2018\"], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2015', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539985/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Genomic Data Commons Data Portal - TARGET-OS Project'], ['Publication 1: Comprehensive Molecular Characterization of Lung Cancer in HIV+ Patients, Journal of Oncology, 2022.', 'Publication 2: Genomic Alterations in HIV-Associated Lung Cancer, Cancer Research, 2023.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Cancer Models: Insights from the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Genomic Profiling of Cancer Models in the HCMI-CMDC'. Cancer Genomics.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in Diffuse Large B-cell Lymphoma. Journal of Hematology.', 'Publication 2: Johnson, L. et al. (2021). Comprehensive genomic profiling of lymphoid neoplasms. Blood Cancer Journal.', 'Publication 3: Lee, H. et al. (2022). The role of EZH2 in lymphoid malignancies. Cancer Research.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-LC Project', \"Publication: 'Comprehensive molecular characterization of lung adenocarcinoma' - The Cancer Genome Atlas Research Network\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Curtis C, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012 Apr 18;486(7403):346-352.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Amplification in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of BRAF Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'The Human Cancer Model Initiative: Insights into BRAF Mutations', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Frequency of BRAF Mutations in Cancer Models', Genomic Data Commons Reports.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders (EXCEPTIONAL_RESPONDERS-ER) Project Documentation'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM project data.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Landa I, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016 Mar 1;126(3):1052-1066.'], [\"Publication 1: Smith et al., 2022, 'KRAS Mutations in Cancer Models', Journal of Cancer Research\", \"Publication 2: Johnson et al., 2023, 'Genomic Data Commons: A Comprehensive Resource', Genomics Journal\"], ['Genomic Data Commons Data Portal - Exceptional Responders Project', \"Publication: 'Molecular Characterization of Exceptional Responders to Cancer Therapy' in Nature, 2020\"], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization of endometrial carcinoma. Nature 497, 6773 (2013).', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 Mutations in Gliomas. N Engl J Med. 2009;360(8):765-773.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009 Feb 19;360(8):765-73.'], [\"Publication 1: Smith, J. et al. (2022). 'KRAS Mutations in Cancer Models: Insights from the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Genomic Data Commons: A Comprehensive Analysis of KRAS Mutations'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2021). 'The Role of KRAS G12V in Cancer Development: Findings from the HCMI-CMDC'. Oncogene Journal.\"], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Lung Cancer: Insights from the CDDP_EAGLE-1 Study', Cancer Research.\"], [\"Publication 1: Smith et al., 2021, 'KRAS Mutations in Exceptional Responders', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Analysis of Exceptional Responders', Nature Medicine.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['TCGA-UCS project data from the Genomic Data Commons'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['Genomic Data Commons, Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project CMI-MBC project dataset', \"Publication: 'Genomic landscape of metastatic breast cancer: Insights from the CMI-MBC project', Journal of Clinical Oncology, 2023\"], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], [\"Publication 1: Smith et al., 2021, 'KRAS Mutations in Exceptional Responders', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Analysis of Exceptional Responders', Nature Medicine.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - TCGA-READ project', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'PIK3CA Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Reference 1: Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', \"Reference 2: Smith et al., 2022, 'Genomic alterations in metastatic breast cancer', Journal of Clinical Oncology\", \"Reference 3: Johnson et al., 2023, 'PIK3CA mutations in breast cancer', Nature Reviews Cancer\"], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['MMRF-COMMPASS: Genomic Data Commons Data Portal', \"Publication: 'Comprehensive genomic characterization of multiple myeloma in the MMRF CoMMpass study' - Nature Communications\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA-COAD project data from the Genomic Data Commons', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - CDDP_EAGLE-1 Project', 'Publication: Comprehensive Molecular Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Project'], [\"Publication 1: Smith et al., 2021, 'KRAS Mutations in Exceptional Responders', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Genomic Analysis of Exceptional Responders', Nature Medicine.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Genomic Data Commons, Count Me In: The Metastatic Prostate Cancer Project (CMI-MPC), TP53 Mutation Data', \"Publication: 'Genomic Landscape of Metastatic Prostate Cancer', Journal of Clinical Oncology, 2023\"], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Liu, J., Lichtenberg, T., Hoadley, K. A., Poisson, L. M., Lazar, A. J., Cherniack, A. D., ... & Hoadley, K. A. (2018). An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell, 173(2), 400-416.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Genomic Data Commons Data Portal', 'Exceptional Responders Study Publications'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM Project. Accessed October 2023.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Mutational Landscape of Exceptional Responders', Nature Genetics.\"], ['TARGET-AML project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic profiling of acute myeloid leukemia in the TARGET-AML project', Journal of Hematology, 2022\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Landscape of Acute Lymphoblastic Leukemia in the TARGET-ALL-P3 Project'. Journal of Hematology.\", \"Publication 2: Johnson, L. et al. (2021). 'Mutational Analysis in Pediatric ALL: Insights from the TARGET-ALL-P3 Study'. Leukemia Research.\", \"Publication 3: Williams, R. et al. (2022). 'NRAS Mutations in Pediatric Leukemia: Data from the Genomic Data Commons'. Pediatric Blood & Cancer.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders Study Publications'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/READ-2017'], ['TARGET-AML project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic profiling of acute myeloid leukemia' in Nature, 2020\", \"Publication: 'Genomic landscape of acute myeloid leukemia' in New England Journal of Medicine, 2018\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'PIK3CA Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature. 2013.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['TCGA-COAD project data from the Genomic Data Commons', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal', 'Exceptional Responders Study Publications'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'PTEN Mutations in Exceptional Responders: A Comprehensive Study', Cancer Research.\"], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Publication 1: Comprehensive genomic characterization of uterine carcinosarcoma in the TCGA-UCS project.', 'Publication 2: Analysis of FBXW7 mutations in uterine carcinosarcoma from the Genomic Data Commons.'], ['Radovich M, Pickering CR, Felau I, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 2018;33(2):244-258.e10.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of thymic epithelial tumors. Cell. 2018;175(2):292-306.e17.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Genomic Data Commons, TCGA-COAD project data', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Genomic Data Commons Data Portal - TCGA-STAD Project', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Genomic Data Commons Data Portal - TCGA-STAD', \"Publication: 'Comprehensive molecular characterization of gastric adenocarcinoma' - Nature, 2014\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Mutational Landscape of Exceptional Responders in the EXCEPTIONAL_RESPONDERS-ER Project', Nature Genetics.\"], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Kim J, Akbani R, Creighton CJ, et al. Genomic and molecular characterization of pre-invasive bladder cancer. J Clin Invest. 2019 Feb 1;129(2):715-727.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Genomic characterization of gastric adenocarcinoma in the TCGA database: implications for precision medicine. BMC Cancer. 2017;17:494.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017.', 'Publication 2: The Genomic Landscape of Hepatocellular Carcinoma, Nature Genetics, 2019.'], [\"Publication 1: 'Genomic Characterization of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research, 2022.\", \"Publication 2: 'Somatic Alterations in Osteosarcoma: Insights from the Genomic Data Commons', Cancer Genomics, 2023.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in pancreatic adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Co-occurrence of genetic mutations in pancreatic cancer. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2022). Comprehensive analysis of TCGA-PAAD data. Pancreatic Cancer Journal.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.'], ['Publication 1: Smith, J. et al. (2022). Analysis of Genomic Alterations in the HCMI-CMDC Project. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Co-occurrence of Genetic Alterations in Cancer Models. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). Somatic Mutations in Cancer: Insights from the HCMI-CMDC. Genomic Data Commons Reports.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: Integrated genomic analysis identifies recurrent mutations and pathways in diffuse large B-cell lymphoma, Nature, 2016.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cell Reports, 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data.'], ['Publication 1: Comprehensive molecular characterization of lung adenocarcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, The Cancer Genome Atlas Research Network.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell, 2014.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Zhang, J., et al. (2016). 'The Genomic Landscape of Adrenocortical Carcinoma.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2017). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell.\"], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics\", \"Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research\"], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Wang Q, Hu B, Hu X, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 2017 Jan 9;32(1):42-56.e6.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], [\"Publication 1: 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research, 2022.\", \"Publication 2: 'Somatic Alterations in Osteosarcoma: Insights from the Genomic Data Commons', Cancer Genomics, 2023.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal: Kidney Chromophobe (TCGA-KICH) project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Nature, 2017\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinomas. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Gross AM, et al. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat Genet. 2014 Sep;46(9):939-43.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-1133.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic data commons: Insights into lung cancer. Cancer Genomics.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic analysis of testicular germ cell tumors in the TCGA project. Nature Genetics, 2019.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2015). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 47(10), 1123-1130.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in osteosarcoma: A comprehensive review. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2021). Co-occurrence of genetic mutations in osteosarcoma. Cancer Genomics.', 'Publication 3: Williams, R. et al. (2022). TARGET-OS project: Insights into osteosarcoma genomics. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Smith, J. et al. (2022). Comprehensive Genomic Profiling of Lung Adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Integrative Analysis of Genomic Alterations in Lung Cancer. Cancer Research.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: Integrated genomic analysis identifies recurrent mutations and pathways in diffuse large B-cell lymphoma, Nature, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 2017.'], ['Genomic Data Commons Data Portal', 'HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA-BLCA) dataset in the Genomic Data Commons'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Zhang, J., et al. (2013). 'The genomic landscape of adrenocortical carcinoma.' Nature Genetics.\", \"Assi, G., et al. (2014). 'Integrated genomic characterization of adrenocortical carcinoma.' Nature Genetics.\"], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Co-occurrence of genetic mutations in HIV-related lymphomas. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2022). Molecular characterization of DLBCL in HIV-positive patients. Oncogene.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['TCGA-READ project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of rectal adenocarcinoma' - Journal of Clinical Oncology\", \"Publication: 'Genomic alterations in rectal cancer: insights from TCGA' - Nature Communications\"], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'The Cancer Genome Atlas Program (https://www.cancer.gov/tcga)'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2015). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 47(10), 1121-1130.'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Alterations in Osteosarcoma: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Co-occurrence of Genetic Alterations in Osteosarcoma', Oncogene.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma' - Cell, 2017\", \"Publication: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia' - New England Journal of Medicine, 2013\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project', 'Publication: Comprehensive molecular characterization of cervical cancer, Nature, 2017'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Co-occurrence of Genetic Alterations', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Integrative Analysis of Somatic Mutations in Lung Cancer', Genomic Data Commons Reports.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cell Reports, 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, et al. Integrated genomic characterization of the TCGA-BLCA cohort. Cell. 2019 Apr 4;177(1):59-74.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic analysis of esophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nature Genetics. 2015.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program (TCGA) - Genomic Data Commons'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Genomic Data Commons Data Portal', 'TARGET Osteosarcoma (TARGET-OS) project data'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Alterations in Cancer Models: Insights from the HCMI-CMDC', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['TCGA Research Network: Comprehensive molecular characterization of chromophobe renal cell carcinoma. Cell Reports, 2019.', 'Genomic Data Commons Data Portal: Kidney Chromophobe (TCGA-KICH) Project.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Nature, 2017\"], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.e9.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Sanchez-Vega, F. et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173, 321337.e10 (2018).'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Zhang, J., et al. (2019). Genomic Landscape of Liver Cancers in China. Nature Genetics.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Co-occurrence of Genetic Alterations in Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Pediatric Osteosarcoma', Pediatric Oncology Journal.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Genomic Data Commons Data Portal: TCGA-LUSC project data.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Co-occurrence of SMARCB1 and TP53 Alterations', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic alterations in pancreatic adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive genomic profiling of pancreatic cancer', Pancreatic Cancer Journal.\"], ['Publication 1: Smith, J. et al. (2022). Co-occurrence of Genetic Alterations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Data Commons: Insights into Cancer Genomics. Cancer Genomics Journal.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['TCGA-KICH project data from the Genomic Data Commons', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], [\"Zhao, X., et al. (2016). 'The Genomic Landscape of Adrenocortical Carcinoma.' Nature Genetics.\", \"Assi, G., et al. (2014). 'Integrated Genomic Characterization of Adrenocortical Carcinoma.' Nature Genetics.\"], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: Integrated genomic characterization of oesophageal carcinoma, Nature, 2017.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in testicular germ cell tumors. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of testicular germ cell tumors. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2022). Co-occurrence of genomic alterations in testicular cancer. Oncogene.'], ['Publication 1: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, The Cancer Genome Atlas Research Network, Cell, 2017.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, New England Journal of Medicine, 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang Y, et al. Genomic Landscape and Clinical Relevance of Somatic Alterations in Adult Soft Tissue Sarcomas. J Clin Oncol. 2018 Apr 10;36(11):1108-1117.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal: Kidney Chromophobe (TCGA-KICH) project data.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project Data.'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2015). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 47(6), 606-612.'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: Integrated genomic characterization of oesophageal carcinoma, Nature, 2017.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Grossman RL, Heath AP, Ferretti V, et al. Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016 Sep 22;375(12):1109-12.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in testicular germ cell tumors. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of testicular germ cell tumors. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Somatic mutations in testicular cancer. Oncogene.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Cancer Genome Atlas Program (TCGA) - Liver Hepatocellular Carcinoma (LIHC) dataset.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network.', 'Publication 2: Integrated Genomic Characterization of Uterine Carcinosarcoma, The Cancer Genome Atlas Research Network.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'PDGFRA Mutations in Cancer Therapy', Oncogene Journal.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PDGFRA Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of PDGFRA Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'PDGFRA Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PDGFRA in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in PDGFRA: Implications for Cancer Therapy', Cancer Genomics.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Uterine Carcinosarcoma', The Cancer Genome Atlas Research Network, 2017.\", \"Publication 2: 'Genomic and Molecular Characterization of Uterine Carcinosarcoma', Smith et al., Journal of Clinical Oncology, 2018.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'PDGFRA Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell. 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PDGFRA Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in PDGFRA: Implications for Cancer Therapy', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in PDGFRA Across Cancer Types', Genomic Data Commons Reports.\"], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'PDGFRA Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PDGFRA Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of PDGFRA Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'PDGFRA Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PDGFRA Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in PDGFRA and Their Role in Tumorigenesis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in PDGFRA: Implications for Cancer Therapy', Oncogene.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, Akdemir KC, Aksoy BA, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas', Nature, 2020\", \"Publication: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2018\"], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, Akdemir KC, Aksoy BA, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma' - The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma' - The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal, TCGA-SKCM project data.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'NRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of NRAS Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in NRAS and Their Impact on Cancer Progression', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, Akdemir KC, Aksoy BA, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'NRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of papillary thyroid carcinoma, Cell, 2014.', 'Publication 3: The Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 2014.'], ['Cancer Genome Atlas Research Network. (2017). Genomic Classification of Cutaneous Melanoma. Cell, 161(7), 1681-1696.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of NRAS Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in NRAS and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of NRAS Mutations in Cancer Development: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, Akdemir KC, Aksoy BA, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'NRAS Mutations in Exceptional Responders: Insights from the EXCEPTIONAL_RESPONDERS-ER Project', Cancer Research.\"], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of NRAS Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in NRAS and Their Impact on Cancer Progression', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, Akdemir KC, Aksoy BA, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ALK Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ALK and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in ALK: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhao, M., et al. (2016). Somatic copy-number alterations and their prognostic implications in kidney renal clear cell carcinoma. Cancer Research, 76(8), 2306-2311.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Genomic Data Commons Data Portal - CPTAC-3 Project', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Adult Soft Tissue Sarcomas' - Nature Communications\", \"Publication: 'The Genomic Landscape of Head and Neck Squamous Cell Carcinoma' - Cancer Cell\"], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], ['Publication 1: Smith, J. et al. (2022). Comprehensive Genomic Profiling of Lung Adenocarcinoma. Journal of Thoracic Oncology.', 'Publication 2: Johnson, L. et al. (2023). Integrative Analysis of Somatic Mutations in Lung Cancer. Cancer Research.', 'Publication 3: Lee, H. et al. (2023). ALK Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project. Nature Genetics.'], ['Genomic Data Commons - Exceptional Responders Project Data', \"Publication: 'Comprehensive Molecular Profiling of Exceptional Responders in Cancer Therapy' - Genomic Data Commons\"], ['TARGET-NBL project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Neuroblastoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Alterations in HIV-Positive DLBCL Patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'ALK Mutations in HIV-Related Lymphomas.' Oncogene Research.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['TCGA-DLBC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of diffuse large B-cell lymphoma' by the TCGA Research Network\"], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Genomic Data Commons Data Portal - TCGA-READ project', 'Publication: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Genomic Data Commons Data Portal, https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-ACC', 'https://portal.gdc.cancer.gov/projects/TCGA-ACC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell lung cancers', Nature, 2012\", \"Publication: 'The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer', Nature, 2012\"], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., et al. (2019). Genomic Data Commons Data Portal: A Platform for Cancer Genomics Research. Journal of Clinical Oncology, 37(15_suppl), e13050-e13050.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Publication 1: Smith, J. et al. (2022). Analysis of KIT Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic Variants in the Human Cancer Model Initiative. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). Copy Number Variants in Cancer Development. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of papillary thyroid carcinoma, Cell, 2014.', 'Publication 3: The Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 2014.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of KIT Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in KIT and Their Role in Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in KIT: Implications for Cancer Therapy', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ALK Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ALK: Implications for Cancer Therapy', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'ALK Alterations in Human Cancer Models: A Comprehensive Study', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhao, M., et al. (2016). Somatic copy-number alterations and their prognostic implications in clear cell renal cell carcinoma. Cancer Research, 76(7), 2016-2024.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Doe, A. et al. (2023). Molecular profiling of Wilms Tumor: A comprehensive analysis. Cancer Genomics & Proteomics.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications', 'Comprehensive Molecular Characterization of Cancer Genomes'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'ALK Alterations in Lung Cancer: Insights from the CDDP_EAGLE-1 Project', Cancer Research.\"], ['Genomic Data Commons - Exceptional Responders Project', \"Publication: 'Comprehensive Molecular Characterization of Exceptional Responders to Cancer Therapy' in Nature, 2020\"], ['TARGET-NBL project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Pediatric High-Grade Glioma through Targeted Sequencing and Copy Number Analysis' in the Journal of Clinical Oncology\", \"Publication: 'Genomic Landscape of Neuroblastoma' in Nature Genetics\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project (HTMCP) - Lung Cancer (CGCI-HTMCP-LC) dataset'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics\", \"Publication 2: Johnson et al., 2023, 'ALK Mutations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research\"], ['TCGA-DLBC project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma' by the Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Cholangiocarcinoma TCGA study publications'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.', 'Genomic Data Commons Data Portal. TCGA-UVM Project.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic alterations in testicular germ cell tumors: A comprehensive analysis. Nature Genetics, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix and endocervical adenocarcinoma', Nature, 2017\"], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., et al. (2019). Genomic Data Commons Data Portal: A Platform for Cancer Genomics Research. Journal of Clinical Oncology, 37(15_suppl), e13050-e13050.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2015). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 47(10), 1121-1130.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang TW, et al. Genomic characterization of gastric adenocarcinoma in the TCGA database: implications for precision medicine. BMC Cancer. 2017;17:494.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411-423.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'PDGFRA Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PDGFRA across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of PDGFRA Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'PDGFRA Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PDGFRA Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in PDGFRA and Their Role in Tumorigenesis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Impact of PDGFRA Alterations in Cancer Development', Oncogene.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM Project. Accessed October 2023.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'BRAF Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['CPTAC-3 Brain Project Publication', 'CPTAC-3 Head and Neck Project Publication', 'CPTAC-3 Kidney Project Publication', 'CPTAC-3 Lung Project Publication', 'CPTAC-3 Pancreas Project Publication', 'CPTAC-3 Uterus Project Publication'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BRAF Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in BRAF and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of BRAF Mutations in Cancer Development: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PIK3CA Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in PIK3CA and Their Role in Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Impact of PIK3CA Alterations in Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling in pediatric renal tumors: A comprehensive analysis. Pediatric Cancer Research.', 'Publication 3: Williams, R. et al. (2023). The role of PIK3CA mutations in Wilms Tumor: Findings from the Genomic Data Commons. Cancer Genomics.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], ['Genomic Data Commons Data Portal', 'Count Me In: The Angiosarcoma Project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Lung Cancer: Frequency and Clinical Implications', Lung Cancer Journal.\"], ['CPTAC-2 Breast Cancer Study: https://gdc.cancer.gov/about-data/publications/CPTAC-2-Breast', 'CPTAC-2 Colon Cancer Study: https://gdc.cancer.gov/about-data/publications/CPTAC-2-Colon', 'CPTAC-2 Ovarian Cancer Study: https://gdc.cancer.gov/about-data/publications/CPTAC-2-Ovarian'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['The Metastatic Breast Cancer (MBC) Project, Count Me In (CMI), Genomic Data Commons, 2023', 'Smith et al., Genomic alterations in metastatic breast cancer, Journal of Clinical Oncology, 2023', 'Johnson et al., PIK3CA mutations in breast cancer, Nature Reviews Cancer, 2023'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Genomics and Cancer.\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982584/'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/PIK3CA'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2022). PIK3CA mutations in HIV-related lymphomas. Oncogene Research.'], ['https://gdc.cancer.gov/about-data/publications/APOLLO-LUAD'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/CHOL-2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Journal of Thoracic Oncology. 2019.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers from the Genomic Data Commons. Cancer Res. 2019;79(3):662-674.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(3), 219-222.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, Liu T, Zhang Z, et al. Integrated analysis of mutation data from TCGA to identify potential genetic drivers in bladder cancer. J Cancer Res Clin Oncol. 2018;144(2):257-267.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.', 'Leemans CR, et al. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018 May;18(5):269-282.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Cancer Therapy', Oncogene Journal.\"], ['Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', \"Publication: 'Genomic landscape of metastatic breast cancer' in Nature, 2020\", \"Publication: 'PIK3CA mutations in breast cancer: clinical implications and treatment strategies' in Journal of Clinical Oncology, 2021\"], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Genomic Data Commons, NCI Cancer Model Development for the Human Cancer Model Initiative HCMI-CMDC project, accessed October 2023', \"Publication: 'Comprehensive Characterization of Cancer Models in the Genomic Data Commons', Journal of Cancer Research, 2023\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Genomic Data Commons Data Portal. TCGA-KIRC project data.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, BRAF mutation frequency data', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: Enabling Genomic and Clinical Discoveries in a Rare Cancer through Patient-Partnered Research. Cancer Cell. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'BRAF Mutations in Lung Cancer: Frequency and Clinical Implications', Lung Cancer Journal.\"], ['Genomic Data Commons Data Portal', 'CPTAC-2 Breast, Colon, Ovary Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'BRAF Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Cancer in HIV+ Patients, Genomic Data Commons', 'Publication 2: Somatic Mutations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project, Genomic Data Commons'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of Cervical Cancer in HIV+ Patients'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'BRAF Mutations in Cervical Cancer: A Study from the Genomic Data Commons'. Oncogene.\"], ['Genomic Data Commons, TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). BRAF mutations in lung cancer: A comprehensive study. Lung Cancer Journal.'], ['https://gdc.cancer.gov/about-data/publications/mmrf-commpass', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774780/', 'https://www.nature.com/articles/s41408-018-0127-1'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['TCGA-DLBC project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma' by the Cancer Genome Atlas Research Network\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Sanchez-Vega, F. et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173, 321337.e10 (2018).'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive Molecular Characterization of Intrahepatic and Extrahepatic Cholangiocarcinomas in the TCGA-CHOL Project'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. Esophageal Carcinoma (TCGA-ESCA) project data.'], ['Genomic Data Commons Data Portal - TCGA-THYM', 'Comprehensive molecular characterization of thymic epithelial tumors - The Cancer Genome Atlas Research Network'], ['TCGA Research Network. Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal, TCGA-MESO project.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Nature. 2013 Oct 17;499(7456):43-9. doi: 10.1038/nature12222.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project Data.'], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Annual Review of Pathology, 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal. TCGA-KIRP project data.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cell. 2016.', 'Zheng, S., et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cell Reports. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. Skin Cutaneous Melanoma (TCGA-SKCM) Project.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BRAF Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in BRAF and Their Implications in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of BRAF Mutations in Cancer Development', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012.'], ['Publication 1: Smith, J. et al. (2021). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2022). Molecular profiling of Wilms Tumor: BRAF mutations and treatment response. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Copy number variations in pediatric renal tumors: A focus on BRAF. Pediatric Cancer Research.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Publication on BRAF mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma. Nature, 2013.', 'Publication 3: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'BRAF Mutations in Exceptional Responders: Insights from the EXCEPTIONAL_RESPONDERS-ER Project', Cancer Research.\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Lung', 'https://gdc.cancer.gov/about-data/publications/HTMCP'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/sample-type-codes'], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: Genomic Alterations in HIV-Associated Lymphomas, Genomic Data Commons'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). BRAF mutations in lung adenocarcinoma: A comprehensive analysis. Oncogene.'], ['MMRF-COMMPASS Study, Genomic Data Commons', \"Publication: 'Genomic landscape of multiple myeloma and clinical impact of mutations in the CoMMpass study', Nature Genetics\"], ['Publication 1: Smith, J. et al. (2022). Genomic Profiling in Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular Alterations in ALL: Implications for Treatment. Leukemia Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2018', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075687/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cell Reports, 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://portal.gdc.cancer.gov/projects/TCGA-TGCT'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Phenotypic Profiles of Intrahepatic Cholangiocarcinoma. Hepatology. 2016 Nov;64(5):1602-1611.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], [\"Ceccarelli, M., et al. (2016). 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.' Cell, 164(3), 550-563.\", \"Cancer Genome Atlas Research Network. (2015). 'Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.' New England Journal of Medicine, 372(26), 2481-2498.\"], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], [\"Kandoth C, et al. (2013) 'Mutational landscape and significance across 12 major cancer types', Nature.\", \"Cancer Genome Atlas Research Network. (2011) 'Integrated genomic analyses of ovarian carcinoma', Nature.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of KRAS Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in KRAS and Their Impact on Cancer Progression', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive Molecular Characterization of Head and Neck Squamous Cell Carcinomas, Nature, 2015.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Comprehensive Molecular Characterization of Breast Cancer in the CPTAC-2 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Genomic Alterations in Colon Cancer: Insights from the CPTAC-2 Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Ovarian Cancer Genomic Landscape in the CPTAC-2 Project', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'KRAS Mutations in HIV+ Lung Cancer Patients', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'KRAS Mutations in Cervical Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['Genomic Data Commons Data Portal - TARGET-ALL-P2 project', \"Publication: 'Comprehensive genomic profiling of pediatric acute lymphoblastic leukemia' in Nature Communications\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Alterations in HIV-Positive DLBCL Patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'KRAS Mutations in HIV-Related Lymphomas.' Oncogene.\"], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Comprehensive analysis of KRAS mutations in lung cancer. Lung Cancer Journal.'], ['https://gdc.cancer.gov/about-data/publications/mmrf-commpass'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Acute Myeloid Leukemia in the TARGET-AML Project', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in AML: Insights from the TARGET-AML Study', Leukemia Research\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data in the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of Burkitt lymphoma reveals novel oncogenic pathways and targets (Nature, 2019)'], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in ALL', Cancer Genomics\"], ['TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012.', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013.'], ['https://gdc.cancer.gov/about-data/publications/pcpg_2017', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951821/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson AG, Hoadley KA, Triche TJ Jr, Laird PW, Baty JD, Fulton LL, Fulton RS, Heath SE, Kalicki-Veizer JM, Kandoth C, Klco JM, Koboldt DC, Kanchi KL, Kulkarni S, Lamprecht TL, Larson DE, Lin L, Lu C, McLellan MD, McMichael JF, Payton JE, Schmidt HK, Spencer DH, Tomasson MH, Wendl MC, Wilson RK, Walter MJ. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2016). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 48(6), 607-612.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic features and clinical outcomes in testicular germ cell tumors. Nature Genetics, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA-CESC) dataset in the Genomic Data Commons'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'KRAS Mutations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project', Genomic Data Commons Reports.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Adenocarcinoma, The Cancer Genome Atlas Research Network, Nature, 2014.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma, The Cancer Genome Atlas Research Network, Cancer Cell, 2017.', 'Publication 3: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, New England Journal of Medicine, 2013.'], ['Publication 1: Smith, J. et al. (2022). Comprehensive Genomic Profiling of Lung Adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). KRAS Mutations in Lung Cancer: Insights from the Genomic Data Commons. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Integrative Analysis of Lung Adenocarcinoma: The Role of KRAS. Genomics and Cancer.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). KRAS mutations in lung cancer: A comprehensive analysis. Lung Cancer Journal.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Publication 1: Comprehensive molecular profiling of lung adenocarcinoma in the HIV+ population, Journal of Thoracic Oncology, 2022.', 'Publication 2: Genomic alterations in lung cancer among HIV-positive individuals, Cancer Research, 2023.'], ['Publication 1: Comprehensive molecular characterization of lung adenocarcinoma, Nature, 2014.', 'Publication 2: Integrated genomic characterization of papillary thyroid carcinoma, Cell, 2014.', 'Publication 3: The Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 2014.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations and Copy Number Variants in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Integrative Genomic Analysis of Lung Adenocarcinoma: Findings from the CDDP_EAGLE-1 Study', Genomics and Oncology.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179(4):964-983.e31.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'EGFR Mutations in Lung Cancer: A Study from the HIV+ Tumor Molecular Characterization Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in EGFR and Their Impact on Lung Cancer in HIV+ Patients', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Cancer: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in EGFR Across Different Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of EGFR in Cancer Progression', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Lung Adenocarcinoma: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Cancer: Insights from the CDDP_EAGLE-1 Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung cancer: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, C. et al. (2023). EGFR mutations in lung adenocarcinoma: A comprehensive study. Lung Cancer Journal.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'EGFR Mutations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Oncology Research.\", \"Publication 2: Johnson et al., 2021, 'Genomic Alterations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], ['Publication 1: Comprehensive molecular characterization of lung adenocarcinoma, Nature, 2014.', 'Publication 2: Integrated genomic characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Lung Adenocarcinoma: A Comprehensive Analysis', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Cancer: Insights from the CDDP_EAGLE-1 Project', Cancer Research.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Clinical Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Razavi P, Chang MT, Xu G, et al. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers. Cancer Cell. 2018 Mar 12;33(2):227-238.e6.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network', 'Publication 2: Integrated Genomic Characterization of Uterine Carcinosarcoma, The Cancer Genome Atlas Research Network'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of PIK3CA Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in PIK3CA and Their Role in Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Impact of PIK3CA Mutations in Cancer Development', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics & Proteomics.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, PIK3CA mutation data', \"Publication: 'Genomic Characterization of Angiosarcoma in the Count Me In Project', Journal of Clinical Oncology, 2023\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Nature Genetics.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in Cervical Cancer: Frequency and Clinical Implications', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], [\"Publication 1: 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research, 2022.\", \"Publication 2: 'PIK3CA Mutations in Osteosarcoma: Insights from the Genomic Data Commons', Cancer Genomics, 2023.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in HIV-Related Lymphomas', Cancer Research Journal\"], ['Genomic Data Commons Data Portal - APOLLO-LUAD Project', 'Publication: Proteogenomic characterization of lung adenocarcinoma in the APOLLO1 project'], ['Genomic Data Commons Data Portal', 'TCGA-DLBC project publications'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of Pheochromocytoma and Paraganglioma. Cell Reports, 2017.', 'Fishbein L, Leshchiner I, Walter V, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell, 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016705/'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers in China. Nat Genet. 2019 Apr;51(4):865-874.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson G, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Genomic Data Commons Data Portal - TCGA-SKCM', 'Nature. 2015 Jan 15;517(7535):576-82. doi: 10.1038/nature14105.', 'Cell. 2015 Apr 9;161(2):286-98. doi: 10.1016/j.cell.2015.02.052.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Nature. 2014 Oct 23;514(7521):202-9. doi: 10.1038/nature13480.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Oct 23;514(7521):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'The Genomic Data Commons Data Portal, https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of lung adenocarcinoma', Nature, 2014\", \"Publication: 'Integrated genomic characterization of endometrial carcinoma', Nature, 2013\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of DDR2 Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of DDR2 in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Hammerman PS, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in DDR2 and Their Role in Lung Cancer', Genomic Data Commons Reports.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of DDR2 Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: A Study from the Genomic Data Commons', Oncogene.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Cancer in HIV+ Patients, Genomic Data Commons', 'Publication 2: Analysis of Somatic Mutations in Lung Cancer from HIV+ Patients, Genomic Data Commons'], ['Publication 1: Comprehensive molecular characterization of lung adenocarcinoma, Nature, 2014.', 'Publication 2: Integrated genomic characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The Role of DDR2 Mutations', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Integrative Analysis of Somatic Mutations in Lung Cancer', Genomic Data Commons Reports.\"], ['TCGA Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics. 2016.'], ['Zhang, H., et al. (2020). Proteogenomic characterization of human lung adenocarcinoma. Cell, 182(1), 245-261.', 'Smith, J., et al. (2021). Comprehensive analysis of DDR2 mutations in lung adenocarcinoma. Journal of Thoracic Oncology, 16(5), 765-775.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'EGFR Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in CPTAC-3 Projects', Journal of Genomic Data\", \"Publication 2: Johnson et al., 2023, 'Analysis of Copy Number Variants in EGFR across Multiple Cancer Types', Cancer Genomics\", \"Publication 3: Lee et al., 2023, 'Comprehensive Genomic Profiling of EGFR in CPTAC-3', Genomics and Cancer Research\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations in Lung Cancer: A Comprehensive Analysis from the Genomic Data Commons', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research Journal.\"], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. National Cancer Institute. Accessed October 2023.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'NOTCH1 Mutations in HIV-Associated Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: Insights from the HTMCP Project', Genomic Medicine.\"], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma, Nature, 2013.', 'Publication 3: The Cancer Genome Atlas Pan-Cancer analysis project, Nature Genetics, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'NOTCH1 Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Genomic Data Commons, Count Me In: The Metastatic Breast Cancer Project (CMI-MBC), TP53 mutation data'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.'], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', \"Publication: 'Genomic landscape of metastatic breast cancer' in Nature, 2020\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['Genomic Data Commons, Count Me In: The Metastatic Breast Cancer Project (CMI-MBC), TP53 mutation data', \"Publication: 'Genomic landscape of metastatic breast cancer: Insights from the CMI-MBC project', Journal of Clinical Oncology, 2023\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'AKT1 Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in AKT1 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of AKT1 Mutations in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'AKT1 Variants in the CPTAC-3 Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Cancer: A Comprehensive Analysis of AKT1 Mutations.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Copy Number Variants in Cancer: Insights from the Human Cancer Model Initiative.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'Somatic Mutations in Cancer: A Study of AKT1 Variants.' Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of FOXL2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FOXL2 Mutations in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in FOXL2 Across Cancer Types', Genomic Data Commons Reports.\"], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-7.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma, Nature, 2013.', 'Publication 3: Comprehensive molecular profiling of lung adenocarcinoma, Nature, 2014.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders (EXCEPTIONAL_RESPONDERS-ER) project data'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer (CGCI-HTMCP-CC) dataset'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['https://gdc.cancer.gov/about-data/publications/pcpg_2017', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951821/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinoma, Nature, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['DOI: 10.1016/j.ccell.2018.03.014', 'DOI: 10.1016/j.celrep.2018.03.086'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/ATACseq-AWG', 'https://gdc.cancer.gov/about-data/publications/mc3-2017'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252710/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CESC'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA-BLCA) dataset in the Genomic Data Commons'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCEC'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S. B., Andry, C. D., ... & Weinstein, J. N. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-LGG'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609615 (2011).', 'Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609615 (2011).'], ['Publication 1: Smith, J. et al. (2022). Analysis of FOXL2 Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Alterations in the HCMI-CMDC Project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Comprehensive Genomic Profiling of Cancer Models. Genomic Data Commons Reports.'], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) project.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"Cerami, E., et al. (2012). 'The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.' Cancer Discovery, 2(5), 401-404.\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project data', \"Publication: 'Comprehensive Molecular Characterization of Wilms Tumor' in the Genomic Data Commons\"], ['Publication 1: Comprehensive molecular characterization of uterine carcinosarcoma. Nature, 2018.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FOXL2 Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], ['Genomic Data Commons - Exceptional Responders Project', \"Publication: 'Comprehensive genomic profiling of exceptional responders in cancer therapy' - Journal of Clinical Oncology\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project data', \"Publication: 'Comprehensive molecular characterization of osteosarcoma' in Nature Communications\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.'], ['Genomic Data Commons Data Portal', 'TCGA-CHOL project publications'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, Nature, 2017.', 'Publication 2: The Genomic Data Commons: A unified platform for cancer genomics research, Nature Biotechnology, 2016.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Program: https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga'], [\"Cancer Genome Atlas Research Network. 'The Cancer Genome Atlas Pan-Cancer analysis project.' Nature genetics 45.10 (2013): 1113-1120.\", \"Robertson, A. Gordon, et al. 'Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.' Cancer Cell 32.2 (2017): 204-220.\"], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], [\"Kandoth C, et al. (2013) 'Mutational landscape and significance across 12 major cancer types', Nature.\", \"The Cancer Genome Atlas Research Network. (2017) 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas', Cell.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-ACC', 'https://portal.gdc.cancer.gov/projects/TCGA-ACC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Litchfield, K., et al. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumors. Nature Communications, 2015.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix and endocervical adenocarcinoma', Nature, 2017\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA-BLCA) dataset in the Genomic Data Commons'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature.\", \"The Cancer Genome Atlas Research Network. (2013). 'Integrated genomic characterization of endometrial carcinoma.' Nature.\"], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543550 (2014).', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine, 2013.', 'Genomic Data Commons Data Portal, TCGA-LAML project data.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: Smith, J. et al. (2022). Analysis of KIT Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in Cancer: A Comprehensive Study. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). The Role of KIT in Cancer Development. Oncogene Journal.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine, 2013.', 'Ley TJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine, 2013.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular Profiling in Leukemia. Leukemia Research Journal.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of NT5C2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in NT5C2 Across Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in NT5C2: Implications for Cancer Therapy', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in acute lymphoblastic leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling in leukemia treatment. Leukemia Research.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zack, T.I., et al. Pan-cancer patterns of somatic copy number alteration. Nature Genetics, 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in XRCC1 Across Multiple Cancer Types', Journal of Cancer Genomics.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in the CPTAC-3 Cohort', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in DNA Repair Genes in Cancer', Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], ['Publication 1: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Publication 2: The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in XRCC1 and Their Role in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in XRCC1 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in XRCC1', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in DNA Repair Genes in Cancer', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Lung Cancer', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Squamous Cell Carcinoma', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Lung Squamous Cell Carcinoma', Cancer Research.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in XRCC1 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in XRCC1', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in XRCC1 and Their Impact on Cancer Progression', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: A Study from the Genomic Data Commons', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Data Commons Analysis of Lung Cancer', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'The Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'Bell D, et al. Nature. 2011; 474(7353):609-615.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Adenocarcinoma', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Lung Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in XRCC1 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: A Study of XRCC1', Genomic Medicine.\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The Role of XRCC1'. Cancer Genomics.\", \"Publication 3: Lee, H. et al. (2023). 'Somatic Mutations and Copy Number Variants in Lung Cancer: Findings from the Genomic Data Commons'. Oncogene.\"], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Genomic Data Commons Data Portal: TCGA-LUSC project data.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Somatic mutations and copy number variants in lung cancer. Genomic Data Commons Reports.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Ovarian Serous Cystadenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Ovarian Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2019, 'ABCB1 Mutations in Ovarian Cancer', Oncogene.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'MTOR Pathway Alterations in Cancer', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Cancer: A Comprehensive Analysis of the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'MTOR Mutations and Their Impact on Cancer Progression'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'Copy Number Variants in Cancer: Insights from the Genomic Data Commons'. Oncogene.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], ['Genomic Data Commons Data Portal', 'Exceptional Responders (EXCEPTIONAL_RESPONDERS-ER) Project Documentation'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MTOR Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of MTOR Mutations in CPTAC-3 Cohorts', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MTOR Pathway Alterations in Cancer: Insights from CPTAC-3', Oncogene.\"], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of MTOR Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in MTOR Across Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in MTOR: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'MTOR Pathway Alterations in Exceptional Responders', Nature Medicine.\"], ['CPTAC-3 Brain Study: Comprehensive molecular characterization of brain tumors', 'CPTAC-3 Head and Neck Study: Integrated proteogenomic characterization of head and neck squamous cell carcinoma', 'CPTAC-3 Kidney Study: Proteogenomic characterization of renal cell carcinoma', 'CPTAC-3 Lung Study: Proteogenomic analysis of lung adenocarcinoma', 'CPTAC-3 Pancreas Study: Integrated proteogenomic characterization of pancreatic ductal adenocarcinoma', 'CPTAC-3 Uterus Study: Proteogenomic characterization of endometrial carcinoma'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MTOR in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'MTOR Pathway Alterations in Human Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], ['Publication 1: Smith et al., 2022, Journal of Cancer Research', 'Publication 2: Johnson et al., 2023, Genomics and Cancer', 'Publication 3: Lee et al., 2023, Cancer Genomics'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MTOR Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of MTOR Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MTOR Pathway Alterations in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], ['Cancer Genome Atlas Research Network. (2017). Comprehensive molecular characterization of uveal melanoma. Cell, 173(2), 511-517.', 'Robertson, A. G., et al. (2017). Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell, 32(2), 204-220.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in the MTOR pathway in cancer models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Comprehensive analysis of MTOR mutations in cancer. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). MTOR copy number variations in human cancer models. Oncogene.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'BRAF Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Genomic Data Commons Data Portal - CPTAC-3 Project', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma' - The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma' - The Cancer Genome Atlas Research Network\"], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BRAF Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in BRAF and Their Implications in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of BRAF Mutations in Cancer Development', Oncogene.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. TCGA-SKCM Project. https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'BRAF Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Publication 1: Smith, J. et al. (2022). Analysis of BRAF Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in the HCMI-CMDC Project. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2021). Somatic Mutations in Cancer: A Comprehensive Study. Genomic Data Commons Reports.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Genetics. 2013;45(8):860-7.'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Publication: Comprehensive molecular portraits of human breast tumours. Nature. 2012.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling of Wilms Tumor: A comprehensive analysis. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). The role of SMO mutations in pediatric renal tumors. Pediatric Cancer Research.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: Insights from the Genomic Data Commons', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Lung Cancer: A Comprehensive Study', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'The Role of SMO Mutations in Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'TARGET-OS Project: Insights into Osteosarcoma Genomics', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016'], ['Genomic Data Commons Data Portal - TCGA-PCPG Project', 'Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma, TCGA Research Network'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Publication 1: Comprehensive Molecular Characterization of Cholangiocarcinoma, The Cancer Genome Atlas Research Network, 2017.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, 2013.'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, Nature, 2017.', 'Publication 2: Genomic alterations in esophageal carcinoma: insights from TCGA, Journal of Clinical Oncology, 2018.'], ['Genomic Data Commons Data Portal - Thymoma TCGA-THYM Project', 'Comprehensive molecular characterization of thymic epithelial tumors - The Cancer Genome Atlas Research Network'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Pancreatic Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Pancreatic Cancer: A TCGA Study', Oncogene.\"], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Papillary Renal Cell Carcinoma. The Cancer Genome Atlas Research Network. Cell Reports, 2017.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., ... & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2017). Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell, 169(7), 1327-1341.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Publication 1: Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma, TCGA Research Network', 'Publication 2: Genomic Data Commons Data Portal, Bladder Urothelial Carcinoma (TCGA-BLCA) Project'], ['Publication 1: Comprehensive molecular characterization of uterine corpus endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 2014'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 1234.'], ['Publication 1: Comprehensive molecular profiling of lung adenocarcinoma, TCGA, 2014.', 'Publication 2: Genomic alterations in lung adenocarcinoma, Nature, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'The Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in the Human Cancer Model Initiative. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Comprehensive analysis of somatic mutations in cancer models. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). Copy number variations in cancer: Insights from the HCMI-CMDC project. Oncogene.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Genetics. 2013;45(8):860-867.'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412.', 'Cell. 2015 Apr 9;161(2):286-98. doi: 10.1016/j.cell.2015.02.048.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Nature Genetics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in HIV+ Lung Cancer Patients', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Cervical Cancer: Findings from the Genomic Data Commons', Genomic Medicine.\"], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Nature Communications\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Genomic Data Commons Data Portal', 'APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project publication'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Cholangiocarcinoma TCGA-CHOL Mutation Analysis Publications'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of oesophageal carcinoma. Nature, 541(7636), 169-175.', 'Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., ... & Vogelstein, B. (1997). Gene expression profiles in normal and cancer cells. Science, 276(5316), 1268-1272.'], ['Genomic Data Commons Data Portal - TCGA-THYM Project', 'Thymoma TCGA Study Publications'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of prognostic molecular factors in bladder urothelial carcinoma. Oncogene, 38(30), 5320-5334.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in EGFR', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Communications. 2013;4:1503.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2012 May;2(5):401-404.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations and Treatment Response in Wilms Tumor', Cancer Genomics & Proteomics.\"], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project (CMI-ASC), accessed 2023'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'EGFR Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'EGFR Mutations in Cervical Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'HIV+ Tumor Molecular Characterization and EGFR Variants', Genomic Data Commons Reports.\"], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Publication 1: Smith et al., 2022, Journal of Clinical Oncology', 'Publication 2: Johnson et al., 2023, Nature Genetics'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell Reports, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Research Network. (2015). Comprehensive genomic characterization of thymic epithelial tumors. Cell, 163(4), 1011-1024.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'EGFR Mutations in Pancreatic Cancer', Oncogene Journal.\"], ['National Cancer Institute Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network publications on Uterine Carcinosarcoma'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2016). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 48(4), 427-435.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao, X., et al. Somatic copy-number alterations in human cancers. Nature Genetics. 2016;48(10):1069-1073.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2016). Comprehensive genomic characterization of uterine corpus endometrial carcinoma in Chinese patients. Nature Communications, 7, 12262.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim Y, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018 Sep;24(9):1449-1458.'], ['TCGA Research Network: Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015; 372:2481-2498.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E167-74.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in EGFR', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in EGFR Across Cancer Types', Genomic Data Commons Review.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.', 'Zhao, H., et al. (2013). The landscape of somatic copy-number alteration across human cancers. Nature. 497(7447): 415-421.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Analyses of Ovarian Carcinoma. Nature. 2011;474(7353):609-615.'], [], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in EGFR across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'EGFR Mutations and Copy Number Variants in CPTAC-3 Cohorts', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Comprehensive Analysis of EGFR Alterations in CPTAC-3', Genomic Data Commons Reports.\"], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations in Exceptional Responders', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'EGFR Mutations in HIV-Associated Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project data', \"Publication: 'Comprehensive genomic characterization of osteosarcoma and its clinical implications' in Nature Communications\"], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: Genomic Alterations in HIV-Associated Lymphomas, Genomic Data Commons'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). EGFR mutations in lung cancer: A comprehensive study. Lung Cancer Journal.'], [], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA dataset'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of thymic epithelial tumors. Cell. 2018 May 17;173(2):291-305.e8.', 'Genomic Data Commons Data Portal. Thymoma (TCGA-THYM) project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Publication 1: Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Publication 2: Raphael, B. J., et al. (2017). Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genetic alterations in liver hepatocellular carcinoma: An overview. Oncotarget, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.', 'Hodis E, et al. A Landscape of Driver Mutations in Melanoma. Cell. 2012 Jul 20;150(2):251-263.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Cervical Squamous Cell Carcinoma. Neoplasia. 2019 Apr;21(4):368-376.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2018). Genomic landscape and analysis of EGFR in Uterine Corpus Endometrial Carcinoma. Journal of Clinical Oncology, 36(15_suppl), 5585-5585.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim Y, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018 Sep;24(9):1449-1458.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['National Cancer Institute Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network publications on Uterine Carcinosarcoma'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget, 10(40), 3929-3940.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-219.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Publication 1: Analysis of somatic mutations in the MAPK1 gene across various cancer types in the CPTAC-3 project.', 'Publication 2: Comprehensive genomic profiling of copy number variants in the MAPK1 gene in the CPTAC-3 dataset.', 'Publication 3: Frequency of MAPK1 mutations in the CPTAC-3 project: A pan-cancer analysis.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the CDDP_EAGLE-1 Project', Oncogene.\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zheng, S., et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cell Reports, 2016.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Genomic Data Commons, Osteosarcoma TARGET-OS project, accessed 2023', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma', Journal of Clinical Oncology, 2022\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of oesophageal carcinoma. Nature, 541(7636), 169-175.', 'Zhang, L., Zhou, Y., Cheng, C., Cui, H., Cheng, L., Kong, P., ... & Wang, L. (2016). Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. American Journal of Human Genetics, 98(4), 667-679.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-404.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project data.'], ['Comprehensive genomic characterization of radiation-related papillary thyroid cancer in the Ukraine REBC-THYR project, Genomic Data Commons'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-CHOL Project Data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao, X., et al. Somatic copy-number alterations in human cancers. Nature Genetics. 2016 Oct;48(10):1069-1073.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017.', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Nature Biotechnology, 2016.'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive molecular characterization of uveal melanoma. Cell, 173(2), 511-517.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Analysis of Somatic Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Variants in Cancer: A Comprehensive Study. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). Copy Number Variants in Cancer Models. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget, 10(25), 2475-2489.', 'Liu, Y., et al. (2018). Comprehensive genomic profiling of bladder urothelial carcinoma in Chinese patients. Oncotarget, 9(23), 17114-17124.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-219.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015 Apr 1;75(7):1783-93.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu D, Zhang W, Chen W. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Phenotypic Profiles of Intrahepatic Cholangiocarcinoma. Hepatology. 2016 Nov;64(5):1602-1611.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], ['Publication 1: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Publication 2: The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Genomics and Cancer.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the CDDP_EAGLE-1 Project', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'ERBB2 Mutations in Lung Cancer: A Study from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: Findings from the CGCI-HTMCP-LC Project', Genomics and Cancer.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications', 'ERBB2 Mutation and CNV Analysis in CPTAC Studies'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'ERBB2 Mutations and Copy Number Variants in Lung Adenocarcinoma: A Study from the CDDP_EAGLE-1 Project', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). ERBB2 mutations and copy number variations in lung cancer. Oncogene.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of IDH1 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in IDH1 and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of IDH1 Mutations in Cancer Development: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Communications. 2013;4:1503.', 'The Cancer Genome Atlas (TCGA) Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['CPTAC-3 Brain Project Publication: Smith et al., 2021', 'CPTAC-3 Head and Neck Project Publication: Johnson et al., 2022', 'CPTAC-3 Kidney Project Publication: Lee et al., 2021', 'CPTAC-3 Lung Project Publication: Brown et al., 2023', 'CPTAC-3 Pancreas Project Publication: Davis et al., 2022', 'CPTAC-3 Uterus Project Publication: Wilson et al., 2023'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal. BEATAML1.0-COHORT Project.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cell Reports, 2018\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu C, Zhang W, Chen W. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['TCGA Research Network: Comprehensive molecular characterization of thymoma. Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-THYM project data.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhao, H., et al. The landscape of somatic mutations in kidney cancer. Nature Communications, 2013.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: a unified platform for cancer genomics data. Nature Biotechnology, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao, P., et al. (2019). Comprehensive characterization of somatic mutations in cervical cancer. International Journal of Cancer, 145(8), 2018-2028.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Cancer Genome Atlas Research Network. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in IDH1 Across Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in IDH1: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Genetics. 2013;45(12):1455-1463.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications', 'Nature Communications, 2021', 'Cell Reports, 2022'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Nature Communications\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA database'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://portal.gdc.cancer.gov/projects/TCGA-THYM'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zheng, S., et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cell Reports, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao, P., et al. (2019). Comprehensive characterization of somatic mutations in cervical cancer. International Journal of Cancer, 145(8), 1968-1978.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of IDH1 mutations in bladder cancer. Journal of Clinical Oncology, 37(15_suppl), e16000-e16000.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2019). Genomic landscape and immune microenvironment features of pre-treatment samples from the NCI-MATCH trial. Cell, 177(4), 1001-1014.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Mutational analysis of IDH1 in paired gastric carcinoma and non-neoplastic gastric tissue. Int J Cancer. 2010;126(7):1809-1812.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of EGFR in bladder cancer. Journal of Clinical Oncology, 37(15_suppl), e16000-e16000.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'EGFR Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinomas. Nature Genetics. 2018.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017', 'Publication 2: Genomic Data Commons: A Platform for Cancer Genomics Research, Cell, 2016'], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Cancer Models', Journal of Cancer Research\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in EGFR', Cancer Genomics\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in EGFR', Genomic Data Commons Review\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in MTOR and Their Implications in Cancer Research', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Study on MTOR mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of MTOR Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of MTOR in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'MTOR Pathway Alterations in Exceptional Responders', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' by the TARGET Osteosarcoma Working Group\"], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-Cell Lymphoma in the HIV+ Population, Genomic Data Commons', 'Publication 2: Genomic Alterations in MTOR Pathway in HIV-Associated Lymphomas, Genomic Data Commons'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/CHOL-2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(5):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers from the Genomic Data Commons. Cancer Res. 2019 Feb 1;79(3):662-674.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(3), 219-222.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Testicular germ cell tumors: Pathogenesis, diagnosis and treatment. Nature Reviews Urology, 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget. 2016;7(6): 6552-6565.', 'Cancer Genome Atlas Research Network. The Molecular Taxonomy of Bladder Cancer: A Comprehensive Review. Cell. 2017 Jan 26;168(4):684-699.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], [\"Ceccarelli, M., et al. (2016). 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.' Cell, 164(3), 550-563.\", \"Cancer Genome Atlas Research Network. (2015). 'Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.' New England Journal of Medicine, 372(26), 2481-2498.\"], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011 Aug 26;333(6046):1157-60.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, Schultz N, Cherniack AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14;374(2):135-145.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', \"Publication: 'Genomic Characterization of Angiosarcoma in the Count Me In Project', Journal of Clinical Oncology, 2023\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MTOR Pathway Alterations in Lung Adenocarcinoma: Data from the CDDP_EAGLE-1 Project', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'MTOR Pathway Alterations in HIV-Associated Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in HIV+ Lung Cancer Patients', Genomic Data Commons Reports.\"], ['Genomic Data Commons Data Portal - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC', 'Publication: Comprehensive molecular characterization of cervical cancer, Nature, 2017'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'MTOR Pathway Alterations in Osteosarcoma', Cancer Genomics & Proteomics.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of HIV-associated lymphomas. Cancer Research.', 'Publication 3: Brown, L. et al. (2022). Somatic mutations in MTOR in DLBCL. Oncogene.'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Journal of Thoracic Oncology. 2019;14(7):1235-1248.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Davis CF, Ricketts CJ, Wang M, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319-330.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/PanCan-CellOfOrigin', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers from the Genomic Data Commons. Cancer Res. 2019 Feb 1;79(3):662-674.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget. 2016;7(6): 6552-6565.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'Zhang H, et al. Nature. 2014; 511(7511):543-550.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research\"], ['Publication 1: Comprehensive molecular characterization of rectal adenocarcinoma in the TCGA-READ project.', 'Publication 2: Genomic alterations in rectal cancer: Insights from the TCGA-READ dataset.'], ['Genomic Data Commons Data Portal', 'Exceptional Responders (EXCEPTIONAL_RESPONDERS-ER) project documentation'], ['Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., ... & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2015). Integrated genomic characterization of adrenocortical carcinoma. Nature genetics, 47(6), 606-612.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Genomic characterization of gastric adenocarcinoma in the Cancer Genome Atlas. Cancer Res Treat. 2017;49(2):385-394.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, Gatza ML, Beck AH, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu L, Zhang T, Wang B, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers in China. Nature Genetics, 2018.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Zhao, M., et al. (2016). Somatic mutation profiling of clear cell renal cell carcinoma across different races. Cancer Medicine, 5(12), 3003-3011.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of KDR Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in Cancer: Insights from the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell.', 'Publication 3: Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas. The Cancer Genome Atlas Research Network. Nature.'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Rectum Adenocarcinoma: Insights from TCGA-READ', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Rectal Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Rectal Adenocarcinoma: A TCGA Study', Oncogene.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders (EXCEPTIONAL_RESPONDERS-ER) Project Documentation'], ['Publication 1: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma, TCGA Research Network', 'Publication 2: Integrated Genomic Characterization of Adrenocortical Carcinoma, Nature Genetics'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project (HTMCP) - Lung Cancer (CGCI-HTMCP-LC) dataset'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Publication: Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'The Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Genomic Data Commons Data Portal: TCGA-LUSC project data.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhao, H., et al. (2016). The landscape of somatic copy number alterations in kidney cancers. Nature Genetics, 48(10), 1177-1182.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Pancreatic Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Pancreatic Adenocarcinoma', Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Cancer: Findings from the CDDP_EAGLE-1 Study', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of KDR Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in KDR and Their Impact on Cancer Progression', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of TP53 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in TP53 and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of TP53 in Cancer: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 4;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Communications. 2013;4:1503.', 'The Genomic Data Commons Data Portal. https://portal.gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling of Wilms Tumor: TP53 mutations and treatment response. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Copy number variations in pediatric renal tumors: A focus on TP53. Pediatric Cancer Research.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications', 'Comprehensive Molecular Characterization of Cancer Genomes'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Publication on TP53 mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders Study Publications'], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], ['Robinson, D. et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell 161, 12151228 (2015).', 'Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 116, 1142811436 (2019).'], ['https://gdc.cancer.gov/about-data/publications/TARGET-WT'], ['Publication 1: Comprehensive Molecular Characterization of Lung Adenocarcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/target-osteosarcoma-2020'], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: TP53 Mutations in HIV-Associated Lymphomas, Genomic Data Commons'], ['https://gdc.cancer.gov/about-data/publications/APOLLO-LUAD'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', 'Publication: Love, C., et al. (2012). The genetic landscape of mutations in Burkitt lymphoma. Nature Genetics.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in TP53 and their impact on treatment response in acute lymphoblastic leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling in ALL: Insights from the MP2PRT-ALL project. Leukemia Research.', 'Publication 3: Brown, L. et al. (2023). The role of TP53 mutations in the prognosis of acute lymphoblastic leukemia. Cancer Genomics.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017;19(12):2878-2886.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/CHOL-2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of thymic epithelial tumors. Cell. 2018.', 'Genomic Data Commons Data Portal. TCGA-THYM project data.'], ['TCGA Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Bailey MH, Tokheim C, Porta-Pardo E, et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell. 2018.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Davis CF, Ricketts CJ, Wang M, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319-330.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhao, M., et al. Somatic mutations and copy number alterations in clear cell renal cell carcinoma: a comprehensive review. Nature Reviews Urology, 2020.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Hodis E, et al. A landscape of driver mutations in melanoma. Cell. 2012 Jul 20;150(2):251-263.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database. 2011.', 'Weinstein, JN., et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nature Genetics. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of TP53 mutations in bladder cancer. Oncotarget, 10(6), 618-630.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang, H., et al. (2016). Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell, 166(3), 755-765.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of FGFR1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in FGFR1 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in FGFR1: Implications for Cancer Therapy', Oncogene.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in FGFR1 Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'FGFR1 Mutations and Their Role in Cancer Progression'. Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2023). 'Comprehensive Analysis of FGFR1 Variants in Cancer'. Oncogene.\"], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network', 'Publication 2: Integrated Genomic Characterization of Endometrial Carcinoma, The Cancer Genome Atlas Research Network'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network, Cell, 2017.', 'Publication 2: The Genomic Landscape of Sarcoma, The Cancer Genome Atlas Research Network, Nature Genetics, 2017.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: FGFR1 Mutations and Their Impact', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'TARGET-OS Project: Comprehensive Genomic Profiling of Osteosarcoma', Cancer Genomics.\"], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], [\"Publication 1: 'Genomic landscape of metastatic breast cancer: Insights from the CMI-MBC project', Journal of Clinical Oncology, 2022.\", \"Publication 2: 'Comprehensive analysis of TP53 mutations in metastatic breast cancer', Nature Genetics, 2023.\"], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma. Nature, 2013.', 'Publication 3: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The Role of TP53 Mutations'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'TP53 Mutations in Lung Cancer: Data from the Genomic Data Commons'. Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MD, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Genomic Data Commons Data Portal', 'APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project publication'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-99.'], ['Genomic Data Commons - Exceptional Responders Project', \"Publication: 'Genomic landscape of exceptional responders to cancer therapy' in Nature\", \"Publication: 'Exceptional responders: a window into the rare biology of cancer' in Nature Reviews Cancer\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in CDK4 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of CDK4 Mutations in CPTAC-3 Cohorts', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'CDK4 Copy Number Variants in Cancer: Insights from CPTAC-3', Oncogene.\"], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project', Genomic Medicine.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Publication 1: Smith, J. et al. (2022). Comprehensive Genomic Profiling of Lung Adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Integrative Analysis of Somatic Mutations in Lung Cancer. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Copy Number Variants in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Somatic mutations and copy number variants in lung cancer. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in CPTAC-3 Projects', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in CPTAC-3', Cancer Genomics.\"], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Genomic Data Commons - NCI Cancer Model Development for the Human Cancer Model Initiative (HCMI-CMDC) project'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.'], ['Koboldt DC, Fulton RS, McLellan MD, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: BRAF Mutations and Treatment Response', Cancer Genomics.\"], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', \"Publication: Painter et al., 2020, 'The Genomic Landscape of Angiosarcoma', Nature Genetics\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of BRAF Mutations in Breast, Colon, and Ovary Cancers', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Analysis of BRAF Alterations in CPTAC-2 Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'BRAF Mutations and Copy Number Variants in CPTAC-2: A Multi-Cancer Study', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/datasets/target-osteosarcoma'], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: Somatic Mutations in HIV-Associated Lymphomas, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['MMRF-COMMPASS Study, Genomic Data Commons', \"Publication: 'Genomic landscape of multiple myeloma and clinical impact of mutations in the CoMMpass study', Nature Genetics\"], [\"Publication 1: Smith et al., 2021, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Alterations in ALL and Treatment Outcomes', Leukemia Research\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018;33(4):721-735.e8.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2018', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075691/'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive molecular characterization of pancreatic ductal adenocarcinoma. Nature, 2017.', 'Bailey, P., et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 2016.'], ['Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a contemporary review of diagnostic biomarkers. Cancer Genetics, 2019.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Oct 9;371(23):2189-2199.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: A Study of the CPTAC-3 Project', Oncogenomics.\"], ['Cancer Genome Atlas Research Network. (2017). Comprehensive molecular characterization of uveal melanoma. Cell, 173(2), 511-517.', 'Robertson, A. G., et al. (2017). Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Lerner SP, et al. Comprehensive molecular characterization of bladder urothelial carcinoma. Nature. 2017 Mar 2;543(7647):60-65.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in FGFR3 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of FGFR3 Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'FGFR3 Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in FGFR3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Human Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Lerner SP, et al. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2017 Mar 20;507(7492):315-22.'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of papillary thyroid carcinoma, Cell, 2014.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in FGFR3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in FGFR3 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2021, 'Somatic Mutations in FGFR3: Implications for Cancer Therapy', Oncogene.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of VHL Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Copy Number Variants in VHL: Insights from the Human Cancer Model Initiative', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in VHL Across Cancer Types', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med 2016; 374:135-145.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell 2017; 32(2):185-203.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell 2017; 171(4):950-965.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'VHL Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Lung Cancer: A Study of HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: Data from the CGCI-HTMCP-LC Project', Genomic Medicine.\"], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, New England Journal of Medicine, 2013'], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' by the TARGET Osteosarcoma Working Group\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of HIV-related lymphomas. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2022). The landscape of somatic mutations in HIV-positive DLBCL. Genomic Medicine.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). APOLLO-LUAD project: Insights into lung cancer genomics. Lung Cancer Journal.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network. Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal. TCGA-CHOL Project.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-ACC', 'https://portal.gdc.cancer.gov/projects/TCGA-ACC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Genomic Data Commons Data Portal, TCGA-TGCT project.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhang W, Edwards A, Flemington EK, Zhang K. The genomic landscape of viral oncogenesis in cervical cancer. Cancer Res. 2018 Apr 1;78(7):1896-1908.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, J., Baran, J., Cros, A., Guberman, J. M., Haider, S., Hsu, J., ... & Ferretti, V. (2011). International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Zack TI, Schumacher SE, Carter SL, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013 Oct;45(10):1134-40.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Genomic Landscape and Clinical Relevance of Somatic Mutations in Ovarian Cancer. Molecular Cancer Research. 2019;17(3):747-755.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of VHL Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Copy Number Variants in VHL: Insights from the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in VHL Across Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14;374(2):135-45.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell, 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell, 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Landscape of Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Cancer: Findings from the CDDP Integrative Analysis', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'VHL Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons Data Portal - HIV+ Tumor Molecular Characterization Project - Cervical Cancer (CGCI-HTMCP-CC)', \"Publication: 'Comprehensive molecular characterization of cervical cancer' - Nature, 2017\"], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200-225.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell. 2019;179(4):964-983.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinomas. Nature Genetics. 2018.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine. 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nature Reviews Urology, 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhang W, Edwards A, Flemington EK, Zhang K. The genomic landscape of viral oncogenesis in cervical cancer. Cancer Res. 2018 Apr 1;78(7):1896-1908.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of tumor mutation burden in Chinese patients with bladder cancer. Frontiers in Oncology, 9, 421.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2016). Genomic landscape and analysis of tumor mutation burden in endometrial cancer. Oncotarget, 7(39), 63901-63912.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Zack TI, Schumacher SE, Carter SL, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013 Oct;45(10):1134-40.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Genomic Landscape and Analysis of Prognostic Molecular Factors in Ovarian Serous Cystadenocarcinoma. J Clin Oncol. 2013;31(17):2177-2184.'], ['Genomic Data Commons Data Portal - TCGA-PAAD', 'Publication: Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization and Its Implications in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in MET Across Various Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of MET Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MET Copy Number Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Research.\"], ['Campbell JD, et al. (2016). Comprehensive genomic characterization of squamous cell lung cancers. Nature.', 'The Cancer Genome Atlas Research Network. (2012). Comprehensive genomic characterization of squamous cell lung cancers. Nature.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Clinical Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Publication 1: Comprehensive Molecular Characterization of Human Colon and Rectal Cancer. Nature, 2012.', 'Publication 2: Integrated Genomic Characterization of Ovarian Carcinoma. Nature, 2011.', 'Publication 3: Comprehensive Molecular Portraits of Human Breast Tumors. Nature, 2012.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2014). Integrated genomic analysis of bladder cancer identifies a subset with a high frequency of ERBB3 mutations. Nature Genetics, 46(6), 595-601.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in ERBB3 Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Johnson, L. et al. (2023). 'Comprehensive Analysis of ERBB3 Mutations in Cancer'. Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2023). 'ERBB3 Variants in the Human Cancer Model Initiative'. Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of ERBB3 mutations in bladder cancer. Journal of Clinical Oncology, 37(15_suppl), e16000-e16000.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ERBB3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ERBB3 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in ERBB3: Implications for Cancer Therapy', Oncogene.\"], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in TSC1 across Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of TSC1 Mutations in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'TSC1 Variants in Human Cancer Models', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data', \"Publication: 'Molecular Profiling to Predict Response to Treatment in Wilms Tumor', Journal of Clinical Oncology, 2023\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the CDDP Integrative Analysis', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in TSC1 and Their Role in Cancer Response', Cancer Research Journal.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of cervical cancer in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Somatic mutations in cervical cancer: A study from the Genomic Data Commons. Oncogene.'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Genomic Characterization of Osteosarcoma' in Nature Communications\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in HIV-associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Characterization of HIV+ DLBCL', Cancer Genomics\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in HIV-related Lymphomas', Genomic Data Commons Reports\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Genomic Data Commons Data Portal', 'Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: Genomic alterations in diffuse large B-cell lymphoma, Nature, 2016.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Nature, 2017'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.', 'Genomic Data Commons Data Portal. Uveal Melanoma (TCGA-UVM) Project.'], ['Davis, C. F., et al. (2014). The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 26(3), 319-330.', 'The Cancer Genome Atlas Research Network. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic analysis of testicular germ cell tumors in the TCGA database. Nature Genetics, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of TSC1 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in TSC1 Across Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/BRCA-2012'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics & Proteomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell. 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in TSC1 and Their Impact on Cancer Treatment Outcomes', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in TSC1 and Their Role in Exceptional Response to Therapy', Nature Genetics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons, TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma', Journal of Clinical Oncology, 2022\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of HIV+ DLBCL. Cancer Genomics.', 'Publication 3: Brown, L. et al. (2022). Somatic mutations in HIV-related lymphomas. Genomic Data Commons Reports.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Alterations in ALL', Leukemia Research\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2015', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129875/'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951821/'], ['National Cancer Institute Genomic Data Commons Data Portal', 'TCGA Research Network publications on Uterine Carcinosarcoma'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Zhang, J., et al. (2019). Genomic Landscape of Liver Cancers from the Genomic Data Commons. Nature Communications.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis CF, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., ... & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2017). Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell, 171(4), 950-965.'], ['Testicular Germ Cell Tumors (TGCT) TCGA dataset in the Genomic Data Commons', 'Comprehensive molecular characterization of testicular germ cell tumors. Nature. 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., Wong-Erasmus, M., Yao, L., Kasprzyk, A. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 2014'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer: A Comprehensive Study', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics & Proteomics.\"], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Genomics.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Research Journal.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis'. Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2019). 'Copy Number Variants in Cervical Cancer: Findings from the HTMCP Project'. Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Osteosarcoma: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Pediatric Osteosarcoma', Pediatric Oncology Journal.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma, TCGA, 2015', 'Publication 2: Genomic Data Commons Data Portal, TCGA-DLBC Project'], ['TCGA Research Network: Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal: TCGA-PCPG project data.'], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.'], ['Publication 1: Comprehensive Molecular Characterization of Cholangiocarcinoma, TCGA Network', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, TCGA Network'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: Integrated genomic characterization of oesophageal carcinoma, Nature, 2017.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Publication 1: Comprehensive Molecular Characterization of Malignant Pleural Mesothelioma, The Cancer Genome Atlas Research Network, 2018.', 'Publication 2: Integrated Genomic Analyses of Ovarian Carcinoma, The Cancer Genome Atlas Research Network, 2011.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-SARC'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Pancreatic Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Pancreatic Cancer', Genomic Medicine.\"], ['Publication 1: Comprehensive Molecular Characterization of Uterine Carcinosarcoma, TCGA Research Network', 'Publication 2: Integrated Genomic and Molecular Characterization of Uterine Carcinosarcoma, Nature Communications'], ['Publication 1: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Papillary Renal Cell Carcinoma. The Cancer Genome Atlas Research Network. Cell Reports, 2017.'], ['Publication 1: Comprehensive Molecular Characterization of Adrenocortical Carcinoma, TCGA Research Network', 'Publication 2: Integrated Genomic Characterization of Adrenocortical Carcinoma, Nature Communications'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of testicular germ cell tumors. Cell Reports, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive genomic characterization of squamous cell carcinoma of the cervix, Nature, 2017.', 'Publication 2: Integrated genomic and molecular characterization of cervical cancer, Nature, 2018.'], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.'], ['Publication 1: Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma, Nature, 2014.', 'Publication 2: The Cancer Genome Atlas Research Network, Cell, 2017.'], ['Publication 1: Comprehensive molecular characterization of uterine corpus endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Grossman RL, Heath AP, Ferretti V, et al. Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016;375(12):1109-1112.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576-582.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'McLendon R, Friedman A, Bigner D, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.'], ['Publication 1: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Publication 2: The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Publication 1: Smith, J. et al. (2022). Analysis of UGT1A1 Variants in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Alterations in the HCMI-CMDC Project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Somatic Mutations in Cancer Models. Genomic Data Commons Reports.'], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 4349 (2013).', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 4349 (2013).'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Adenocarcinoma, The Cancer Genome Atlas Research Network, 2014.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, 2013.'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons Data Portal', 'HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Oct 9;32(3):405-418.e13.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], ['TCGA Research Network: Comprehensive molecular characterization of esophageal carcinoma. Nature 2017.', 'Genomic Data Commons Data Portal: TCGA-ESCA project data.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2015', 'https://portal.gdc.cancer.gov/projects/TCGA-THYM'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-SARC'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal: Kidney Renal Papillary Cell Carcinoma (TCGA-KIRP) dataset.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-ACC', 'https://portal.gdc.cancer.gov/projects/TCGA-ACC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://portal.gdc.cancer.gov/projects/TCGA-TGCT'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. NEJM 2015.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Gross AM, et al. (2014). 'The Genomic Landscape of Head and Neck Squamous Cell Carcinoma'. Cancer Discovery.\", \"The Cancer Genome Atlas Network. (2015). 'Comprehensive genomic characterization of head and neck squamous cell carcinomas'. Nature.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Analysis of MLH1 Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Variants in Cancer: A Comprehensive Study. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2021). The Role of MLH1 in Cancer Development. Oncogene Journal.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications', 'Cancer Genome Atlas Research Network'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'MLH1 Mutations in Lung Cancer: A Study from the CDDP Integrative Analysis'. Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in MLH1 and Their Impact on Cancer Treatment Outcomes', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in MLH1 and Their Role in Cancer Progression', Genomic Medicine.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project data', \"Publication: 'Comprehensive molecular characterization of lung cancer in HIV-positive patients' - Journal of Cancer Research, 2022\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular characterization of cervical cancer in HIV-positive patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Somatic mutations in cervical cancer: A comprehensive analysis.' Genomic Data Commons Reports.\"], [\"Publication 1: 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research, 2022.\", \"Publication 2: 'Somatic Mutations in Pediatric Osteosarcoma: Insights from the Genomic Data Commons', Pediatric Oncology Journal, 2023.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Research Journal.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Somatic mutations and copy number variants in lung cancer. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Zhang J, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2013.', 'Reddy A, et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017.'], ['Genomic Data Commons Data Portal - TCGA-PCPG project', 'TCGA Research Network publications on Pheochromocytoma and Paraganglioma'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['PubMed ID: 12345678', 'PubMed ID: 23456789', 'PubMed ID: 34567890'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'The Cancer Genome Atlas Research Network publications on Kidney Chromophobe'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis, K., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.', 'Beroukhim, R., et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zehir, A., Benayed, R., Shah, R. H., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, Schultz N, Cherniack AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of MLH1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in MLH1 and Their Impact on Cancer Development', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in MLH1: Frequency and Implications', Genomic Data Commons Review.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao, M., et al. (2016). Somatic mutation profiling and analyses in renal cell carcinoma. Oncotarget, 7(22), 33498-33510.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Characterization of Somatic Mutations in Exceptional Responders', Nature Genetics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cell Reports, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Gillette MA, Satpathy S, Cao S, et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell. 2020;182(1):200-225.e35.', 'Clark DJ, Dhanasekaran SM, Petralia F, et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2019;179(4):964-983.e31.'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA database'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://portal.gdc.cancer.gov/projects/TCGA-THYM'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic features of testicular germ cell tumors. Nature Genetics, 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MLH1 Across Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in MLH1: Insights from the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in MLH1: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in MLH1 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of MLH1 Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MLH1 Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in MLH1 and Their Impact on Cancer Treatment Outcomes', Cancer Research Journal.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization and Its Implications in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of cervical cancer in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Somatic mutations and copy number variations in cervical cancer: A study from the Genomic Data Commons. Oncogene.'], [\"Publication 1: 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research, 2022.\", \"Publication 2: 'Somatic Mutations in Pediatric Osteosarcoma: Insights from the Genomic Data Commons', Pediatric Oncology Journal, 2023.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Characterization of HIV-Positive Lymphomas', Cancer Genomics\", \"Publication 3: Lee et al., 2021, 'Copy Number Variants in HIV-Related Lymphomas', Genomic Data Commons Reports\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma, TCGA, 2015', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Diffuse Large B-cell Lymphoma, Nature, 2018'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):363-373.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive Molecular Characterization of Intrahepatic and Extrahepatic Cholangiocarcinomas in the TCGA-CHOL Project'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['PubMed ID: 12345678', 'PubMed ID: 23456789', 'PubMed ID: 34567890'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['TCGA-KICH publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', 'Genomic Data Commons Data Portal: Kidney Chromophobe (TCGA-KICH) project'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adrenocortical Carcinoma. Cell. 2016.', 'Genomic Data Commons Data Portal: TCGA-ACC Project'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Cervical Squamous Cell Carcinoma. Neoplasia. 2019 Apr;21(4):368-376.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of MLH1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'MLH1 Mutations in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in MLH1 Across Cancer Types', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['CPTAC-3 Project Data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma' - The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Endometrial Carcinoma' - The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in MLH1 and Their Impact on Cancer Treatment Outcomes', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in MLH1 and Their Role in Cancer Response', Nature Genetics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['Genomic Data Commons, TARGET-OS project data'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2022). Somatic mutations in HIV-related lymphomas. Genomic Data Commons Reports.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Cerami, E. et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012.', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Fishbein L, Leshchiner I, Walter V, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018;33(4):721-735.e8.'], ['PubMed ID: 28481359', 'PubMed ID: 29625050'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['TCGA Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378-384.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 619-629.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic features of testicular germ cell tumors. Nature Genetics, 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of MLH1 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in MLH1 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in MLH1: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-404.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of MLH1 Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: A Study from the Genomic Data Commons', Genomics and Oncology.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in MLH1 and Their Impact on Cancer Treatment Outcomes', Cancer Research.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in HIV+ Lung Cancer Patients', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization and Its Implications in Cervical Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in MLH1 and Their Role in Cervical Cancer', Genomic Data Commons Reports.\"], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the Genomic Data Commons\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in HIV-associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Characterization of HIV+ DLBCL', Cancer Genomics\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in HIV-related Lymphomas', Genomic Data Commons Reports\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: Genomic alterations in diffuse large B-cell lymphoma, Nature, 2016.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Thymoma TCGA-THYM project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors in the TCGA database'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Genomic Data Commons Data Portal', 'TCGA-KICH project publications'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute.'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Pancreatic Adenocarcinoma', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pancreatic Cancer', Nature Genetics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Cancer Genomics', Cancer Research.\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Cancer Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic analysis of testicular germ cell tumors in the TCGA project. Nature Genetics, 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-525.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['TCGA Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Cibulskis, K., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MSH6 Across Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in MSH6: Insights from the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in MSH6: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['CPTAC-3: Comprehensive Proteogenomic Characterization of Human Cancer', 'Genomic Data Commons Data Portal', 'MSH6 Mutation Analysis in Cancer Studies'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MSH6 Mutations in Lung Adenocarcinoma: A Study from the CDDP Integrative Analysis', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Characterization of Somatic Mutations in Exceptional Responders', Nature Genetics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC', 'Publication: Comprehensive molecular characterization of lung cancer in HIV-positive patients, Journal of Clinical Oncology, 2022'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project', \"Publication: 'Comprehensive Molecular Characterization of Cervical Cancer' - Nature, 2017\"], ['Genomic Data Commons, TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma', Journal of Clinical Oncology, 2022\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Research Journal.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Johnson, L. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', 'Publication: Comprehensive genomic analysis of Burkitt lymphoma reveals novel oncogenic pathways and mutations. Nature Genetics, 2019.'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (TCGA-DLBC) project.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\", \"Publication: 'Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia' - New England Journal of Medicine, 2013\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu D, Zhang W, Chen W. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis CF, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of VHL Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in VHL Across Cancer Models', Cancer Genomics Journal.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14;374(2):135-45.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons Data Portal - CPTAC-3 Project', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma' - The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma' - The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Publication 1: Smith et al., 2022, Journal of Cancer Research', 'Publication 2: Johnson et al., 2023, Genomics and Cancer', 'Publication 3: Lee et al., 2023, Exceptional Responders Study'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC'], ['Genomic Data Commons - TARGET-OS project data'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Proteomics\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Cancer Research\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Genomic Data Commons, TCGA-CHOL project data', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinoma. Cell Reports, 2017.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.', 'Genomic Data Commons Data Portal. TCGA-UVM Project.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang Y, et al. Genomic Landscape of Soft Tissue Sarcomas in the TCGA. J Clin Oncol. 2018;36(15_suppl):11515-11515.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-ACC', 'https://portal.gdc.cancer.gov/projects/TCGA-ACC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://portal.gdc.cancer.gov/projects/TCGA-TGCT'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, J., Baran, J., Cros, A., Guberman, J. M., Haider, S., Hsu, J., ... & Ferretti, V. (2011). International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., Van Allen, E. M., Wu, Y. M., Schultz, N., Lonigro, R. J., Mosquera, J. M., ... & Chinnaiyan, A. M. (2015). Integrative clinical genomics of advanced prostate cancer. Cell, 161(5), 1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-98.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-63.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Genomic Landscape and Analysis of Prognostic Molecular Factors in Ovarian Serous Cystadenocarcinoma. Cancer Cell. 2013 Dec 9;24(6):728-41.'], ['Publication 1: Smith, J. et al. (2022). Analysis of Somatic Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Variants in Cancer Development. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Copy Number Variants in Cancer Models. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling in pediatric renal tumors: A comprehensive study. Pediatric Cancer Research.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in DNA Mismatch Repair Genes in Exceptional Responders', Cancer Research.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Comprehensive Genomic Profiling of Lung Cancer in HIV+ Patients'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'MSH6 Mutations in Lung Cancer: A Study from the CGCI-HTMCP-LC Project'. Genomic Medicine.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'HIV-associated cervical cancer: Genomic insights from the HTMCP project.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Somatic mutations in cervical cancer: A comprehensive analysis from the HTMCP-CC project.' Genomics and Cancer.\"], ['Genomic Data Commons, TARGET-OS project, accessed 2023', \"Publication: 'Comprehensive Genomic Characterization of Osteosarcoma', Journal of Cancer Research, 2022\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Somatic mutations in HIV-related lymphomas. Genomic Data Commons Research.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of Burkitt lymphoma reveals novel oncogenic pathways and mutations' - Journal of Clinical Oncology\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['TCGA-KICH project data from the Genomic Data Commons', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017 Apr 10;31(4):411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors: a review. International Journal of Clinical and Experimental Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., Wong-Erasmus, M., Yao, L., Kasprzyk, A. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-25.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-28.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Publication 1: Smith, J. et al. (2022). Analysis of SLCO1B1 mutations in cancer models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in SLCO1B1 across cancer types. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Copy number variations in SLCO1B1 in the HCMI-CMDC project. Genomic Data Commons Reports.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Publication: Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive molecular characterization of the CPTAC-3 project, Nature, 2020.', 'Publication 2: Genomic alterations in cancer: The CPTAC-3 perspective, Cancer Research, 2021.'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project', \"Publication: 'Genomic Characterization of Angiosarcoma in the Count Me In Project', Journal of Clinical Oncology, 2023\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Genomics.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in SLCO1B1 and Their Role in Lung Cancer', Cancer Research Journal.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET-OS project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: Genomic alterations in diffuse large B-cell lymphoma, Nature, 2016'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Publication 1: Comprehensive Molecular Characterization of Cholangiocarcinoma, The Cancer Genome Atlas Research Network, 2017.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network, 2013.'], ['Genomic Data Commons Data Portal - TCGA-ESCA', \"Publication: 'Comprehensive molecular characterization of esophageal carcinoma' - Nature, 2017\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Pancreatic Cancer', Pancreatic Cancer Journal.\"], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'GDC Data Portal: Kidney Renal Papillary Cell Carcinoma (TCGA-KIRP) project.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/acc_2016'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in testicular germ cell tumors. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of testicular germ cell tumors. Cancer Genomics.', 'Publication 3: Brown, L. et al. (2019). Somatic mutations in testicular cancer. Oncogene.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Genomic Data Commons Data Portal', 'TCGA-CESC project publications'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Grossman RL, et al. Toward a Shared Vision for Cancer Genomic Data. N Engl J Med. 2016;375(12):1109-1112.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113-1120.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Genomic Data Commons Data Portal - TCGA-LUSC Project', 'Publication: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['Publication 1: Comprehensive molecular characterization of human ovarian serous cystadenocarcinoma, Nature, 2011.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma, Nature, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, et al. The Genomic Landscape of Lung Squamous Cell Carcinoma and Its Impact on Therapy. Nature Reviews Cancer. 2017.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics. 2016.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in the Human Cancer Model Initiative. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Comprehensive analysis of somatic mutations in cancer models. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Copy number variations in cancer: Insights from the HCMI-CMDC project. Genomic Data Commons Reports.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/target-osteosarcoma-2020'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', \"Publication: Painter et al., 2020, 'The Genomic Landscape of Angiosarcoma', Nature Communications\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of DDX41 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in DDX41 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in DDX41 and Their Impact on Cancer Progression', Genomic Medicine.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/BRCA-2012'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in DDX41 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in CPTAC-3 Cohorts', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: Insights from CPTAC-3', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-PCPG', 'https://portal.gdc.cancer.gov/projects/TCGA-PCPG'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 2017.', 'The Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], [\"Publication 1: 'Comprehensive molecular characterization of esophageal carcinoma', The Cancer Genome Atlas Research Network, Nature, 2017.\", \"Publication 2: 'Genomic alterations in esophageal carcinoma: insights from TCGA', Smith et al., Journal of Clinical Oncology, 2018.\"], ['Genomic Data Commons, TCGA-THYM project data', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors in The Cancer Genome Atlas, Nature Communications'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pancreatic Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Pancreatic Adenocarcinoma', Genomic Medicine.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-ACC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://portal.gdc.cancer.gov/projects/TCGA-TGCT'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Genomic Data Commons Data Portal. TCGA-BLCA project data.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal. Uterine Corpus Endometrial Carcinoma (TCGA-UCEC) Project.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Campbell JD, et al. (2016). Comprehensive, Integrative, and Comparative Genomic Analysis of Lung Adenocarcinoma. Cell.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-OV'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of DDX41 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in Cancer: A Study of DDX41', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in DDX41 Across Cancer Types', Genomic Data Commons Reports.\"], ['TCGA Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal. National Cancer Institute. Accessed October 2023.'], ['Genomic Data Commons Data Portal', 'TCGA-BRCA project publications'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data', \"Publication: 'Comprehensive Molecular Characterization of Wilms Tumor' in the Genomic Data Commons\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons Data Portal', 'HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project dataset'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/sample-type-codes'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma CGCI-HTMCP-DLBCL project'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Alterations in ALL', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Leukemia', Cancer Genomics\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-PCPG', 'https://portal.gdc.cancer.gov/projects/TCGA-PCPG'], ['Genomic Data Commons Data Portal - TCGA-READ project'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], ['TCGA Research Network: Comprehensive molecular characterization of esophageal carcinoma. Nature 2017.', 'Genomic Data Commons Data Portal: TCGA-ESCA project data.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-THYM'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-LIHC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-ACC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix and endocervical adenocarcinoma' in Nature, 2017\"], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015; 372:2481-2498.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics. 2016.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature 2011.', 'Genomic Data Commons Data Portal: TCGA-OV project data.'], ['Campbell JD, et al. (2016). Genomic and Immune Profiling of Preinvasive Lung Adenocarcinoma. Nature Communications.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'ERBB2 Mutations in HIV+ Lung Cancer Patients', Genomic Data Commons Reports.\"], ['Publication 1: Smith, J. et al. (2022). Comprehensive Genomic Characterization of ERBB2 in CPTAC-3. Journal of Genomic Data, 15(3), 123-135.', 'Publication 2: Johnson, L. et al. (2023). Somatic Mutations and Copy Number Variants in ERBB2 Across Multiple Cancer Types. Cancer Genomics, 18(2), 45-60.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'ERBB2 Mutations and Copy Number Variants in Lung Adenocarcinoma: Findings from the CDDP_EAGLE-1 Study', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.', 'Weinstein JN, Collisson EA, Mills GB, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). ERBB2 mutations in lung cancer: A comprehensive analysis. Lung Cancer Journal.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'ERBB2 Mutations in Lung Cancer: A Study from the CGCI-HTMCP-LC Project.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'Copy Number Variants in Lung Cancer: Findings from the Genomic Data Commons.' Oncogene Research.\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell, 2017.', 'Publication 3: Integrated Genomic and Molecular Characterization of Cervical Cancer. The Cancer Genome Atlas Research Network. Nature, 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the CDDP_EAGLE-1 Study', Genomic Medicine.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). ERBB2 mutations in lung cancer: A comprehensive study. Oncogene.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of VHL Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in VHL and Their Impact on Cancer Progression', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 4;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine.', 'Publication 2: Integrated Genomic Characterization of Head and Neck Squamous Cell Carcinoma. The Cancer Genome Atlas Research Network. Nature.', 'Publication 3: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. The Cancer Genome Atlas Research Network. New England Journal of Medicine.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders EXCEPTIONAL_RESPONDERS-ER project documentation'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons, TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the Genomic Data Commons\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). APOLLO-LUAD project: Insights into lung cancer genomics. Lung Cancer Journal.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017;19(12):2878-2886.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Journal of Thoracic Oncology. 2019;14(7):1235-1248.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Davis, C. F., et al. (2014). The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 26(3), 319-330.', 'The Cancer Genome Atlas Research Network. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu; Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13. doi: 10.1016/j.ccell.2017.07.007. PMID: 28810144; PMCID: PMC5554564.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52. doi: 10.1038/nature16965. PMID: 26909576; PMCID: PMC4893174.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine. 2016.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687490/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhang W, Edwards A, Flemington EK, Zhang K. The genomic landscape of viral oncogenesis in cervical cancer. Cancer Res. 2018 Apr 1;78(7):1896-1908.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of tumor mutation burden in Chinese patients with locally advanced or metastatic urothelial carcinoma. Annals of Oncology, 30, v356-v357.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Zack TI, Schumacher SE, Carter SL, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013 Oct;45(10):1134-40.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Genomic Landscape and Phenotype Correlation of TCGA-OV. Cell. 2013 Apr 11;153(2):287-98.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Annual Review of Pathology: Mechanisms of Disease, 2018.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Models: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: A Comprehensive Analysis', Genomics and Cancer.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao, H., et al. (2013). The landscape of somatic copy-number alteration across human cancers. Nature. 497, 6773.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell. 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Landscape of Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Cancer: Findings from the CDDP_EAGLE-1 Study', Oncogene.\"], ['Publication 1: Comprehensive Molecular Characterization of Human Colon and Rectal Cancer, Nature, 2012.', 'Publication 2: Integrated Genomic Characterization of Ovarian Carcinoma, Nature, 2011.', 'Publication 3: Comprehensive Molecular Portraits of Human Breast Tumors, Nature, 2012.'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'Somatic Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Nature Medicine.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539987/'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'The Cancer Genome Atlas Research Network publications'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/TCGA-ACC', 'https://portal.gdc.cancer.gov/projects/TCGA-ACC'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Sanchez-Vega, F., et al. (2018). Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell, 173(2), 321-337.e10.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PTEN in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PTEN Mutations in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in PTEN Across Cancer Types', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao, M., et al. (2016). Somatic copy-number alterations and their prognostic implications in clear cell renal cell carcinoma. Cancer Research, 76(7), 2016-2024.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling of Wilms Tumor: PTEN mutations and treatment response. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Copy number variations in pediatric renal tumors: A focus on PTEN. Pediatric Cancer Research.'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['CPTAC-2 Breast Cancer Study, Genomic Data Commons', 'CPTAC-2 Colon Cancer Study, Genomic Data Commons', 'CPTAC-2 Ovarian Cancer Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PTEN Mutations in Cancer Therapy Response', Cancer Genomics.\"], ['Reference 1: Genomic Data Commons - Count Me In: The Metastatic Prostate Cancer Project', 'Reference 2: Study on PTEN mutations in metastatic prostate cancer - Genomic Data Commons'], ['Genomic Data Commons, Count Me In: The Metastatic Breast Cancer Project (CMI-MBC), PTEN mutation and copy number variant data, accessed 2023.'], ['Genomic Data Commons - TARGET-CCSK project'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'PTEN Mutations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). PTEN mutations in cervical cancer: A comprehensive analysis. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). The role of PTEN in cervical cancer pathogenesis. Oncogene.'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/datasets/target-osteosarcoma'], ['Genomic Data Commons Data Portal - TARGET-ALL-P2 Project', \"Publication: 'Comprehensive Genomic Characterization of Pediatric Acute Lymphoblastic Leukemia' in Nature Genetics\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of HIV-Related Lymphomas', Cancer Genomics\", \"Publication 3: Lee et al., 2019, 'PTEN Mutations in HIV-Positive Lymphomas', Oncogene\"], ['Genomic Data Commons - APOLLO-LUAD Project', 'Publication: Proteogenomic characterization of lung adenocarcinoma in the APOLLO1 project'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of Burkitt lymphoma reveals distinct somatic mutation patterns and potential therapeutic targets'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in PTEN and their impact on treatment response in ALL. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling in acute lymphoblastic leukemia: Insights from the MP2PRT-ALL project. Leukemia Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/CHOL-2017'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['PubMed ID: 25691460', 'PubMed ID: 26544997'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378-384.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093088/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., Wong-Erasmus, M., Yao, L., Kasprzyk, A. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'PDGFRA Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Publication 1: Comprehensive molecular characterization of the CPTAC-3 project', 'Publication 2: Genomic alterations in PDGFRA across various cancer types', 'Publication 3: Analysis of somatic mutations and copy number variants in cancer'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive molecular characterization of uveal melanoma. Cell, 173(2), 511-517.', 'Robertson, A. G., et al. (2017). Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell, 32(2), 204-220.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in PDGFRA across cancer types. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Comprehensive analysis of PDGFRA mutations in cancer. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). PDGFRA in cancer: Mutation and copy number variation landscape. Oncogene.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ERBB2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ERBB2 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in ERBB2: Implications for Targeted Therapy', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-404.'], ['Publication 1: Smith, J. et al. (2022). Molecular Profiling in Wilms Tumor: Insights from the MP2PRT-WT Project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in Wilms Tumor: A Comprehensive Analysis. Cancer Genomics & Proteomics.'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', \"Publication: Painter et al., 2020, 'The Genomic Landscape of Angiosarcoma', Nature Communications\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations and Copy Number Variants in Exceptional Responders', Cancer Research Journal.\"], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017', 'Publication 2: The Genomic Landscape of Cervical Cancer, Cancer Cell, 2018'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/target-osteosarcoma-2020'], [\"Publication 1: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Clinical Oncology, 2022.\", \"Publication 2: 'Genomic Alterations in HIV-Associated Lymphomas', Blood Journal, 2023.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Publication 1: Comprehensive Molecular Characterization of Intrahepatic and Extrahepatic Cholangiocarcinomas in the TCGA-CHOL Project', 'Publication 2: Genomic Alterations in Cholangiocarcinoma: Insights from the TCGA-CHOL Dataset'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Kim J, Bowlby R, Mungall AJ, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.'], ['PubMed ID: 28874634', 'PubMed ID: 31757952'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., ... & Schultz, N. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling, 6(269), pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers in China. Nature Genetics, 2019.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Papillary Renal Cell Carcinoma. The Cancer Genome Atlas Research Network. Cell Reports, 2017.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-641.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology. 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Cancer Genome Atlas Research Network. The Molecular Taxonomy of Bladder Cancer: A Comprehensive Review. Cell. 2017.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim, P., et al. Genomic landscape of gastric cancer. Nat Genet. 2014;46(6):598-604.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ERBB2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ERBB2 and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in ERBB2: Frequency and Implications', Genomic Data Commons Review.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell, 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell, 2017.'], ['Reference 1: Genomic Data Commons - Count Me In (CMI): The Angiosarcoma (ASC) Project', 'Reference 2: Publication on ERBB2 mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations and Copy Number Variants in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of ERBB2 in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of Lung Cancer in HIV+ Patients'. Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2019). 'ERBB2 Mutations in Lung Cancer: A Study from the Genomic Data Commons'. Oncogene.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: Genomic Alterations in HIV-Associated Lymphomas, Genomic Data Commons'], [\"Publication 1: 'Proteogenomic characterization of lung adenocarcinoma in the APOLLO-LUAD project', Journal of Proteomics, 2023.\", \"Publication 2: 'Genomic alterations in ERBB2 and their impact on lung adenocarcinoma', Cancer Research, 2023.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia: Insights from the MP2PRT-ALL Project', Journal of Hematology.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations and Their Impact on Treatment Response in ALL', Leukemia Research.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['https://gdc.cancer.gov/about-data/publications/pcpg_2017', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951821/'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinomas. Nature Genetics. 2018.'], ['The Cancer Genome Atlas Research Network. (2015). Comprehensive genomic characterization of thymic epithelial tumors. Cell, 163(4), 1014-1027.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database. 2019.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Papillary Renal Cell Carcinoma. The Cancer Genome Atlas Research Network. Cell Reports, 2017.'], ['The Cancer Genome Atlas Research Network. (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New England Journal of Medicine, 368(22), 2059-2074.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.', 'Ciriello G, Miller ML, Aksoy BA, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney C, McConkey DJ. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014 Feb 10;25(2):152-65.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, Chan AS, Tsui WY, Ho SL, Chan AK, Chan TL, Wu C, Li VS, Clevers H, Rejto PA, Leung SY. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014 Jun;46(6):573-82.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by The Cancer Genome Atlas. Cancer. 2015;121(12):1969-78.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Beroukhim R, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A. 2007 Oct 23;104(50):20007-12.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Chin L, Andersen JN, Futreal PA. Cancer genomics: from discovery science to personalized medicine. Nat Med. 2011 Mar;17(3):297-303.', 'Weinstein JN, Collisson EA, Mills GB, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'The Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in ERBB2 Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Johnson, L. et al. (2023). 'Comprehensive Analysis of ERBB2 Mutations in Cancer'. Cancer Genomics.\", \"Publication 3: Lee, M. et al. (2023). 'ERBB2 Variants in the Human Cancer Model Initiative'. Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project data'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell, 2017.', 'Publication 3: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. The Cancer Genome Atlas Research Network. Cell, 2017.'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project (CMI-ASC), ERBB2 mutation and copy number variant data.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'ERBB2 Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'ERBB2 Mutations in Lung Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\", \"Publication 3: 'The Genomic Data Commons: A Platform for Precision Medicine Research', Journal of the American Medical Informatics Association, 2016.\"], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Nature Communications\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of HIV-Related Lymphomas.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'ERBB2 Mutations in HIV-Positive Lymphomas.' Oncogene.\"], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). ERBB2 mutations in lung adenocarcinoma: A comprehensive analysis. Oncogene.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2, 401404 (2012).', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA dataset'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: Genomic alterations in esophageal carcinoma: insights from The Cancer Genome Atlas (TCGA) project, Journal of Thoracic Oncology, 2018.'], ['PubMed ID: 12345678', 'PubMed ID: 23456789', 'PubMed ID: 34567890'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'ERBB2 Mutations in Pancreatic Cancer', Oncogene.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Pancreatic Adenocarcinoma', Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Nature Reviews Gastroenterology & Hepatology, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zehir, A., Benayed, R., Shah, R. H., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network publications on TCGA-LAML'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in testicular germ cell tumors. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of testicular germ cell tumors. Cancer Genomics.', 'Publication 3: Brown, L. et al. (2022). Somatic mutations in testicular cancer: A genomic data commons analysis. Oncogene.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Publication 1: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Publication 2: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cheng T, Roth B, Choi W, et al. Fibroblast growth factor receptors and their ligands in urothelial carcinoma of the bladder. Urol Oncol. 2013 Nov;31(8):1697-706.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., ... & Perou, C. M. (2015). Comprehensive molecular portraits of invasive lobular breast cancer. Cell, 163(2), 506-519.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Berger AC, Korkut A, Kanchi RS, et al. A comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell. 2018 Apr 9;33(4):690-705.e9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project', \"Publication: 'Genomic Characterization of Wilms Tumor and its Implications for Treatment' in Journal of Clinical Oncology\"], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, NRAS mutation frequency data'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project', 'Publication: Comprehensive molecular characterization of cervical cancer, Nature, 2017'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Osteosarcoma: Insights from the TARGET-OS Project', Genomic Medicine.\"], ['Genomic Data Commons Data Portal - TARGET-ALL-P2 Project', \"Publication: 'Comprehensive genomic profiling of pediatric acute lymphoblastic leukemia' in Nature Communications\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Genomic Data Commons - APOLLO-LUAD Project', 'Proteogenomic Characterization of Lung Adenocarcinoma - APOLLO1 Study'], ['Multiple Myeloma Research Foundation (MMRF) CoMMpass Study, Genomic Data Commons', \"Publication: 'Genomic landscape of multiple myeloma and clinical impact of mutations in the CoMMpass study', Nature Genetics\"], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Acute Myeloid Leukemia in the TARGET-AML Project', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'NRAS Mutations in Acute Myeloid Leukemia: Insights from the Genomic Data Commons', Leukemia Research\"], ['Publication 1: Smith, J. et al. (2020). Genomic Landscape of Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Johnson, L. et al. (2021). NRAS Mutations in Pediatric Leukemia. Leukemia Research.', 'Publication 3: Williams, R. et al. (2022). Copy Number Variants in ALL. Cancer Genomics.'], ['Publication 1: Smith, J. et al. (2022). Molecular Profiling in Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Genomic Alterations in ALL: Insights from the MP2PRT-ALL Project. Leukemia Research.'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the Genomic Data Commons'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu, Y., Sethi, N. S., Hinoue, T., et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2018', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075691/'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project data.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Wang, Y., et al. Genomic features of testicular germ cell tumors. Nature Genetics. 2018.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-525.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet. 2003 Nov;114(6):118-20.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], ['Publication 1: Smith, J. et al. (2020). Genomic Landscape of Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). NRAS Mutations in Pediatric Leukemia. Leukemia Research.', 'Publication 3: Johnson, L. et al. (2019). Copy Number Variants in Leukemia. Cancer Genomics.'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Acute Myeloid Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'NRAS Mutations in AML: Clinical Implications', Leukemia Research\"], ['Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', \"Publication: 'Genomic landscape of metastatic breast cancer' in Nature, 2020\", \"Publication: 'PIK3CA mutations in breast cancer: prognostic and therapeutic implications' in Cancer Research, 2019\"], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons Data Portal', 'CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovary Cancer Study'], ['Genomic Data Commons, NCI Cancer Model Development for the Human Cancer Model Initiative HCMI-CMDC project, accessed October 2023.', \"Publication: 'Comprehensive Molecular Characterization of Human Cancer Models: The NCI Cancer Model Development for the Human Cancer Model Initiative', Journal of Cancer Research, 2023.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project data'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in Lung Cancer: A Study from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: Findings from the CGCI-HTMCP-LC Project', Genomics and Cancer.\"], [\"Publication 1: 'Genomic Characterization of HIV-Associated Cervical Cancer', Journal of Cancer Research, 2022.\", \"Publication 2: 'Somatic Mutations in Cervical Cancer: Insights from the Genomic Data Commons', Cancer Genomics, 2023.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in Osteosarcoma: Implications for Targeted Therapy', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'The Role of PIK3CA in Osteosarcoma Progression', Oncogene.\"], [\"Publication 1: 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Clinical Oncology, 2022.\", \"Publication 2: 'Molecular Profiling of HIV-Positive Lymphomas', Blood Advances, 2023.\"], ['Genomic Data Commons Data Portal - APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project', 'Publication: Proteogenomic characterization of lung adenocarcinoma in the APOLLO-LUAD project'], ['https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Sanchez-Vega, F. et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173, 321337.e10 (2018).'], ['Genomic Data Commons Data Portal - TCGA-CHOL', 'Nature, 2015, Comprehensive molecular characterization of human colon and rectal cancer', 'Cell, 2018, Integrated genomic characterization of cholangiocarcinoma'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['Genomic Data Commons Data Portal - TCGA-MESO', 'The Cancer Genome Atlas Research Network publications on Mesothelioma'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Robertson AG, et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell. 2017 Oct 9;32(4):204-220.e15.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Nature. 2013 Oct 17;502(7471):333-9. doi: 10.1038/nature12579. Epub 2013 Oct 9.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. Accessed October 2023.'], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['Publication 1: Comprehensive genomic characterization of uterine carcinosarcoma in the TCGA-UCS project.', 'Publication 2: Analysis of PIK3CA mutations in uterine carcinosarcoma from the Genomic Data Commons.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers in the Cancer Genome Atlas. Nat Genet. 2017 Apr;49(4):514-522.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Genomic Data Commons Data Portal - TCGA-ACC Project', 'Publication: Comprehensive and Integrated Genomic Characterization of Adult Adrenocortical Carcinoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2014). Integrated genomic analysis of bladder cancer identifies a subset with a high frequency of PIK3CA mutations. Nature Genetics, 46(6), 595-599.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Levine, D. A., & The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'The Genomic Data Commons Data Portal, https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PIK3CA in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Human Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling of Wilms Tumor: Implications for targeted therapy. Cancer Genomics & Proteomics.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', \"Publication: 'Genomic Characterization of Angiosarcoma in the Count Me In Project', Journal of Clinical Oncology, 2023\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Cohort', Cancer Research.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Cancer Therapy', Oncogene Journal.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in metastatic breast cancer: Insights from the CMI-MBC project. Journal of Clinical Oncology.', 'Publication 2: Johnson, L. et al. (2023). Comprehensive genomic profiling of metastatic breast cancer: Findings from the Genomic Data Commons. Nature Medicine.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'PIK3CA Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Lung Cancer in HIV+ Patients', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/PIK3CA-osteosarcoma'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in HIV-associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of HIV+ DLBCL', Cancer Genomics\", \"Publication 3: Lee et al., 2022, 'PIK3CA Mutations in HIV-related Lymphomas', Oncogene\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive molecular profiling of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.', 'The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378-384.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers in the Cancer Genome Atlas. Nat Genet. 2017 Apr;49(4):514-523.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, Liu T, Zhang Z, et al. Integrated analysis of mutation data from TCGA to identify potential genetic drivers in bladder cancer. Sci Rep. 2018;8(1):12357.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Stransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011 Aug 26;333(6046):1157-60.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, Wang J, Shah P, Cha SW, Aiyetan P, Woo S, Tian Y, Gritsenko MA, Clauss TR, Choi C, Monroe ME, Thomas S, Nie S, Wu C, Moore RJ, Yu KH, Tabb DL, Fenyo D, Bafna V, Wang Y, Rodriguez H, Boja ES, Hiltke T, Rivers RC, Sokoll L, Zhu H, Shih IM, Zhang Z, Chan DW, Rodland KD, Smith RD, Paulovich AG, Liebler DC, Liu T. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Tyner JW, Tognon CE, Bottomly D, Wilmot B, Kurtz SE, Savage SL, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018 Apr;562(7728):526-531.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2021, 'Copy Number Variants in Leukemia', Cancer Genomics\"], ['Publication 1: Smith, J. et al. (2022). Analysis of ATM mutations in cancer models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in the Human Cancer Model Initiative. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). Copy number variations in cancer development. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['Publication 1: Smith et al., 2022, Journal of Cancer Genomics', 'Publication 2: Johnson et al., 2023, Cancer Research', 'Publication 3: Lee et al., 2023, Genomic Medicine'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in ATM Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'ATM Mutations in Cancer: A Comprehensive Study'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'Copy Number Variants in ATM and Their Role in Cancer'. Genomic Data Commons Reports.\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in KRAS in the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Analysis of Somatic Mutations in Cancer Models'. Cancer Genomics.\", \"Publication 3: Lee, T. et al. (2023). 'Copy Number Variants in KRAS: Insights from the HCMI-CMDC'. Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Genomic Data Commons Data Portal', 'Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) Project Documentation'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Analysis of KRAS Mutations in CPTAC-3 Projects', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutational Landscape in CPTAC-3: Implications for Targeted Therapy', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in KRAS Across Multiple Cancer Types in CPTAC-3', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The CDDP_EAGLE-1 Study', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'KRAS Mutations in Lung Adenocarcinoma: Data from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Comprehensive Molecular Characterization of Breast Cancer in the CPTAC-2 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Genomic Alterations in Colon Cancer: Insights from the CPTAC-2 Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Ovarian Cancer Genomics: Findings from the CPTAC-2 Project', Gynecologic Oncology Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'KRAS Mutations in Lung Cancer: A Study from the CGCI-HTMCP-LC Project.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Copy Number Variants in Lung Cancer: Data from the Genomic Data Commons.' Oncogene Research.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], ['Osteosarcoma TARGET-OS project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Publication 1: Smith, J. et al. (2020). Genomic Landscape of Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Mutational Analysis in Pediatric Leukemia. Pediatric Oncology Journal.'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL', 'https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL-2017'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). KRAS mutations in lung adenocarcinoma: A comprehensive analysis. Lung Cancer Journal.'], ['Reference 1: The Genomic Data Commons (GDC) - Multiple Myeloma CoMMpass Study MMRF-COMMPASS project', 'Reference 2: Publication from the GDC on KRAS mutations in Multiple Myeloma'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Acute Myeloid Leukemia in the TARGET-AML Project', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Mutational Analysis of KRAS in Acute Myeloid Leukemia', Leukemia Research\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of Burkitt lymphoma reveals frequent mutations in the TCF3 and ID3 genes' - Nature Genetics\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Annual Review of Pathology: Mechanisms of Disease, 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project. Accessed October 2023.'], ['Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., ... & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell, 171(4), 950-965.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in testicular germ cell tumors. Journal of Clinical Oncology.', 'Publication 2: Johnson, L. et al. (2021). Comprehensive genomic profiling of testicular germ cell tumors. Nature Genetics.', 'Publication 3: Brown, A. et al. (2019). KRAS mutations in testicular germ cell tumors: A TCGA analysis. Cancer Research.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by The Cancer Genome Atlas. Cancer. 2015 Jun 1;121(11):1969-78.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, accessed October 2023', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Cancer Cell. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer', Genomic Data Commons Reports.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project data'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma CGCI-HTMCP-DLBCL project'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic mutations in lung cancer', Oncogene.\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. Esophageal Carcinoma (TCGA-ESCA) project.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal, TCGA-MESO project.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis CF, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project.'], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Genomic Data Commons Data Portal - TCGA-ACC Project', 'Publication: Comprehensive and Integrated Genomic Characterization of Adult Adrenocortical Carcinoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic features of testicular germ cell tumors. Nature Genetics, 2017.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. New England Journal of Medicine, 2015.', 'Ceccarelli, M., et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell, 2016.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Genetics. 2013;45(8):860-7.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The CDDP_EAGLE-1 Study', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'PDGFRA Mutations and Copy Number Variants in Lung Adenocarcinoma: Findings from the CDDP_EAGLE-1 Project', Nature Genetics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/projects/CGCI-HTMCP-CC'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/sample-type-codes'], ['National Cancer Institute Genomic Data Commons Data Portal', 'APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project publication'], ['Publication 1: Smith et al., 2022, Journal of Hematology', 'Publication 2: Johnson et al., 2023, Leukemia Research'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cancer Genome Atlas Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(3), 298-306.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689211/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Liu, Y., et al. (2019). Comprehensive molecular characterization of human cervical squamous cell carcinoma and adenocarcinoma. Nature, 543(7645), 378-384.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, et al. Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget. 2016 Apr 5;7(14):17220-33.', 'Kim J, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2016 Apr 11;29(4):554-68.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S. B., Andry, C. D., ... & Weinstein, J. N. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cheng DT, et al. Comprehensive detection of genomic alterations in tumors by massively parallel DNA sequencing. Nat Commun. 2015;6:10001.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015 Apr 1;75(7):1783-93.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Kandoth C, et al. Nature. 2013; 502(7471):333-339.', 'Cancer Genome Atlas Research Network. Nature. 2011; 474(7353):609-615.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of KIT Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in KIT and Their Role in Cancer Progression', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of papillary thyroid carcinoma, Cell, 2014.', 'Publication 3: The Cancer Genome Atlas Research Network, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 2014.'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, accessed October 2023', \"Smith et al., 2022, 'Genomic Characterization of Angiosarcoma', Journal of Clinical Oncology\", \"Johnson et al., 2023, 'Somatic Mutations in Angiosarcoma', Cancer Research\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Somatic Mutations in KIT in HIV-Related Lymphomas.' Cancer Research Journal.\", \"Publication 3: Lee, R. et al. (2019). 'Copy Number Variants in HIV-Positive Lymphoma Patients.' Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Genomic Data Commons Analysis of Lung Cancer', Cancer Research Journal.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in acute lymphoblastic leukemia: Insights from the MP2PRT-ALL project. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling in ALL: KIT mutations and treatment response. Leukemia Research.'], ['Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2, 401404 (2012).', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cancer Cell, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['National Cancer Institute Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network publications on Uterine Carcinosarcoma'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project. Accessed October 2023.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cell. 2016.', 'Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of ERBB2 in patients with bladder cancer. Oncogene, 38(30), 4647-4658.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Smith et al., 2022, Journal of Genomic Research', 'Reference 3: Doe et al., 2023, Cancer Genomics'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project (HTMCP) - Lung Cancer (CGCI-HTMCP-LC) dataset'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Genomic Data Commons - APOLLO-LUAD project data', \"Publication: 'Proteogenomic characterization of lung adenocarcinoma' in the Genomic Data Commons\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA-DLBC project.', 'Publication 2: Analysis of somatic mutations in diffuse large B-cell lymphoma using TCGA data.', 'Publication 3: Genomic alterations in diffuse large B-cell lymphoma: Insights from the TCGA-DLBC project.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.e9.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Cholangiocarcinoma (CHOL) TCGA dataset analysis'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project Data'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'GDC Data Portal: TCGA-KIRP project summary and mutation analysis.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Ley TJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix and endocervical adenocarcinoma', Nature, 2017\"], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-404.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in KIT across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Comprehensive Analysis of KIT Mutations in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'KIT Variants in the CPTAC-3 Cohort', Genomic Data Commons Reports.\"], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Study on KIT mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Nature Communications\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Cholangiocarcinoma TCGA study publications'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2016.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. TCGA-SARC Project. https://portal.gdc.cancer.gov/projects/TCGA-SARC'], ['Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689211/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Zhang, J., et al. The genomic landscape of acute myeloid leukemia. Nature. 2012 May 17;485(7397): 157-162.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in ALL', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'ATM Mutations in Leukemia', Cancer Genomics\"], ['Publication 1: Smith, J. et al. (2022). Analysis of ATM mutations in the Human Cancer Model Initiative. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in cancer models: A comprehensive study. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). Copy number variations in cancer: Insights from the HCMI-CMDC project. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in ATM in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ATM Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in ATM: Implications for Cancer Therapy', Oncogene.\"], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Zhang, J., et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012 Jan 12;481(7380):157-63.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Leukemia', Cancer Genomics\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ATM Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ATM and Their Role in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in ATM Across Different Cancer Types', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.'], ['Publication 1: Smith, J. et al. (2022). Analysis of CTNNB1 Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Alterations in Cancer: A Comprehensive Study. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). The Role of CTNNB1 in Tumorigenesis. Oncogene Journal.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-49.', 'Zhao H, et al. The oncogenic role of CTNNB1 in clear cell renal cell carcinoma: a comprehensive analysis of TCGA and GEO datasets. Oncotarget. 2016 Nov 22;7(47):78465-78478.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Genomic Profiling of Lung Adenocarcinoma'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'Somatic Mutations and Copy Number Variants in Lung Cancer'. Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'CTNNB1 Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Genomic Data Commons - Count Me In: The Metastatic Prostate Cancer Project', \"Publication: 'Genomic Characterization of Metastatic Prostate Cancer' in Nature, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project data'], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cancer Cell, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Genomic Data Commons Data Portal - APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project', \"Publication: 'Proteogenomic Characterization of Lung Adenocarcinoma through the APOLLO1 Project', Journal of Proteomics, 2023\"], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Genomic Data Commons Data Portal - TCGA-CHOL', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['Genomic Data Commons Data Portal - Esophageal Carcinoma (TCGA-ESCA) Project', \"Publication: 'Comprehensive molecular characterization of esophageal carcinoma' - The Cancer Genome Atlas Research Network\"], ['Genomic Data Commons Data Portal - Thymoma TCGA-THYM project', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors in the TCGA database'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons Data Portal', 'TCGA Pancreatic Adenocarcinoma (PAAD) Study'], ['National Cancer Institute Genomic Data Commons Data Portal', 'TCGA Research Network publications on Uterine Carcinosarcoma'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zucman-Rossi, J., Villanueva, A., Nault, J.C., & Llovet, J.M. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. Gastroenterology, 2015.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-337.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Zhang, X., et al. Genomic analysis of bladder cancer: a survey of TCGA data. Chinese Journal of Cancer. 2016.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['Genomic Data Commons Data Portal - TCGA-STAD', 'Publication: Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 2014'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25;372(26):2481-98.'], ['Genomic Data Commons Data Portal - TCGA-LUSC', 'Publication: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature.\"], ['Reference 1: Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', 'Reference 2: Publication on PIK3CA mutations in metastatic breast cancer from the Genomic Data Commons'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, NRAS mutation data', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020;26(2):181-187.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'NRAS Mutations in Lung Adenocarcinoma: Frequency and Clinical Implications', Lung Cancer Journal.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Molecular Characterization of HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Lung Cancer: A Comprehensive Study', Genomic Data Commons Reports.\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of Cervical Cancer in HIV+ Patients'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Somatic Mutations in Cervical Cancer: A Study from the Genomic Data Commons'. Oncogene.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons Data Portal - TARGET-ALL-P2 Project', \"Publication: 'Comprehensive genomic profiling of pediatric acute lymphoblastic leukemia' in Nature Communications\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-DLBCL project', \"Publication: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma' in Cancer Cell, 2017\"], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). NRAS mutations in lung adenocarcinoma: A comprehensive analysis. Oncogene.'], ['Multiple Myeloma Research Foundation (MMRF) CoMMpass Study, Genomic Data Commons', \"Publication: 'Genomic landscape of multiple myeloma and clinical impact of mutations in the CoMMpass study', Nature Genetics\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Landscape of Acute Myeloid Leukemia in the TARGET-AML Project.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'NRAS Mutations in Pediatric AML: Insights from the Genomic Data Commons.' Leukemia Research.\"], ['Genomic Data Commons Data Portal - TARGET-ALL-P3 Project', \"Publication: 'Comprehensive Genomic Profiling of Pediatric Acute Lymphoblastic Leukemia' in Nature Communications\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'NRAS Mutations in ALL', Cancer Genomics\"], ['TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012.', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu, Y., Sethi, N. S., Hinoue, T., et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['Genomic Data Commons Data Portal - TCGA-THYM Project', 'Thymoma (TCGA, Firehose Legacy) - cBioPortal for Cancer Genomics'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell lung cancers', Nature, 2012\", \"Publication: 'The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer', Nature, 2012\"], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet. 2003 Nov;114(6):118-20.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Cancer Treatment Response', Cancer Research.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PIK3CA Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of PIK3CA Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'PIK3CA Mutations and Their Impact on Cancer Progression', Oncogene.\"], ['Cancer Genome Atlas Research Network. (2017). Comprehensive molecular characterization of uveal melanoma. *Cell*, 173(2), 511-517.', 'Robertson, A. G., et al. (2017). Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. *Cancer Cell*, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PIK3CA in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in PIK3CA Across Cancer Types', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of KRAS Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in KRAS and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2021, 'The Role of KRAS Mutations in Cancer Development: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell. 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell. 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations and Copy Number Variants in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of KRAS in Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of KRAS Mutations in Breast, Colon, and Ovary Cancers', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Copy Number Variants in KRAS Across Different Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Analysis of KRAS Mutations in CPTAC-2 Project', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'KRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Lung Adenocarcinoma', Nature, 2014.\", \"Publication 2: 'The Genomic Landscape of Lung Cancer in People Living with HIV', Journal of Thoracic Oncology, 2018.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/PanCan-Analysis-Project'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Landscape of Acute Lymphoblastic Leukemia in Children'. Journal of Hematology.\", \"Publication 2: Johnson, L. et al. (2021). 'KRAS Mutations in Pediatric Leukemia'. Pediatric Oncology Journal.\", \"Publication 3: Lee, H. et al. (2022). 'Copy Number Variants in Childhood Leukemia'. Genomics and Cancer Research.\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL', 'https://gdc.cancer.gov/about-data/publications/PanCan-Analysis'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma in the APOLLO-LUAD project. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO1 project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Comprehensive analysis of KRAS mutations in lung adenocarcinoma. Genomic Data Commons Reports.'], ['Multiple Myeloma Research Foundation (MMRF) CoMMpass Study, Genomic Data Commons', \"Publication: 'Comprehensive genomic analysis of multiple myeloma identifies recurrent mutations in pathways regulating chromatin and transcription' - Nature Genetics\"], ['TARGET-AML project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic profiling of acute myeloid leukemia in the TARGET-AML project', Journal of Hematology, 2022\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data in the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in ALL', Cancer Genomics\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Rep. 2017 Feb 7;18(6):1560-1574.'], ['TCGA-READ project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.', 'Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: TCGA-SARC Project.'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Tyner JW, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018 Apr;562(7728):526-531.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(3), 219-222.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Wang, Y., et al. Genomic data commons: a unified platform for cancer genomics data. Nature Biotechnology. 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, Akdemir KC, Aksoy BA, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-25.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-28.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Ceccarelli, M., et al. (2016). 'Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.' Cell, 164(3), 550-563.\", \"Cancer Genome Atlas Research Network. (2015). 'Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.' New England Journal of Medicine, 372(26), 2481-2498.\"], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E167-74.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609615 (2011).'], ['Publication 1: Smith, J. et al. (2022). Analysis of KRAS Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Alterations in Cancer: A Comprehensive Study. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2021). The Role of KRAS in Cancer Development. Oncogene Journal.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Breast Cancer: A CPTAC Study', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Colon Cancer: Insights from CPTAC-2', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Ovarian Cancer Genomics: A Comprehensive Analysis from CPTAC-2', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'KRAS Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\", \"Publication 3: 'The Genomic Data Commons: A Platform for Precision Medicine Research', Journal of the American Medical Informatics Association, 2016.\"], ['Genomic Data Commons Data Portal - TARGET-OS Project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - TARGET-ALL-P2 project data', \"Publication: 'Comprehensive genomic profiling of pediatric acute lymphoblastic leukemia' in Nature\", \"Publication: 'Genomic landscape of acute lymphoblastic leukemia in children' in Cancer Cell\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Alterations in HIV-Related Lymphomas.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'Somatic Mutations in HIV-Positive Lymphoma Patients.' Genomic Data Commons Reports.\"], ['Reference 1: The Genomic Data Commons Data Portal - MMRF-COMMPASS Study', 'Reference 2: Publication on KRAS mutations in Multiple Myeloma from the Genomic Data Commons'], ['Genomic Data Commons - TARGET-AML project data', \"Publication: 'Comprehensive genomic profiling of acute myeloid leukemia' in Nature, 2020\", \"Publication: 'Genomic landscape of acute myeloid leukemia' in New England Journal of Medicine, 2018\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of Burkitt lymphoma reveals novel oncogenic pathways and targets' - Nature Genetics\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['TCGA Research Network. Comprehensive genomic characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Cerami, E. et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.e9.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Cell Reports, 2017\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project Data.'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal, TCGA-KIRP project.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.', 'Zheng S, Cherniack AD, Dewal N, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell lung cancers' - The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated genomic and molecular characterization of cervical cancer' - The Cancer Genome Atlas Research Network\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Cancer: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in EGFR and Their Role in Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2021, 'The Impact of EGFR Alterations in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Alterations in ALL and Treatment Outcomes', Leukemia Research\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of ABL1 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in ABL1 Across Cancer Models', Cancer Genomics.\"], ['Publication 1: Smith, J. et al. (2022). Genomic Profiling in Acute Lymphoblastic Leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular Alterations in ALL: Insights from the MP2PRT-ALL Project. Leukemia Research.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Analysis of Somatic Mutations in Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models: Insights from the HCMI-CMDC', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015.', 'Akbani R, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in AKT3 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of AKT3 Mutations in the CPTAC-3 Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. (2017). Genomic Classification of Cutaneous Melanoma. Cell, 161(7), 1681-1696.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Cancer', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.e17.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.e15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of AKT3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in Cancer: A Study of AKT3', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in AKT3 Across Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Akbani R, et al. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in AKT3 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of AKT3 Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'AKT3 Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Cancer Models in the HCMI-CMDC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations and Copy Number Variants in Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'AKT3 Alterations in Cancer Models: Insights from the Genomic Data Commons', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Communications. 2013;4:1503.', 'The Genomic Data Commons Data Portal. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Publication 1: Smith et al., 2022, Journal of Cancer Research', 'Publication 2: Johnson et al., 2023, Oncogene', 'Publication 3: Lee et al., 2023, Cancer Genomics'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017', 'Publication 2: Genomic Data Commons: A Platform for Cancer Genomics Research, Cell, 2016'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' - TARGET Consortium\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Diffuse Large B-Cell Lymphoma: Insights from the HIV+ Tumor Molecular Characterization Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'EGFR Mutations in HIV-Associated Lymphomas: A Comprehensive Analysis'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Molecular Profiling of HIV-Associated Diffuse Large B-Cell Lymphoma'. Oncogene.\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A unified platform for cancer genomics research, Grossman et al., 2016'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: Genomic alterations in esophageal carcinoma: insights from The Cancer Genome Atlas (TCGA) project, Journal of Thoracic Oncology, 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2015', 'https://gdc.cancer.gov/about-data/publications/pancanatlas'], ['TCGA Research Network: Comprehensive molecular profiling of malignant pleural mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network, Cell, 2017.', 'Publication 2: Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., Nature Biotechnology, 2016.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'EGFR Mutations in Pancreatic Cancer', Oncogene Journal.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Pancreatic Adenocarcinoma', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genetic alterations in liver cancer: an update. World Journal of Gastroenterology, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhao, H., et al. The landscape of somatic copy-number alteration across human cancers. Nature, 2013.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 2017.', 'Zehir, A., Benayed, R., Shah, R. H., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-TGCT'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix' - Nature, 2017\", \"Publication: 'Integrated genomic and molecular characterization of cervical cancer' - Nature, 2018\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Publication 1: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Publication 2: The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2018). Comprehensive genomic characterization of uterine corpus endometrial carcinoma in Chinese patients. Nature Communications, 9(1), 1-10.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. TCGA-STAD project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'EGFR Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in EGFR: Implications for Cancer Therapy', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Zhao H, et al. The landscape of somatic copy number alterations in kidney cancer. Nature Genetics. 2013;45(8):860-7.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], [], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, accessed October 2023', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020;26(2):181-187.'], [\"Publication 1: Smith et al., 2021, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2022, 'EGFR Mutations in Exceptional Responders: Insights from the EXCEPTIONAL_RESPONDERS-ER Project', Cancer Research.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in EGFR and Their Role in Exceptional Response to Cancer Treatment', Nature Genetics.\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS-2018', 'https://gdc.cancer.gov/about-data/publications/PanCan-2018'], ['Publication 1: Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma, Genomic Data Commons', 'Publication 2: Genomic Alterations in HIV-Associated Lymphomas, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia: Insights from the MP2PRT-ALL Project', Journal of Hematology.\", \"Publication 2: Johnson et al., 2023, 'EGFR Mutations and Their Role in Acute Lymphoblastic Leukemia', Leukemia Research.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project. https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of oesophageal carcinoma. Nature, 541(7636), 169-175.', 'Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997). Gene expression profiles in normal and cancer cells. Science, 276(5316), 1268-1272.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of thymic epithelial tumors. Cell. 2018.', 'Genomic Data Commons Data Portal. TCGA-THYM project data.'], ['TCGA Research Network: Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genetic alterations in liver hepatocellular carcinoma: a review. Journal of Hepatology, 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine. 2016.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Sep 11;371(23):2189-2199.', 'Hodis E, et al. A Landscape of Driver Mutations in Melanoma. Cell. 2012 Jul 20;150(2):251-263.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Cervical Squamous Cell Carcinoma. Neoplasia. 2019 Apr;21(4):368-376.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, et al. Genomic landscape of bladder cancer. Nat Genet. 2013 Nov;45(11):1156-60.', 'The Cancer Genome Atlas (TCGA) Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Cell. 2017 Jan 26;168(3):684-695.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2019). Comprehensive genomic characterization of uterine corpus endometrial carcinoma in Chinese patients. Nature Communications, 10(1), 1-12.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang TW, et al. EGFR gene amplification and protein overexpression in squamous cell carcinoma of the esophagus. Int J Cancer. 2007;120(2):273-278.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202-209.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in ABL1 and their impact on treatment response in acute lymphoblastic leukemia. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Comprehensive genomic profiling of ALL: Insights from the MP2PRT-ALL project. Leukemia Research.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'The Role of ABL1 in Cancer Pathogenesis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: Insights from the Genomic Data Commons', Genomics and Cancer.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, New England Journal of Medicine, 2013.'], ['Genomic Data Commons - TARGET-OS project', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cell Reports, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Clinical Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Nature Genetics.'], ['MMRF CoMMpass Study (NCT01454297) - Genomic Data Commons', \"Walker BA, et al. (2018) 'The landscape of somatic mutations in multiple myeloma: a meta-analysis of 2,554 cases.' Blood.\", \"Zhou Y, et al. (2014) 'The molecular landscape of multiple myeloma.' Nature Reviews Cancer.\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA-DLBC project.', 'Publication 2: Analysis of somatic mutations in BRAF in lymphoid neoplasms from the Genomic Data Commons.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075681/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Kandoth C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017 Feb 13;31(3):411-423.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Ley TJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Testicular Germ Cell Tumors', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Testicular Cancer', Cancer Research.\", \"Publication 3: Lee et al., 2019, 'Copy Number Variants in Testicular Germ Cell Tumors', Nature Genetics.\"], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Liu Y, et al. Comprehensive genomic characterization of cervical squamous cell carcinoma and endocervical adenocarcinoma. Cell. 2019 Apr 4;179(3):529-543.e20.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Landa I, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016 Mar 1;126(3):1052-1066.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Kandoth C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Genomics and Cancer.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Mutation and Copy Number Variant Analysis in Lung Cancer: A Study from the CDDP Integrative Analysis', Oncogene.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Genomic Data Commons Data Portal', 'APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project publication'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in lung cancer: Insights from the HIV+ Tumor Molecular Characterization Project. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Comprehensive genomic profiling of lung cancer in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2021). Somatic mutations and copy number variations in lung cancer: A study from the CGCI-HTMCP-LC project. Genomics and Cancer.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Genomic Data Commons - Exceptional Responders Project', \"Publication: 'Genomic landscape of exceptional responders to cancer therapy', Nature, 2020\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['Genomic Data Commons, NCI Cancer Model Development for the Human Cancer Model Initiative (HCMI-CMDC) project data'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Genomic Data Commons - Exceptional Responders Project', \"Publication: 'Genomic landscape of exceptional responders to cancer therapy' in Nature\", \"Publication: 'Comprehensive molecular profiling of exceptional responders' in Cancer Cell\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons, NCI Cancer Model Development for the Human Cancer Model Initiative HCMI-CMDC project, accessed October 2023', \"Publication: 'Comprehensive Molecular Characterization of Cancer Models', Journal of Cancer Research, 2023\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Genomics and Cancer.\"], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer', Genomic Data Commons Reports.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics. 2016.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['CPTAC-3: Comprehensive Proteogenomic Characterization of Human Cancer', 'Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in TP53 and Their Role in Cancer Treatment Response', Cancer Research Journal.\"], ['Publication 1: Comprehensive Molecular Characterization of Lung Adenocarcinoma, The Cancer Genome Atlas Research Network.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia, The Cancer Genome Atlas Research Network.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao P, et al. Somatic copy number alterations and mutations in cervical cancer: a comprehensive review. Oncotarget. 2017;8(24):39664-39676.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of TP53 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in TP53 Across Cancer Models', Cancer Genomics Journal.\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in TP53 Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Analysis of TP53 Mutations in Cancer'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'The Role of TP53 in Cancer Development'. Oncogene Journal.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao, M., et al. (2016). Somatic copy-number alterations and their prognostic implications in clear cell renal cell carcinoma. Cancer Research, 76(7), 2016-2024.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"Ciriello, G., et al. (2015). 'Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.' Cell, 163(2), 506-519.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling of Wilms Tumor: TP53 mutations and treatment response. Cancer Genomics.'], ['Publication 1: Comprehensive and Integrative Genomic Characterization of TP53 in Cancer, Genomic Data Commons', 'Publication 2: The Genomic Landscape of TP53 Mutations in Cancer, Genomic Data Commons', 'Publication 3: TP53 Alterations in Cancer: A Comprehensive Review, Genomic Data Commons'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', \"Publication: Painter et al., 2020, 'The Genomic Landscape of Angiosarcoma', Nature Communications\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\"], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma. Nature, 2013.', 'Publication 3: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Publication 1: Smith et al., 2022, Journal of Cancer Research', 'Publication 2: Johnson et al., 2023, Genomic Data Commons Review'], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], ['Reference 1: Genomic Data Commons - Count Me In: The Metastatic Prostate Cancer Project', 'Reference 2: Smith et al., 2022, Journal of Clinical Oncology', 'Reference 3: Johnson et al., 2023, Cancer Research'], ['Genomic Data Commons - Count Me In: The Metastatic Breast Cancer Project', \"Publication: 'Genomic landscape of metastatic breast cancer' - Journal of Clinical Oncology\"], [\"Publication 1: Smith et al., 2020, 'Genomic Analysis of High-Risk Wilms Tumor', Journal of Pediatric Oncology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric Kidney Cancers', Cancer Research\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Wilms Tumor', Genomics and Cancer\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in lung cancer: Insights from the CGCI-HTMCP-LC project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular characterization of lung cancer in HIV-positive patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'TP53 mutations in lung cancer: A study from the Genomic Data Commons.' Oncogene.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in osteosarcoma: A comprehensive review. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2021). TP53 mutations in osteosarcoma: Implications for targeted therapy. Cancer Genomics.', 'Publication 3: Williams, R. et al. (2022). The role of TP53 in osteosarcoma: A genomic perspective. Oncogene.'], [\"Publication 1: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Cancer Research, 2022.\", \"Publication 2: 'Genomic Alterations in HIV-Positive Diffuse Large B-Cell Lymphoma', Cancer Genomics, 2023.\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Cancer Research Journal\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Reddy A, Zhang J, Davis NS, et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell. 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Liu, Y., Sethi, N. S., Hinoue, T., et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33, 721735.e8 (2018).'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['PubMed ID: 25691460', 'PubMed ID: 26544997'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Bailey MH, Tokheim C, Porta-Pardo E, et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell. 2018 Apr 5;173(2):371-385.e18.'], ['Cancer Genome Atlas Research Network. (2017). Genomic Classification of Cutaneous Melanoma. Cell, 161(7), 1681-1696.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013.'], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zack, T.I., et al. Pan-cancer patterns of somatic copy number alteration. Nature Genetics, 2013.', 'The Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Zhang, J., et al. Genomic landscape of testicular germ cell tumors. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'The Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao P, et al. Somatic copy number alterations and mutations in cervical cancer: a comprehensive review. Oncotarget. 2017;8(24):39664-39676.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, X., et al. (2019). Genomic Data Commons: A Comprehensive Platform for Integrative Analysis of Cancer Genomic Data. Cancer Research, 79(13), 3539-3545.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database. 2011.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2012.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang, H., et al. (2016). Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell, 166(3), 755-765.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med. 2006 Jan;3(1):e13.'], ['Smith, J. et al. (2021). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Doe, A. et al. (2022). Molecular profiling of Wilms Tumor: TP53 mutations and treatment response. Cancer Genomics.', 'Brown, L. et al. (2023). Copy number variations in pediatric renal tumors: A study from the MP2PRT-WT project. Pediatric Cancer Research.'], ['Reference 1: Genomic Data Commons - Count Me In (CMI): The Angiosarcoma (ASC) Project', 'Reference 2: Study on TP53 mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of TP53 Mutations in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of TP53 in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], ['Genomic Data Commons - Count Me In: The Metastatic Prostate Cancer Project', \"Publication: 'Genomic landscape of metastatic prostate cancer' in Nature, 2020\", \"Publication: 'Comprehensive molecular characterization of metastatic prostate cancer' in Cell, 2019\"], ['https://gdc.cancer.gov/about-data/publications/Pediatric-WT', 'https://gdc.cancer.gov/about-data/publications/target-wt'], ['Chen X, et al. (2014). Targeting the p53 pathway in osteosarcoma. Nature Reviews Cancer.', 'Kansara M, et al. (2014). Translational biology of osteosarcoma. Nature Reviews Cancer.', 'The Genomic Data Commons Data Portal - TARGET-OS project.'], [\"Publication 1: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Clinical Oncology, 2020.\", \"Publication 2: 'Genomic Alterations in HIV-Associated Lymphomas', Blood Journal, 2019.\"], [\"Publication 1: 'Proteogenomic characterization of lung adenocarcinoma', Genomic Data Commons, 2023.\", \"Publication 2: 'APOLLO-LUAD project: Insights into TP53 mutations', Genomic Data Commons, 2023.\"], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', 'Publication: Love, C. et al. (2012). The genetic landscape of mutations in Burkitt lymphoma. Nature Genetics.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/CHOL-2017'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of thymic epithelial tumors. Cell. 2018;175(2):292-306.', 'Genomic Data Commons Data Portal. TCGA-THYM project. https://portal.gdc.cancer.gov/projects/TCGA-THYM'], ['TCGA Research Network. Comprehensive genomic characterization of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Bailey, M. H., et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell, 2018.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Davis CF, Ricketts CJ, Wang M, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319-330.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.', 'The Cancer Genome Atlas Research Network. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Zhao H, Ljungberg B, Grankvist K, et al. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med. 2006;3(1):e13.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-339.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of TP53 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in TP53 Across Cancer Models', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 4;499(7456):43-9.', 'Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med. 2006 Jan;3(1):e13.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: TP53 Mutations and Treatment Response', Cancer Genomics.\"], ['CPTAC-3: Comprehensive Proteogenomic Characterization of Human Cancer', 'Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, TP53 mutation data'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Exceptional Responders', Cancer Genomics.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal. BEATAML1.0-COHORT Project.'], ['Genomic Data Commons - Count Me In: The Metastatic Prostate Cancer Project', 'Publication: Robinson, D. et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['https://gdc.cancer.gov/about-data/publications/Pediatric-WT'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular Characterization of Lung Cancer in HIV+ Patients'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'TP53 Mutations in Lung Cancer: A Study from the Genomic Data Commons'. Oncogene.\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/target-osteosarcoma-2020'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in TP53 in HIV-Related Lymphomas', Cancer Research Journal\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', 'Publication: Love, C., et al. (2012). The genetic landscape of mutations in Burkitt lymphoma. Nature Genetics.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['PubMed ID: 28481359', 'PubMed ID: 29625050', 'PubMed ID: 30275452'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhao, M., et al. Somatic mutations landscape in human cancers: a comprehensive study of 1,062 cancer genomes. Nature Communications, 2018.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Zhang H, et al. The genomic landscape of acute myeloid leukemia. Nat Genet. 2012 Mar 25;44(3):251-5.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Hodis E, et al. A landscape of driver mutations in melanoma. Cell. 2012 Jul 20;150(2):251-263.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-525.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, X., et al. (2019). Genomic Data Commons Data Portal: A Platform for Cancer Genomics Research. Journal of Clinical Oncology, 37(15_suppl), e13050-e13050.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'VHL Mutations in Cancer: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants and Their Role in Cancer Progression', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013;6(269):pl1.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'VHL Mutations in Cancer: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project data', \"Publication: 'Comprehensive molecular characterization of osteosarcoma' in Cell Reports, 2020\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Proteogenomic Analysis of Lung Adenocarcinoma: Findings from the APOLLO1 Study', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma, TCGA, 2015', 'Publication 2: Genomic Data Commons Data Portal, TCGA-DLBC Project'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA dataset'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Zhang, J., et al. Genomic landscape of mesothelioma. Nature Reviews Cancer, 2019.'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Comprehensive molecular characterization of papillary renal-cell carcinoma. Nature. 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project Data.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zehir, A., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Zhang, J., et al. Genomic landscape of testicular germ cell tumors. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhang W, Edwards A, Flemington EK, Zhang K. The genomic landscape of viral oncogenesis in human cancers. Nat Genet. 2017;49(5):654-660.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, Y., et al. (2016). Genomic landscape and analysis of tumor mutation burden in endometrial cancer. Oncotarget, 7(39), 63901-63912.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. Accessed October 2023.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Zack TI, Schumacher SE, Carter SL, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013 Oct;45(10):1134-40.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of POLE Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in POLE and Their Impact on Cancer Progression', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Endometrial Carcinoma. The Cancer Genome Atlas Research Network. Nature. 2013.', 'Publication 3: Comprehensive genomic characterization of squamous cell lung cancers. The Cancer Genome Atlas Research Network. Nature. 2012.'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, POLE mutation data', \"Publication: 'Genomic Characterization of Angiosarcoma in the Count Me In Project', Journal of Clinical Oncology, 2023\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2022, 'Genomic Analysis of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Characterization of Somatic Mutations in Exceptional Responders', Nature Genetics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Lung Cancer: A Study from the Genomic Data Commons', Genomics and Cancer.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2021). Comprehensive genomic profiling of cervical cancer in HIV-positive patients. Cancer Genomics.', 'Publication 3: Williams, R. et al. (2022). The role of POLE mutations in cervical cancer: A study from the Genomic Data Commons. Oncogene.'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Osteosarcoma: Insights from the TARGET-OS Project', Genomic Medicine.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Comprehensive genomic profiling of HIV+ DLBCL. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2021). Mutation landscape in HIV-related lymphomas. Genomic Data Commons Reports.'], ['Genomic Data Commons Data Portal', 'APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project publication'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Zhang J, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A. 2013.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'GDC Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE mutations in colorectal cancer. Cancer Res. 2013;73(10 Suppl):Abstract nr 1234.'], ['TCGA-CHOL publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', 'Genomic Data Commons Data Portal: TCGA-CHOL project'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Zhang L, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. J Pathol. 2019;248(4):451-462.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Davis, C. F., et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell, 2014.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang J, et al. The Genomic Landscape of Cancer. Nature. 2013 Oct 17;502(7471):333-339.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhao, H., et al. The genomic landscape of renal cell carcinoma. Nature Reviews Nephrology, 2020.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zehir, A., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: a comprehensive platform for exploring cancer genomics data. Nature Biotechnology, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE and POLD1 mutations in colorectal cancer. Cancer Res. 2013;73(19 Suppl):Abstract nr 1234.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and immune microenvironment features of pre-invasive and invasive bladder cancer. Journal of Clinical Investigation, 129(10), 4519-4531.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], [\"Campbell, J. D., et al. (2016). 'Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.' Nature Genetics.\", \"Cancer Genome Atlas Research Network. (2014). 'Comprehensive molecular profiling of lung adenocarcinoma.' Nature.\"], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015 Nov 5;163(4):1011-25.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of POLE Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in Cancer: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data', \"Publication: 'Molecular Profiling to Predict Response to Treatment in Wilms Tumor', Journal of Clinical Oncology, 2023\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Endometrial Carcinoma. The Cancer Genome Atlas Research Network. Nature. 2013.', 'Publication 3: Comprehensive genomic characterization of squamous cell lung cancers. The Cancer Genome Atlas Research Network. Nature. 2012.'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Publication on genomic alterations in angiosarcoma from the CMI-ASC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Landscape of Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Cancer: Findings from the Genomic Data Commons', Oncogene.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in POLE and Their Impact on Cancer Treatment Outcomes', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/projects/CGCI-HTMCP-CC'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], ['Publication 1: Smith, J. et al. (2020). Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Somatic Mutations in HIV-Related Lymphomas. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Copy Number Variants in HIV-Positive Lymphoma Patients. Genomic Data Commons Reports.'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of Burkitt lymphoma reveals frequent mutation of the POLE gene', Journal of Hematology, 2022\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['https://gdc.cancer.gov/about-data/publications/pcpg_2017'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE mutations in colorectal cancer. J Clin Oncol. 2015;33(15_suppl):3587-3587.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', Nature, 2017\"], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu L, Zhang T, Wang B, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal', 'TCGA-KICH project publications'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang J, et al. The Genomic Landscape of the NIH Genomic Data Commons. Nat Genet. 2016 Nov;48(11):1313-1320.'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106459/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao P, et al. Comprehensive characterization of somatic mutations in cervical cancer. Int J Cancer. 2019 Jan 1;144(1):196-204.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE mutations in colorectal cancer. J Clin Oncol. 2015;33(15_suppl):3587-3587.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of prognostic molecular factors in bladder urothelial carcinoma. Oncogene, 38(30), 5320-5334.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015 Nov 5;163(4):1011-25.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of POLE Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'Copy Number Variants in POLE and Their Impact on Cancer Development', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of POLE Mutations in Cancer Progression', Genomic Data Commons Review.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics.\"], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Brain, Head and Neck, Kidney, Lung, Pancreas, and Uterus Cancers' - CPTAC Consortium\"], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, POLE mutation data', \"Publication: 'Genomic characterization of angiosarcoma identifies potential therapeutic targets', Journal of Clinical Oncology, 2022\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Mutation and Copy Number Variation Analysis in Lung Cancer: Results from the Genomic Data Commons', Oncogene.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'The Role of POLE Mutations in Cancer Treatment Response', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS-2018', 'https://gdc.cancer.gov/about-data/publications/PanCan-Atlas'], ['https://gdc.cancer.gov/about-data/publications/CGCI-HTMCP-DLBCL'], ['Zhang, H., et al. (2020). Proteogenomic characterization of human lung adenocarcinoma. Cell, 182(1), 245-261.', 'Wang, L. B., et al. (2021). Proteogenomic and metabolomic characterization of human lung adenocarcinoma. Nature, 589(7841), 395-400.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017 Feb 7;18(6):1560-1574.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE and POLD1 mutations in colorectal cancer. Cancer Res. 2013;73(10 Suppl):Abstract nr 1234.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinoma. Cell Rep. 2017.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu L, Zhang T, Wang B, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive molecular characterization of uveal melanoma. Cell, 173(2), 511-517.', 'Robertson, A. G., et al. (2017). Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378-384.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao S, Choi M, Overton JD, et al. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci U S A. 2013 Apr 16;110(8):2916-2921.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE mutations in colorectal cancer. J Clin Oncol. 2015;33(15_suppl):3587-3587.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of tumor mutation burden in Chinese patients with bladder cancer. Frontiers in Oncology, 9, 421.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Campbell JD, et al. (2016). Comprehensive analysis of somatic mutations in lung adenocarcinoma. Nature.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-63.'], ['Campbell JD, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of POLE Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in POLE and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in POLE: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med. 2016.', 'Publication 2: Integrated Genomic Characterization of Endometrial Carcinoma. The Cancer Genome Atlas Research Network. Nature. 2013.', 'Publication 3: Comprehensive genomic characterization of squamous cell lung cancers. The Cancer Genome Atlas Research Network. Nature. 2012.'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Publication on genomic alterations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations and Copy Number Variants in Exceptional Responders', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project data'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017-supplementary'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/target-osteosarcoma-2020'], ['Publication 1: Smith, J. et al. (2020). Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Somatic Mutations in HIV-Related Lymphomas. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Copy Number Variants in HIV-Positive Lymphoma Patients. Genomic Data Commons Reports.'], ['Smith, J. et al. (2022). Comprehensive Proteogenomic Characterization of Lung Adenocarcinoma. Journal of Proteomics.', 'Doe, A. et al. (2023). Genomic Alterations in Lung Adenocarcinoma: Insights from the APOLLO-LUAD Project. Cancer Research.'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data in the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of Burkitt lymphoma reveals distinct somatic mutation patterns and potential therapeutic targets' - Nature Genetics\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE mutations in colorectal cancer. J Clin Oncol. 2015;33(15_suppl):3587-3587.'], ['TCGA Research Network. Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma. Cell Reports, 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Zhang L, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018;50(4):488-497.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO Project.'], ['The Cancer Genome Atlas Research Network. (2017). Genomic Classification of Cutaneous Melanoma. Cell, 161(7), 1681-1696.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/ATACseq-AWG', 'https://gdc.cancer.gov/about-data/publications/MC3-2017'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Zhang Y, et al. Genomic Landscape and Immune Microenvironment Features of Sarcoma. Cancer Cell. 2020 Apr 13;37(4):486-499.e9.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378-384.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31(3):411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zehir, A., Benayed, R., Shah, R. H., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], ['Zheng, S., et al. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic features of testicular germ cell tumors. Nature Genetics, 2017.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Snyder A, et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med. 2014 Dec 4;371(23):2189-2199.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-582.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhou W, et al. Comprehensive characterization of POLE mutations in colorectal cancer. Cancer Res. 2013;73(10 Suppl):Abstract nr 1234.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of prognostic molecular factors in bladder urothelial carcinoma. Oncotarget, 10(6), 648-660.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015 Nov 5;163(4):1011-25.'], ['Campbell JD, et al. Comprehensive analysis of somatic mutations in lung squamous cell carcinoma. Nature Genetics. 2016.', 'The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of DICER1 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in DICER1 Across Cancer Types', Cancer Genomics Journal.\"], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics & Proteomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell, 2017.', 'Publication 3: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. The Cancer Genome Atlas Research Network. Cell, 2017.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The Role of DICER1 Mutations', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma CGCI-HTMCP-DLBCL'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Oncogene.'], [\"Publication 1: Smith et al., 2022, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Alterations in ALL', Leukemia Research\", \"Publication 3: Brown et al., 2023, 'Copy Number Variants in Pediatric Leukemia', Cancer Genomics\"], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.'], ['TCGA Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal, TCGA-ESCA project.'], ['TCGA Research Network: Comprehensive molecular characterization of thymoma. Cell. 2018.', 'Genomic Data Commons Data Portal: TCGA-THYM project data.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['Ricketts CJ, et al. (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports.', 'Davis CF, et al. (2014). The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal: Kidney Renal Papillary Cell Carcinoma (TCGA-KIRP) project.'], [\"Zhang, J., et al. (2013). 'The genomic landscape of adrenocortical carcinoma.' Nature Genetics.\", \"Assi, G., et al. (2014). 'Integrated genomic characterization of adrenocortical carcinoma.' Nature Genetics.\"], ['Publication 1: TCGA Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Publication 2: Smith et al. Genomic analysis of DICER1 mutations in testicular germ cell tumors. Journal of Clinical Oncology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-339.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal: Uterine Corpus Endometrial Carcinoma (TCGA-UCEC) Project.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S. B., Andry, C. D., ... & Weinstein, J. N. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature. 2011.', 'Genomic Data Commons Data Portal: TCGA-OV project data.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of DICER1 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in Cancer: Insights from the HCMI-CMDC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling of Wilms Tumor: A comprehensive analysis. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). The role of DICER1 mutations in pediatric renal tumors. Pediatric Cancer Research.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell.', 'Publication 3: Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas. The Cancer Genome Atlas Research Network. Nature.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of Cervical Cancer in HIV+ Patients'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Somatic Mutations in Cervical Cancer: A Study of HIV+ Patients'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2022). 'Copy Number Variants in Cervical Cancer: Insights from the HTMCP Project'. Genomic Data Commons Reports.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in Cell Reports, 2020\"], ['https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Lung Cancer Journal.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma', Nature, 2018.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Diffuse Large B-cell Lymphoma', Cell Reports, 2019.\"], [\"Ricketts, C. J., et al. (2018). 'The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.' Cell Reports.\", \"Fishbein, L., et al. (2017). 'Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.' Cancer Cell.\"], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['TCGA Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['PubMed ID: 28481359', 'PubMed ID: 29625050'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Choi, H., et al. Genomic landscape of sarcoma: Analysis of TCGA data reveals various subtypes with distinct molecular characteristics. Nature Communications. 2018;9:1050.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Kandoth C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.', 'Cherniack AD, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017 Feb 13;31(3):411-423.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Ricketts CJ, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports, 2018.'], [\"Zhang, J., et al. (2013). 'The genomic landscape of adrenocortical carcinoma.' Nature Genetics.\", \"Assi, G., et al. (2014). 'Integrated genomic characterization of adrenocortical carcinoma.' Nature Genetics.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Testicular Germ Cell Tumors', Nature, 2018.\", \"Publication 2: 'Genomic Analyses Identify Recurrent Amplifications and Mutations in Testicular Germ Cell Tumors', Cell Reports, 2019.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-339.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive genomic characterization of uterine corpus endometrial carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal. Uterine Corpus Endometrial Carcinoma (TCGA-UCEC) dataset.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Abeshouse A, Ahn J, Akbani R, et al. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Ramos, A. H., et al. (2015). 'Somatic mutations in DICER1 in brain lower grade glioma.' Nature Genetics.\", \"Johnson, B. E., et al. (2014). 'Comprehensive genomic characterization of lower grade gliomas.' New England Journal of Medicine.\"], ['TCGA Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 2015.', 'Genomic Data Commons Data Portal, TCGA-HNSC project.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], [\"Publication 1: 'Comprehensive Genomic Characterization of DICER1 Mutations in Cancer Models', Journal of Cancer Research, 2022.\", \"Publication 2: 'The Role of DICER1 in Tumorigenesis: Insights from the Human Cancer Model Initiative', Cancer Genomics, 2023.\"], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: Kidney Renal Clear Cell Carcinoma (TCGA-KIRC) dataset.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics & Proteomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. N Engl J Med 2016; 374:135-145.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell 2017; 32(2):185-203.', 'Publication 3: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. The Cancer Genome Atlas Research Network. Cell 2017; 169(7):1327-1341.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons Data Portal - CGCI-HTMCP-CC Project', \"Publication: 'Comprehensive Molecular Characterization of Cervical Cancer' by The Cancer Genome Atlas Research Network\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' by the TARGET Osteosarcoma Working Group\"], ['https://gdc.cancer.gov/about-data/publications/CGCI-HTMCP-DLBCL', 'https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL-2015'], ['Chakravarty, D., Gao, J., Phillips, S. M., et al. (2017). OncoKB: A Precision Oncology Knowledge Base. JCO Precision Oncology.', 'Campbell, J. D., Alexandrov, A., Kim, J., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['TCGA-DLBC project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Diffuse Large B-cell Lymphoma' - TCGA Research Network\"], ['Ricketts, C. J., et al. (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports, 23(1), 313-326.', 'Fishbein, L., et al. (2017). Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell, 31(2), 181-193.'], ['TCGA Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['TCGA Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017.', 'Genomic Data Commons Data Portal. TCGA-ESCA project data.'], ['PubMed ID: 28481359', 'PubMed ID: 28874634'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.e17.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA-KICH project data from the Genomic Data Commons', 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], [\"Raman, P., et al. (2016). 'Comprehensive analysis of DICER1 mutations in sarcomas from the TCGA-SARC project.' Journal of Clinical Oncology.\", \"Smith, J., et al. (2017). 'Genomic characterization of sarcomas: Insights from the TCGA-SARC project.' Nature Genetics.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['TCGA Research Network: Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal: Kidney Renal Papillary Cell Carcinoma (TCGA-KIRP) dataset.'], [\"Roth, F. L., et al. (2016). 'Comprehensive genomic analysis reveals prognostic value of tumor purity and molecular subtypes in adrenocortical carcinoma.' Nature Communications.\", \"Zheng, S., et al. (2016). 'Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.' Cancer Cell.\", \"The Cancer Genome Atlas Research Network. (2017). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell.\"], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689211/', 'https://www.nature.com/articles/ng.3164'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-339.'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix and endocervical adenocarcinoma' by The Cancer Genome Atlas Research Network\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive genomic characterization of endometrial carcinoma. Nature 497, 6773 (2013).', 'Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 6773 (2013).'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S. B., Andry, C. D., ... & Cancer Genome Atlas Research Network. (2015). The molecular taxonomy of primary prostate cancer. Cell, 163(4), 1011-1025.'], ['TCGA Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang HC, et al. Genomic characterization of gastric adenocarcinoma in the Cancer Genome Atlas. Cancer Res Treat. 2017;49(2):385-394.'], [\"Ramaswamy, V., et al. (2015). 'DICER1 mutations in non-epithelial gonadal tumors: an emerging role for microRNA dysregulation in oncogenesis.' Cancer Research.\", \"Schultz, K. A. P., et al. (2014). 'DICER1-related disorders.' GeneReviews [Internet].\", \"Hill, D. A., et al. (2009). 'DICER1 mutations in familial pleuropulmonary blastoma.' Science.\"], ['TCGA Research Network: Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 2015.', 'Genomic Data Commons Data Portal: TCGA-HNSC project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Genomic Data Commons Data Portal: TCGA-LUSC project data.'], ['TCGA Research Network: Comprehensive molecular characterization of ovarian serous cystadenocarcinoma. Nature 2011.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in RAD50 Across Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in Cancer Genomics', Cancer Genomics Journal.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics.\"], ['Publication 1: Comprehensive molecular characterization of head and neck squamous cell carcinomas, Nature, 2015.', 'Publication 2: Integrated genomic characterization of pancreatic ductal adenocarcinoma, Cancer Cell, 2017.', 'Publication 3: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, New England Journal of Medicine, 2013.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons Data Portal', 'Exceptional Responders (EXCEPTIONAL_RESPONDERS-ER) Project Data'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], [\"Publication 1: 'Comprehensive Molecular Characterization of Osteosarcoma', Journal of Genomic Data, 2022.\", \"Publication 2: 'Genomic Alterations in Osteosarcoma: Insights from the TARGET-OS Project', Cancer Research, 2023.\"], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-Cell Lymphoma in the HIV+ Population, Journal of Hematology, 2022.', 'Publication 2: Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma, Cancer Research, 2023.'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Leukemia', Cancer Genomics\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: Genomic alterations in diffuse large B-cell lymphoma uncovered by whole-genome sequencing, Nature, 2016.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Rectum Adenocarcinoma: Insights from TCGA-READ', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Rectal Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Rectum Adenocarcinoma: TCGA-READ Findings', Oncogenomics.\"], ['Genomic Data Commons Data Portal - TCGA-CHOL', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA dataset'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu L, Zhang T, Wang F, Zhang W, Chen W, Zhan Q. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015;96(4):597-611.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-THYM'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', The Cancer Genome Atlas Research Network, 2016.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', The Cancer Genome Atlas Research Network, 2013.\"], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network, Cell, 2017.', 'Publication 2: Genomic and Molecular Characterization of Sarcomas, The Cancer Genome Atlas Research Network, Nature, 2018.'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of Pancreatic Adenocarcinoma in TCGA-PAAD', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pancreatic Cancer: Insights from TCGA', Pancreatic Cancer Journal.\", \"Publication 3: Lee et al., 2019, 'Copy Number Variants in Pancreatic Adenocarcinoma: A TCGA Study', Genomics and Cancer.\"], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network', 'Publication 2: Integrated Genomic Characterization of Uterine Carcinosarcoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zehir, A., et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 2017.'], [\"Publication 1: 'Comprehensive molecular characterization of testicular germ cell tumors', Nature, 2018.\", \"Publication 2: 'Genomic analysis of testicular germ cell tumors in the TCGA dataset', Journal of Clinical Oncology, 2019.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Cervical Squamous Cell Carcinoma. Neoplasia. 2019 Jan;21(1):59-69.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, et al. Genomic landscape and analysis of ERBB2 in human cancers. Oncotarget. 2016;7(6):6555-72.', 'Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-25.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-28.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Characterization of DICER1 Mutations in Cancer Models.' Journal of Cancer Research.\", \"Publication 2: Johnson, L. et al. (2023). 'Copy Number Variants in DICER1 Across Cancer Types.' Cancer Genomics.\", \"Publication 3: Lee, M. et al. (2023). 'Somatic Mutations in DICER1: Insights from the Human Cancer Model Initiative.' Genomic Data Commons Reports.\"], ['TCGA Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['Genomic Data Commons Data Portal', 'Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project documentation'], ['Publication 1: Comprehensive molecular characterization of DICER1 mutations in cancer. Journal of Genomic Data, 2022.', 'Publication 2: Analysis of somatic mutations in the CPTAC-3 project. Cancer Research Journal, 2023.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the Genomic Data Commons', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization and Its Implications in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in DICER1 and Their Role in Lung Cancer Pathogenesis', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['TARGET Osteosarcoma (TARGET-OS) project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of DLBCL in HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV-Associated Lymphomas', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in DLBCL: A Study of HIV+ Cases', Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Genomic Data\", \"Publication 2: Johnson et al., 2023, 'APOLLO1: Insights into Lung Adenocarcinoma', Genomic Research Journal\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell Reports, 2018.', 'Publication 2: Smith, J. et al. Genomic alterations in diffuse large B-cell lymphoma. Nature Genetics, 2019.'], ['Ricketts CJ, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports. 2018.', 'Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.'], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by The Cancer Genome Atlas Research Network\"], ['TCGA Research Network: Comprehensive molecular characterization of esophageal carcinoma. Nature 2017.', 'Genomic Data Commons Data Portal: TCGA-ESCA project data.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UVM'], ['Ricketts CJ, et al. (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports.', 'Davis CF, et al. (2014). The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cherniack AD, Shen H, Walter V, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017.'], ['TCGA-LIHC project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Ricketts CJ, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports, 2018.'], [\"Roth, F. L., et al. (2016). 'Comprehensive genomic profiling of adrenocortical carcinoma reveals new insights into the molecular landscape of the disease.' Journal of Clinical Oncology.\", \"Zheng, S., et al. (2016). 'Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.' Cancer Cell.\"], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689211/', 'https://www.nature.com/articles/ng.3823'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-339.'], ['TCGA-CESC project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Bladder Urothelial Carcinoma (TCGA-BLCA) dataset in the Genomic Data Commons'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Endometrial Carcinoma. Nature, 2013.', 'Genomic Data Commons Data Portal: Uterine Corpus Endometrial Carcinoma (TCGA-UCEC) Project.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], [\"Ramaswamy, V., et al. (2015). 'DICER1 mutations in non-epithelial gonadal tumors: a report from the International Ovarian and Testicular Stromal Tumor Registry.' Journal of Clinical Oncology.\", \"Schultz, K. A. P., et al. (2014). 'DICER1-related disorders.' GeneReviews [Internet].\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-63.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Publication 1: Smith, J. et al. (2022). Analysis of DICER1 Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in Cancer: A Comprehensive Study. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). The Role of DICER1 in Tumorigenesis. Oncogene.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Ricketts CJ, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5.'], [\"Publication 1: 'Comprehensive Molecular Portraits of Human Breast Tumors', Nature, 2012.\", \"Publication 2: 'The Genomic Data Commons: A Platform for Precision Medicine Research', Journal of the American Medical Informatics Association, 2016.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling of Wilms Tumor: A comprehensive analysis. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). The role of DICER1 mutations in pediatric renal tumors. Pediatric Cancer Research.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine.', 'Publication 2: Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. The Cancer Genome Atlas Research Network. Cancer Cell.', 'Publication 3: Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas. The Cancer Genome Atlas Research Network. Nature.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer from HIV+ Patients', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Individuals', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in osteosarcoma: A comprehensive review. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2021). The role of DICER1 mutations in osteosarcoma. Cancer Genomics.', 'Publication 3: Williams, R. et al. (2022). Copy number variations in pediatric osteosarcoma. Pediatric Oncology Journal.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma CGCI-HTMCP-DLBCL project'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Somatic mutations in lung cancer. Oncogene.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in ALL', Cancer Research Journal\"], ['Publication 1: TCGA Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Nature, 2018.', 'Publication 2: Schmitz, R., et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. New England Journal of Medicine, 2018.'], [\"Ricketts, C. J., et al. (2018). 'The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.' Cell Reports.\", \"Fishbein, L., et al. (2017). 'Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.' Cancer Cell.\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], [\"Publication 1: 'Comprehensive Molecular Characterization of Cholangiocarcinoma', The Cancer Genome Atlas Research Network, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', The Cancer Genome Atlas Research Network, 2013.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Esophageal Carcinoma', The Cancer Genome Atlas Research Network, 2017.\", \"Publication 2: 'Genomic Data Commons: A Platform for Cancer Genomics Research', Grossman et al., 2016.\"], ['TCGA Research Network: Comprehensive molecular characterization of thymoma. Nature, 2017.', 'Genomic Data Commons Data Portal: Thymoma (TCGA-THYM) project data.'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'The Cancer Genome Atlas Research Network. (2018). Genomic Classification of Cutaneous Melanoma. Cell, 173(4), 853-868.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma', The Cancer Genome Atlas Research Network, 2016.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', The Cancer Genome Atlas Research Network, 2013.\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Publication 1: TCGA Research Network. Comprehensive molecular characterization of pancreatic ductal adenocarcinoma. Nature, 2017.', 'Publication 2: Bailey, P., et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013.', 'The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011.'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Publication 1: TCGA Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Publication 2: Cancer Genome Atlas Research Network. The Cancer Genome Atlas Pan-Cancer analysis project. Nature Genetics, 2013.'], ['Publication 1: TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Publication 2: Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics. 2016.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Testicular Germ Cell Tumors', Nature, 2018.\", \"Publication 2: 'Genomic Data Commons: A Platform for Cancer Genomics Research', Cell, 2017.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cutaneous Melanoma', The Cancer Genome Atlas Research Network, 2015.\", \"Publication 2: 'Genomic Classification of Cutaneous Melanoma', Nature, 2016.\"], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix and endocervical adenocarcinoma', Nature, 2017\"], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang L, et al. Genomic Analysis of Colon Cancer Reveals Patterns of Tumor Evolution. Cancer Cell. 2018 Feb 12;33(2):321-327.e3.'], ['Publication 1: Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma, TCGA Research Network', 'Publication 2: Genomic Data Commons Data Portal, TCGA-BLCA Project'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], [\"Publication 1: 'Comprehensive molecular characterization of gastric adenocarcinoma', Nature, 2014.\", \"Publication 2: 'The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of gastric adenocarcinoma', Cell, 2014.\"], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Korshunov A, et al. Integrated analysis of pediatric glioblastoma multiforme. Cancer Cell. 2010 Jul 13;18(1):1-12.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013 Oct 17;502(7471):333-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Genomic Data Commons, Count Me In: The Angiosarcoma Project, BRAF mutation data', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Thoracic Oncology.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The CDDP_EAGLE-1 Study', Cancer Research.\"], ['CPTAC-2 Breast Cancer Study', 'CPTAC-2 Colon Cancer Study', 'CPTAC-2 Ovarian Cancer Study'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'BRAF Mutations in Lung Cancer: A Study from the CGCI-HTMCP-LC Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Lung Cancer: Data from the Genomic Data Commons', Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'BRAF Mutations in Cervical Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Chen, X., et al. (2014). 'Targeting the BRAF V600E mutation in osteosarcoma: a new therapeutic strategy.' Cancer Research.\", \"Smith, L. M., et al. (2015). 'Genomic characterization of osteosarcoma and its implications for targeted therapy.' Journal of Clinical Oncology.\", \"Jones, R. L., et al. (2016). 'BRAF mutations in osteosarcoma: frequency and clinical implications.' Annals of Oncology.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV-Related Lymphomas', Cancer Research\", \"Publication 3: Lee et al., 2019, 'Copy Number Variants in HIV-Positive Lymphoma Patients', Genomics and Cancer\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Clinical Oncology.', 'Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Nature Genetics.'], ['MMRF-COMMPASS Study, Genomic Data Commons', \"Publication: 'Genomic landscape of multiple myeloma and clinical impact of mutations in the BRAF gene', Journal of Hematology, 2022\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia: Insights from the MP2PRT-ALL Project', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in ALL: BRAF Mutations and Treatment Response', Leukemia Research\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma, Cell Reports, 2017'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://portal.gdc.cancer.gov/projects/TCGA-THYM'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Annual Review of Pathology: Mechanisms of Disease, 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013 May 30;368(22):2059-74.', 'Genomic Data Commons Data Portal. TCGA-LAML project data.'], ['Weinstein JN, et al. (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet.', 'Zheng S, et al. (2016) Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: a comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Liu Y, et al. Comprehensive genomic characterization of cervical squamous cell carcinoma and endocervical adenocarcinoma. Cell. 2019 Apr 4;179(3):529-543.e20.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. TCGA-LUAD project. Accessed October 2023.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Publication 1: Comprehensive Molecular Characterization of Head and Neck Squamous Cell Carcinomas, Nature, 2015.', 'Publication 2: Integrated Genomic Characterization of Papillary Thyroid Carcinoma, Cell, 2014.', 'Publication 3: The Cancer Genome Atlas Research Network, Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma, Nature, 2014.'], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Cancer Therapy', Oncogene Journal.\"], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis, K., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim P, et al. FGFR3 mutations in gastric cancer: association with clinicopathological features and prognosis. Gastric Cancer. 2015 Apr;18(2):256-62.'], [\"Publication 1: Smith et al., 2020, 'Genomic alterations in osteosarcoma: FGFR3 mutations and their impact', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive genomic profiling of osteosarcoma: Insights from the TARGET-OS project', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of HIV+ Lung Cancer Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in FGFR3 in Lung Cancer', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E167-74.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhao, S., Bellone, S., Lopez, S., Thakral, D., Schwab, C. L., English, D. P., ... & Santin, A. D. (2013). Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proceedings of the National Academy of Sciences, 113(43), 12238-12243.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature, 511(7511), 543-550.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology. 2019.'], ['TCGA Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA-DLBC project.', 'Publication 2: Analysis of somatic mutations and copy number variants in lymphoid neoplasms.', 'Publication 3: FGFR3 alterations in diffuse large B-cell lymphoma: A study from the Genomic Data Commons.'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular characterization of HIV+ cervical cancer: FGFR3 mutations and implications.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Copy number variations in cervical cancer: A study from the HTMCP project.' Genomic Medicine.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of FGFR3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in FGFR3 and Their Role in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in FGFR3 Across Different Cancer Types', Genomic Data Commons Reports.\"], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Publication 1: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014.', 'Publication 2: The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014.', 'Publication 3: Integrated genomic characterization of endometrial carcinoma. Nature. 2013.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis, K., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.', 'Beroukhim, R., et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: FGFR3 Mutations and Their Impact', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Osteosarcoma: Insights from the TARGET-OS Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'The Role of FGFR3 in Osteosarcoma: A Genomic Perspective', Oncogene.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], ['Publication 1: Comprehensive molecular characterization of uterine corpus endometrial carcinoma. Nature, 2013.', 'Publication 2: Integrated genomic characterization of endometrial carcinoma. Cell, 2017.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'FGFR3 Mutations in Pancreatic Cancer', Oncogene.\", \"Publication 3: Lee et al., 2022, 'Comprehensive Genomic Profiling of Pancreatic Adenocarcinoma', Cancer Genomics.\"], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of oesophageal carcinoma. Nature, 541(7636), 169-175.', 'Zhang, L., et al. (2018). Genomic landscape and immune microenvironment features of pre-invasive and invasive esophageal squamous cell carcinoma. Nature Communications, 9(1), 1533.'], ['TCGA Research Network. Comprehensive molecular characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal. TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'Weinstein JN, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.', 'Cerami et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery. 2012.', 'Gao et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Zhang J, et al. The genomic landscape of lung cancer in the Genomic Data Commons. Cancer Res. 2016;76(12):3507-3515.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Pathology, 2019.'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell lung cancers', Nature, 2012\", \"Publication: 'The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer', Nature, 2012\"], ['Cerami et al., 2012, The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data', 'Gao et al., 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal'], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in FGFR3 Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'FGFR3 Mutations and Their Role in Cancer Progression'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'Comprehensive Analysis of FGFR3 Variants in Cancer'. Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in H3-3B Across Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'H3-3B Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in H3-3B and Their Role in Tumorigenesis', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Wilms Tumor: Insights from the MP2PRT-WT Project', Journal of Pediatric Oncology.\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Wilms Tumor: A Comprehensive Analysis', Cancer Genomics & Proteomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer: A Study of the CPTAC-3 Project', Oncogenomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization and Its Implications in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Lung Cancer: A Comprehensive Analysis from the Genomic Data Commons', Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization Project Findings', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric Osteosarcoma', Pediatric Oncology Journal.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Osteosarcoma: Insights from the Genomic Data Commons', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma CGCI-HTMCP-DLBCL project'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic characterization of lung adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic alterations in lung adenocarcinoma', Cancer Genomics.\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Bailey, M. H., Tokheim, C., Porta-Pardo, E. et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173, 371385.e18 (2018).'], ['Genomic Data Commons Data Portal', 'TCGA-CHOL project publications'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['Genomic Data Commons, Thymoma TCGA-THYM project data', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors, The Cancer Genome Atlas Research Network'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Mesothelioma: A Comprehensive Analysis', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Mesothelioma: Insights from TCGA Data', Cancer Genomics.\"], [\"Cancer Genome Atlas Research Network. 'The Cancer Genome Atlas Pan-Cancer analysis project.' Nature genetics 45.10 (2013): 1113-1120.\", \"Robertson, A. Gordon, et al. 'Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.' Cancer Cell 32.2 (2017): 204-220.\"], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. TCGA-SARC Project Data.'], ['Genomic Data Commons Data Portal', 'TCGA Pancreatic Adenocarcinoma (PAAD) Study'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Liver Cancer', Journal of Hepatology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Liver Cancer', Cancer Research\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Hepatocellular Carcinoma', Oncogene\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Genomic Data Commons Data Portal. TCGA-KIRP project data.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of testicular germ cell tumors. Cell Reports, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Bailey, M. H., Tokheim, C., Porta-Pardo, E., et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173, 371385.e18 (2018).'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, Chan AS, Tsui WY, Ho SL, Chan AK, Man JL, Foglizzo V, Ng MK, Chan AS, Ching YP, Cheng GH, Xie T, Fernandez J, Li VW, Leung SY. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014 Jun;46(6):573-82.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28;164(3):550-563.'], ['Genomic Data Commons Data Portal', 'TCGA Research Network Publications'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of H3-3B Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in H3-3B: Insights from the Human Cancer Model Initiative', Cancer Genomics.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], [\"Publication 1: Smith et al., 2022, 'Comprehensive Genomic Analysis of H3-3B Mutations in Cancer', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'The Role of H3-3B in Tumorigenesis: Insights from the Genomic Data Commons', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'H3-3B Variants in CPTAC-3: A Multi-Cancer Study', Genomics and Cancer.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in osteosarcoma: A comprehensive review. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2021). The landscape of somatic mutations in osteosarcoma. Cancer Genomics.', 'Publication 3: Williams, R. et al. (2022). Copy number variations in pediatric osteosarcoma. Pediatric Oncology Journal.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic data commons: Insights into lung adenocarcinoma. Cancer Genomics.'], ['Genomic Data Commons Data Portal', 'Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project documentation'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Genomic Data Commons (GDC) - TCGA-CHOL project data', 'Publication: Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['Genomic Data Commons - Thymoma TCGA-THYM project data', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors in The Cancer Genome Atlas (TCGA)'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2017). Comprehensive Molecular Characterization of Uveal Melanoma. Cell, 173(2), 511-517.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-PAAD'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], [\"Zhang, J., et al. (2013). 'The genomic landscape of adrenocortical carcinoma.' Nature Genetics.\", \"Assi, G., et al. (2014). 'Integrated genomic characterization of adrenocortical carcinoma.' Nature Genetics.\"], ['Publication 1: Comprehensive molecular characterization of testicular germ cell tumors. Nature, 2018.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015.', 'Krauthammer M, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Zhao, P., et al. (2019). Comprehensive characterization of somatic mutations in cervical cancer. International Journal of Cancer, 145(8), 2018-2028.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543550 (2014).', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in H3-3B across cancer models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Comprehensive analysis of somatic mutations in cancer models. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Copy number variations in cancer development. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Publication: Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['CPTAC-3 Brain Study, Genomic Data Commons', 'CPTAC-3 Head and Neck Study, Genomic Data Commons', 'CPTAC-3 Kidney Study, Genomic Data Commons', 'CPTAC-3 Lung Study, Genomic Data Commons', 'CPTAC-3 Pancreas Study, Genomic Data Commons', 'CPTAC-3 Uterus Study, Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in osteosarcoma: A comprehensive review. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2021). The landscape of somatic mutations in osteosarcoma. Cancer Genomics.', 'Publication 3: Williams, R. et al. (2022). Copy number variations in pediatric osteosarcoma. Pediatric Oncology Journal.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project. https://portal.gdc.cancer.gov/'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/READ-2017'], ['TCGA-CHOL publication: Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma', 'Genomic Data Commons Data Portal: TCGA-CHOL project'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2015', 'https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-MESO'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2017). 'Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/ATACseq-AWG', 'https://gdc.cancer.gov/about-data/publications/mc3-2017'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., ... & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S, Chu KM, Law S, Chan TL, Ho SL, Chan AS, Tsui WY, Li VS, Clevers H, Rejto PA, Leung SY. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014 Jun;46(6):573-82.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], [\"Kandoth, C., et al. (2013). 'Mutational landscape and significance across 12 major cancer types.' Nature, 502(7471), 333-339.\", \"The Cancer Genome Atlas Research Network. (2011). 'Integrated genomic analyses of ovarian carcinoma.' Nature, 474(7353), 609-615.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of H3-3A Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in H3-3A: Insights from the Human Cancer Model Initiative', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in H3-3A Across Cancer Types', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 4;499(7456):43-9.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project'], ['Publication 1: Comprehensive molecular characterization of the CPTAC-3 project, Genomic Data Commons, 2023.', 'Publication 2: Analysis of somatic mutations in cancer, Genomic Data Commons, 2023.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], [\"Publication 1: Smith et al., 2020, 'Genomic Landscape of Osteosarcoma in the TARGET-OS Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in Pediatric Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Osteosarcoma: Insights from the Genomic Data Commons', Oncogene.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Smith et al., 2022, Journal of Proteomics', 'Johnson et al., 2023, Cancer Research', 'Williams et al., 2023, Genomics Data Commons Reports'], ['Burkitt Lymphoma Genome Sequencing Project (CGCI-BLGSP) data from the Genomic Data Commons'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: TCGA-DLBC project data.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018.'], ['Genomic Data Commons (GDC) - Thymoma TCGA-THYM project data', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors (The Cancer Genome Atlas Research Network)'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015.', 'Robertson AG, et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell. 2017.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Raphael, B. J., Hruban, R. H., Aguirre, A. J., et al. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Zehir, A., Benayed, R., Shah, R. H., & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature Medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic features of testicular germ cell tumors. Nature Genetics, 2017.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012 Sep;44(9):1006-14.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network.', 'Publication 2: Integrated Genomic Characterization of Uterine Carcinosarcoma, The Cancer Genome Atlas Research Network.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MET Across Various Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of MET Mutations in Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Role of MET in Tumorigenesis: Insights from Genomic Data', Oncogene.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Exceptional Responders', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'MET Mutations in Cancer: A Comprehensive Study', Cancer Genomics.\"], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 2016.', 'Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Shih, J. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Barretina J, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: A Comprehensive Review', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'The Role of MET Mutations in Osteosarcoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Osteosarcoma: Implications for Targeted Therapy', Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'HIV+ Tumor Molecular Characterization and Its Implications in Lung Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Comprehensive Study', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'GDC Data Portal: TCGA-PCPG project data'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015;75(15 Suppl):Abstract nr 4000.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nat Genet. 2018 Sep;50(9):1332-1340.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers in China. Nature Genetics, 2019.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics. 2016.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer: Insights from the CGCI-HTMCP-CC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Cervical Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Somatic Mutations in Cervical Cancer: A Comprehensive Analysis', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Genomic Data Commons Data Portal - TCGA-CHOL Project', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Cervical Cancer', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'MET Mutations in Cervical Cancer', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in Cervical Squamous Cell Carcinoma', Genomic Medicine.\"], ['Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017 Aug 14;32(2):185-203.e13.', 'Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 3;531(7592):47-52.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'MET Alterations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Cancer Genome Atlas Research Network. 'The Cancer Genome Atlas Pan-Cancer analysis project.' Nature genetics 45.10 (2013): 1113-1120.\", \"Robertson, A. Gordon, et al. 'Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.' Cancer Cell 32.2 (2017): 204-220.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MET Across Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'MET Mutations and Cancer: A Comprehensive Review', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in MET and Their Role in Cancer', Oncogene.\"], ['National Cancer Institute Genomic Data Commons Data Portal', 'The Cancer Genome Atlas Research Network publications on Uterine Carcinosarcoma'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Liu Y, Sethi NS, Hinoue T, et al. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018 Apr 9;33(4):721-735.e8.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Publication 1: Smith et al., 2022, Journal of Genomic Data, DOI: 10.1234/jgd.2022.5678', 'Publication 2: Johnson et al., 2023, Cancer Genomics, DOI: 10.5678/cg.2023.1234'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Cell, 170(4), 744-757.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Davis CF, Ricketts CJ, Wang M, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319-330.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Genomic Data Commons, TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma', Journal of Clinical Oncology, 2020\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Fishbein L, Leshchiner I, Walter V, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2015). Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell, 163(2), 506-519.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Kandoth C, Schultz N, Cherniack AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 2;497(7447):67-73.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2021). Comprehensive genomic profiling of cervical cancer in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). The landscape of somatic mutations in cervical cancer. Genomic Data Commons Reports.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Sato Y, Yoshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013 Aug;45(8):860-7.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-CHOL'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['Robertson AG, et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell.', 'The Cancer Genome Atlas Research Network. (2018). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in MET and Their Impact on Cancer Development', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of MET Variants in Human Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2021, 'The Role of MET Mutations in Tumorigenesis', Oncogene.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in NT5C2 and their impact on treatment response in ALL. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling of NT5C2 in acute lymphoblastic leukemia. Leukemia Research.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in NT5C2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in NT5C2: Implications for Cancer Development', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in NT5C2 Across Cancer Types', Genomic Data Commons Reports.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Profiling in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Alterations in ALL', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Leukemia', Cancer Genomics\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in NT5C2 across cancer models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Comprehensive analysis of NT5C2 mutations in cancer. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). NT5C2 copy number variations in the Human Cancer Model Initiative. Genomic Data Commons Reports.'], [\"Publication 1: Smith et al., 2021, 'Genomic Characterization of CHEK2 Variants in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'CHEK2 Mutations in the Human Cancer Model Initiative', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Analysis of Copy Number Variants in Cancer Models', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-49.', 'Zhao, H., et al. (2013). The landscape of somatic copy-number alteration across human cancers. Nature. 497, 67-73.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery. 2(5), 401-404.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in Wilms Tumor: Insights from the MP2PRT-WT project. Journal of Pediatric Oncology.', 'Publication 2: Johnson, L. et al. (2023). Molecular profiling in pediatric renal tumors: CHEK2 mutations and treatment response. Pediatric Cancer Research.'], ['CPTAC-3 project data from the Genomic Data Commons', \"Publication: 'Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma' - The Cancer Genome Atlas Research Network\", \"Publication: 'Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma' - The Cancer Genome Atlas Research Network\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'CHEK2 Mutations in Lung Cancer: Frequency and Implications', Lung Cancer Journal.\"], ['Genomic Data Commons Data Portal', 'HIV+ Tumor Molecular Characterization Project - Lung Cancer (CGCI-HTMCP-LC) dataset'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-Cervical-2017', 'https://gdc.cancer.gov/projects/CGCI-HTMCP-CC'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, H. et al. (2023). Comprehensive analysis of somatic mutations in lung cancer. Genomic Data Commons Reports.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the TCGA-DLBC project.', 'Publication 2: Analysis of somatic mutations in lymphoid neoplasms using TCGA data.', 'Publication 3: The role of CHEK2 mutations in lymphoid malignancies: Insights from the TCGA-DLBC project.'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive and Integrative Genomic Characterization of Cholangiocarcinoma' by the Cancer Genome Atlas Research Network\"], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Cibulskis, K., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.', 'Beroukhim, R., et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['Genomic Data Commons, TCGA-THYM project data', 'Publication: Comprehensive molecular characterization of thymic epithelial tumors in The Cancer Genome Atlas, Nature Communications, 2020'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/ATACseq-AWG'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951821/'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma, TCGA Research Network', 'Publication 2: Genomic Data Commons: A Platform for Cancer Genomics Research, Grossman et al.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & Integrated Genomic Characterization of Adrenocortical Carcinoma. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Wang, Z., et al. The Genomic Landscape of Testicular Germ Cell Tumors. Nature Genetics. 2018.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Analysis of Prognostic Molecular Factors in Cervical Cancer. J Clin Oncol. 2019 Apr 1;37(10):768-777.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Comprehensive Genomic Characterization of Radiation-Related Papillary Thyroid Cancer in the Ukraine REBC-THYR Project, Genomic Data Commons'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013;45(10):1127-1133.'], ['TCGA Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 2015.', 'Ciriello, G., et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-690.', 'Landa I, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016 Mar 1;126(3):1052-1066.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Zhang J, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013 Oct;45(10):1113-20.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of FLT3 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in FLT3 and Their Impact on Cancer Progression', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in FLT3: Insights from the HCMI-CMDC Project', Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 4;499(7456):43-9.'], ['Genomic Data Commons Data Portal', 'The Cancer Genome Atlas (TCGA) Research Network'], ['https://gdc.cancer.gov/about-data/publications/MP2PRT-WT'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Publication: Painter CA, Jain E, Tomson BN, et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 2020.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: The Role of FLT3 Mutations', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'FLT3 Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Tyner, J. W., et al. (2018). Functional Genomic Landscape of Acute Myeloid Leukaemia. Nature, 562(7728), 526-531.', 'Genomic Data Commons Data Portal: BEATAML1.0-COHORT project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Genomic Data Commons - TARGET Osteosarcoma (TARGET-OS) project'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma.' Journal of Hematology.\", \"Publication 2: Doe, A. et al. (2021). 'Somatic Mutations in HIV-Related Lymphomas.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Copy Number Variants in HIV-Positive Lymphoma Patients.' Genomic Medicine.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Thoracic Oncology.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Research.'], ['Publication 1: Smith et al., 2022, Journal of Hematology', 'Publication 2: Johnson et al., 2023, Leukemia Research'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic profiling of diffuse large B-cell lymphoma in the Genomic Data Commons'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA dataset'], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: Genomic alterations in esophageal carcinoma: insights from The Cancer Genome Atlas (TCGA) project, Journal of Thoracic Oncology, 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-KICH'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.e28.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017.'], ['Publication 1: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, 2017.', 'Publication 2: The Genomic Landscape of Hepatocellular Carcinoma, Nature Genetics, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016;374(2):135-145.', 'Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson AG, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-49.'], ['Zheng, S., Cherniack, A. D., Dewal, N., Moffitt, R. A., Danilova, L., Murray, B. A., ... & TCGA Research Network. (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics, 49(4), 620-625.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, T., et al. Genomic and transcriptomic profiling of testicular germ cell tumors: insights into tumorigenesis and potential therapeutic targets. Nature Communications, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-519.', 'Zhang W, et al. Genomic Landscape and Phenotypic Profiles of Intrahepatic Cholangiocarcinoma. Hepatology. 2016 Nov;64(5):1602-1611.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhang, J., Baran, J., Cros, A., Guberman, J. M., Haider, S., Hsu, J., ... & Ferretti, V. (2011). International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database, 2011.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-25.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-28.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BCL2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in BCL2 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in BCL2 and Their Impact on Cancer Progression', Genomic Medicine.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Copy number variations in BCL2 among HIV+ DLBCL patients. Oncogene Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BCL2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in BCL2 Across Cancer Types', Genomics and Cancer.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in BCL2: Insights from the HCMI-CMDC Project', Cancer Genomics.\"], ['Publication 1: Comprehensive Molecular Characterization of Diffuse Large B-Cell Lymphoma in the HIV+ Population, Journal of Hematology, 2022.', 'Publication 2: Genomic Alterations in HIV-Associated Diffuse Large B-Cell Lymphoma, Cancer Research, 2023.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of BCL2 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in BCL2 Across Cancer Types', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in BCL2 and Their Impact on Cancer Progression', Genomic Medicine.\"], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Publication 1: Comprehensive Molecular Characterization of Cervical Cancer, Nature, 2017.', 'Publication 2: The Genomic Landscape of Cervical Cancer in HIV+ Patients, Journal of Clinical Oncology, 2018.'], ['https://gdc.cancer.gov/about-data/publications/TARGET-OS-2018', 'https://gdc.cancer.gov/about-data/publications/OS-2018'], ['https://gdc.cancer.gov/about-data/publications/HTMCP-DLBCL'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2023, 'Molecular Profiling in Leukemia', Leukemia Research Journal\"], ['Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2, 401404 (2012).', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).'], ['Fishbein L, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017 Feb 13;31(2):181-193.', 'The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pheochromocytoma and Paraganglioma. Cell Reports. 2017 Feb 7;18(3):789-803.'], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['TCGA-CHOL project data from the Genomic Data Commons', 'Publication: Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas in the TCGA-CHOL project'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas (TCGA) Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan, W. M., Spellman, P. T., Ricketts, C. J., et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['Bailey, P., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network', 'Publication 2: Integrated Genomic Characterization of Uterine Carcinosarcoma, The Cancer Genome Atlas Research Network'], ['TCGA Research Network: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017.', 'Zhang, J., et al. (2019). Genomic Landscape of Liver Cancers in China. Nature Genetics.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2013.'], ['Zhao, L., et al. (2016). Comprehensive characterization of the genomic alterations in adrenocortical carcinoma. Journal of Clinical Oncology.', 'Assi, G., et al. (2014). Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Hodis E, et al. A landscape of driver mutations in melanoma. Cell. 2012 Jul 20;150(2):251-63.'], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543(7645), 378-384.', 'Liu, Y., et al. (2019). Comprehensive genomic characterization of cervical squamous cell carcinoma and endocervical adenocarcinoma. Cell, 179(3), 529-543.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhao, S., Bellone, S., Lopez, S., Thakral, D., Schwab, C. L., English, D. P., ... & Santin, A. D. (2013). Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proceedings of the National Academy of Sciences, 113(43), 12238-12243.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Ciriello G, Miller ML, Aksoy BA, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25;372(26):2481-98.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015 Apr 1;75(7):1046-56.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013 Oct;45(10):1127-33.'], ['TCGA Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609615 (2011).'], [\"Publication 1: Smith et al., 2020, 'Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology\", \"Publication 2: Johnson et al., 2021, 'Somatic Mutations in HIV-Related Lymphomas', Cancer Research Journal\", \"Publication 3: Lee et al., 2022, 'Copy Number Variants in HIV+ DLBCL', Genomics and Cancer\"], ['Cerami, E. et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2, 401404 (2012).', 'Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of EZH2 Mutations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in EZH2 and Their Role in Tumorigenesis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'The Impact of EZH2 Alterations in Cancer Development', Oncogene.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Research Journal.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell. 2018.', 'Zhang, J., et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences. 2013.', 'Schmitz, R., et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. New England Journal of Medicine. 2018.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in EZH2 Across Cancer Types'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Analysis of EZH2 Mutations in Cancer'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'EZH2 Variants in the Human Cancer Model Initiative'. Genomic Data Commons Reports.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma', Journal of Hematology, 2022.\", \"Publication 2: 'Genomic Alterations in HIV-Positive Diffuse Large B-Cell Lymphoma', Cancer Research, 2023.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Publication 1: Smith, J. et al. (2022). Analysis of EZH2 Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Johnson, L. et al. (2023). Genomic Alterations in the Human Cancer Model Initiative. Cancer Genomics.', 'Publication 3: Lee, M. et al. (2023). Copy Number Variants in Cancer Development. Genomic Data Commons Reports.'], [\"Publication 1: 'Comprehensive Molecular Characterization of Diffuse Large B-Cell Lymphoma in the HIV+ Population', Journal of Hematology, 2022.\", \"Publication 2: 'Genomic Alterations in HIV-Associated Lymphomas', Cancer Research, 2023.\"], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Nature, 2016'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Characterization of EZH2 in Cancer Models.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Somatic Mutations in EZH2 Across Cancer Types.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'Copy Number Variants in EZH2 and Their Impact on Cancer Progression.' Genomic Medicine.\"], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Genomic Data Commons - Exceptional Responders Project', \"Publication: 'Comprehensive Molecular Characterization of Exceptional Responders' in the Genomic Data Commons\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in NTRK3 Across Multiple Cancer Types', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of NTRK3 Mutations in the CPTAC-3 Cohort', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'NTRK3 Variants in Cancer: Insights from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in NTRK3 Across Cancer Models'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Comprehensive Analysis of NTRK3 Mutations in Cancer'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'NTRK3 Variants in Human Cancer Models'. Genomic Data Commons Reports.\"], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Somatic mutations in HIV-related lymphomas. Genomic Data Commons Reports.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016.'], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in cancer: A comprehensive analysis. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). The role of PIM1 mutations in cancer progression. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2023). Copy number variations in cancer: Insights from the Human Cancer Model Initiative. Genomic Data Commons Reports.'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Somatic mutations in HIV-related lymphomas. Genomic Data Commons Research.'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in PIM1 across Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Analysis of Somatic Mutations in Cancer Models', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Human Cancer Models', Genomic Data Commons Reports.\"], ['Publication 1: Smith, J. et al. (2020). Genomic Characterization of HIV-Associated Diffuse Large B-Cell Lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Somatic Mutations in HIV-Related Lymphomas. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2019). Copy Number Variants in HIV-Positive Lymphoma Patients. Genomic Data Commons Research.'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of diffuse large B-cell lymphoma in the Genomic Data Commons'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Characterization of PIM1 Mutations in Cancer Models.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Copy Number Variants in Cancer: Insights from the HCMI-CMDC Project.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2021). 'Somatic Mutations in Cancer Models: A Comprehensive Study.' Genomic Data Commons Reports.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Reference 1: Genomic Data Commons - Count Me In: The Angiosarcoma Project', 'Reference 2: Publication on PIK3CA mutations in angiosarcoma from the Genomic Data Commons'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'PIK3CA Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], ['Genomic Data Commons Data Portal - CGCI-HTMCP-LC Project', \"Publication: 'Comprehensive Molecular Characterization of Lung Cancer in HIV-Positive Patients' - Journal of Clinical Oncology\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['https://gdc.cancer.gov/about-data/publications/target-osteosarcoma', 'https://gdc.cancer.gov/about-data/publications/target-osteosarcoma-2020'], ['Publication 1: Smith, J. et al. (2020). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2021). Molecular characterization of DLBCL in HIV-positive patients. Cancer Research Journal.', 'Publication 3: Brown, L. et al. (2019). PIK3CA mutations in HIV-related lymphomas. Oncogene.'], ['Genomic Data Commons Data Portal', 'APOLLO1: Proteogenomic characterization of lung adenocarcinoma APOLLO-LUAD project'], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-DLBC'], ['Cancer Genome Atlas Research Network. Integrated genomic characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(3):393-406.e9.', 'Genomic Data Commons Data Portal. Pheochromocytoma and Paraganglioma (TCGA-PCPG) project.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Genomic Data Commons Data Portal - TCGA-CHOL', 'Nature. 2015 Oct 15;526(7573):100-4. doi: 10.1038/nature14667. Epub 2015 Oct 5.', 'Cell. 2018 Apr 5;173(2):291-304.e6. doi: 10.1016/j.cell.2018.03.046.'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive molecular profiling of malignant pleural mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., & Robertson, A. G. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499(7456), 43-49.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, & Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.e13.', 'Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A. M., Gingras, M. C., Miller, D. K., Christ, A. N., Bruxner, T. J., Quinn, M. C., Nourse, C., Murtaugh, L. C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, J. L., Holmes, O., ... & Biankin, A. V. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017 Apr 27;169(7):1327-1341.e23.', 'Zhang J, et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Annu Rev Pathol. 2018 Jan 24;13:231-252.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Creighton, C. J., et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 2013.'], ['Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., ... & Berger, M. F. (2017). Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nature medicine, 23(6), 703-713.', 'Cancer Genome Atlas Research Network. (2016). Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell, 166(4), 950-965.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 8;163(2):506-19.', 'The Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang H, Liu T, Zhang Z, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016 Jun 30;166(3):755-765.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Head Neck. 2015 Sep;37(9):E166-76.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Bell D, Berchuck A, Birrer M, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'The Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 25;499(7456):43-9.', 'Sato Y, Yoshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013 Aug;45(8):860-7.'], ['Publication 1: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Publication 2: The Cancer Genome Atlas Network. Comprehensive molecular characterization of human breast tumors. Cell. 2015.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Lung Cancer: A Comprehensive Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons', Oncogene.\"], ['Publication 1: Smith et al., 2022, Journal of Genomic Data', 'Publication 2: Johnson et al., 2023, Cancer Genomics Research'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of Lung Cancer in HIV+ Patients', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'FGFR3 Mutations in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"], [\"Publication 1: 'Comprehensive Molecular Characterization of Cervical Cancer', Nature, 2017.\", \"Publication 2: 'Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia', New England Journal of Medicine, 2013.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Osteosarcoma: FGFR3 Mutations and Their Clinical Implications', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Comprehensive Genomic Profiling of Osteosarcoma: Insights from the TARGET-OS Project', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'The Role of FGFR3 in Osteosarcoma: A Genomic Data Commons Analysis', Oncogene.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in HIV-associated diffuse large B-cell lymphoma. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular characterization of DLBCL in HIV-positive patients. Cancer Genomics.', 'Publication 3: Lee, T. et al. (2021). FGFR3 mutations in HIV-related lymphomas. Oncogene Research.'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Alterations in Lung Adenocarcinoma', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2021, 'Genomic Alterations in Acute Lymphoblastic Leukemia', Journal of Hematology\", \"Publication 2: Johnson et al., 2022, 'Molecular Profiling in Leukemia', Leukemia Research\", \"Publication 3: Lee et al., 2023, 'FGFR3 Mutations in Hematologic Malignancies', Blood Cancer Journal\"], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in diffuse large B-cell lymphoma: A comprehensive analysis.' Journal of Hematology.\", \"Publication 2: Johnson, L. et al. (2021). 'FGFR3 mutations in lymphoid neoplasms: Implications for targeted therapy.' Cancer Research Journal.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017.', 'Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell. 2017.'], ['Publication 1: Comprehensive molecular characterization of rectal adenocarcinoma in the TCGA-READ project.', 'Publication 2: Analysis of FGFR3 mutations and copy number variations in rectal cancer from the Genomic Data Commons.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['Publication 1: Comprehensive molecular characterization of esophageal carcinoma, The Cancer Genome Atlas Research Network, Nature, 2017.', 'Publication 2: FGFR3 alterations in esophageal carcinoma: A study from the TCGA-ESCA project, Journal of Clinical Oncology, 2018.'], ['TCGA Research Network: Comprehensive molecular characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], [\"Robertson, A. G., et al. (2017). 'Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.' Cancer Cell, 32(2), 204-220.e15.\", \"The Cancer Genome Atlas Research Network. (2018). 'Comprehensive and Integrative Genomic Characterization of Adult Soft Tissue Sarcomas.' Cell, 171(4), 950-965.e28.\"], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Publication 1: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas, The Cancer Genome Atlas Research Network, Cell, 2017.', 'Publication 2: Genomic and Molecular Characterization of Sarcomas, The Cancer Genome Atlas Research Network, Nature, 2018.'], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Pancreatic Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'FGFR3 Mutations in Pancreatic Cancer', Oncogene Journal.\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Uterine Carcinosarcoma. Nature, 2018.', 'Genomic Data Commons Data Portal: TCGA-UCS Project Data'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers: Implications for Diagnosis and Treatment. Annual Review of Pathology: Mechanisms of Disease, 2018.'], ['Publication 1: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 2016.', 'Publication 2: Integrated Genomic Characterization of Papillary Renal Cell Carcinoma. The Cancer Genome Atlas Research Network. Cell Reports, 2017.'], ['Zhao, X., et al. (2016). Comprehensive Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736.', 'The Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Adrenocortical Carcinoma. Nature Genetics, 49(4), 634-642.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Clinical Pathology, 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Hodis E, et al. A landscape of driver mutations in melanoma. Cell. 2012 Jul 20;150(2):251-263.'], ['TCGA-CESC project data from the Genomic Data Commons', 'Publication: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.'], ['The Cancer Genome Atlas Research Network. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487(7407), 330-337.', 'Cerami, E., et al. (2012). The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401-404.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), pl1.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhao, S., Bellone, S., Lopez, S., Thakral, D., Schwab, C. L., English, D. P., ... & Santin, A. D. (2013). Mutational landscape of uterine serous carcinoma. Cancer Research, 73(20), 6031-6041.'], ['The Cancer Genome Atlas Research Network. (2015). The Molecular Taxonomy of Primary Prostate Cancer. Cell, 163(4), 1011-1025.', 'Robinson, D., et al. (2015). Integrative Clinical Genomics of Advanced Prostate Cancer. Cell, 161(5), 1215-1228.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Bass AJ, Thorsson V, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Chung CH, et al. Genomic alterations in head and neck squamous cell carcinoma determined by the Cancer Genome Atlas. Cancer Res. 2015 Apr 1;75(7):1046-56.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10;155(2):462-77.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.'], ['Publication 1: Comprehensive molecular characterization of human colon and rectal cancer. Nature, 2012.', 'Publication 2: Integrated genomic analyses of ovarian carcinoma. Nature, 2011.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-49.', 'Cerami E, Gao J, Dogrusoz U, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-404.', 'Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'FGFR3 Mutations in Lung Cancer: A Comprehensive Analysis'. Cancer Genomics.\", \"Publication 3: Lee, H. et al. (2023). 'Copy Number Variants in Lung Adenocarcinoma: Findings from the Genomic Data Commons'. Oncogene.\"], [\"Publication 1: Smith et al., 2020, 'Genomic Alterations in Diffuse Large B-Cell Lymphoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2021, 'Molecular Characterization of HIV-Associated Lymphomas', Cancer Genomics.\", \"Publication 3: Lee et al., 2022, 'FGFR3 Mutations in Lymphoma: A Comprehensive Study', Oncogene.\"], ['Publication 1: Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). FGFR3 mutations in lung cancer: A comprehensive analysis. Lung Cancer Journal.'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia (MP2PRT-ALL) project data', \"Publication: 'Comprehensive genomic profiling of acute lymphoblastic leukemia' in the Genomic Data Commons\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181-193.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['Genomic Data Commons, TCGA-CHOL project data', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['Genomic Data Commons Data Portal - TCGA-KICH', 'Publication: Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, The Cancer Genome Atlas Research Network'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zucman-Rossi, J., Villanueva, A., Nault, J.C., & Llovet, J.M. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. Gastroenterology, 2015.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Cerami, E., et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2012.', 'Gao, J., et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 2013.'], ['Genomic Data Commons Data Portal - TCGA-ACC Project', 'Publication: Comprehensive Molecular Characterization of Adrenocortical Carcinoma, The Cancer Genome Atlas Research Network'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['The Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. New England Journal of Medicine, 2015.', 'Ceccarelli, M., et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell, 2016.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of FGFR3 in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Copy Number Variants in FGFR3 and Their Role in Tumorigenesis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations in FGFR3 Across Different Cancer Types', Oncogene.\"], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Apr 18;499(7456):43-9.', 'Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.', 'Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.'], [\"Publication 1: Smith et al., 2021, 'Comprehensive Genomic Characterization of FGFR3 in Various Cancers', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2022, 'FGFR3 Mutations and Their Role in Cancer Progression', Oncogene.\", \"Publication 3: Lee et al., 2023, 'Analysis of FGFR3 Alterations in the CPTAC-3 Cohort', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma in the CDDP_EAGLE-1 Study', Cancer Genomics.\"], [\"Publication 1: Smith et al., 2022, 'Genomic Characterization of Exceptional Responders in Cancer Therapy', Journal of Clinical Oncology.\", \"Publication 2: Johnson et al., 2023, 'FGFR3 Mutations in Exceptional Responders: Insights from the Genomic Data Commons', Cancer Research.\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic alterations in cervical cancer: Insights from the CGCI-HTMCP-CC project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Molecular characterization of cervical cancer in HIV-positive patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'FGFR3 mutations in cervical cancer: A study from the HTMCP project.' Oncogene.\"], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Diffuse Large B-Cell Lymphoma (CGCI-HTMCP-DLBCL) dataset'], [\"Publication 1: Smith et al., 2022, 'Proteogenomic Characterization of Lung Adenocarcinoma', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Genomic Data Commons Analysis of Lung Cancer', Cancer Genomics.\"], ['Publication 1: Smith, J. et al. (2022). Genomic alterations in acute lymphoblastic leukemia: Insights from the MP2PRT-ALL project. Journal of Hematology.', 'Publication 2: Doe, A. et al. (2023). Molecular profiling in ALL: FGFR3 mutations and treatment response. Leukemia Research.'], ['Publication 1: Comprehensive genomic characterization of diffuse large B-cell lymphoma, TCGA, 2015.', 'Publication 2: The Genomic Data Commons: A Unified Platform for Cancer Genomics, Grossman et al., 2016.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cell. 2017 Feb 9;168(4):584-600.', 'Genomic Data Commons Data Portal. TCGA-PCPG project data.'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Cerami E, et al. The cBio Cancer Genomics Portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.', 'Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.'], ['TCGA-CHOL project data from the Genomic Data Commons', \"Publication: 'Comprehensive molecular characterization of intrahepatic and extrahepatic cholangiocarcinomas' - Nature, 2017\"], ['The Cancer Genome Atlas Research Network. (2017). Integrated genomic characterization of oesophageal carcinoma. Nature, 541(7636), 169-175.', 'Zhang, L., Zhou, Y., Cheng, C., Cui, H., Cheng, L., Kong, P., ... & Wang, F. (2019). Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. American Journal of Human Genetics, 104(4), 709-719.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature Genetics, 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Robertson, A. G., et al. (2017). Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell, 32(2), 204-220.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med. 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Bailey, P., Chang, D. K., Nones, K., et al. (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52.', 'Cancer Genome Atlas Research Network. (2017). Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell, 32(2), 185-203.'], ['The Cancer Genome Atlas Research Network. (2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell, 171(4), 950-965.', 'Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., ... & Cancer Genome Atlas Research Network. (2017). Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell, 31(3), 411-423.'], ['The Cancer Genome Atlas Research Network. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell, 2017.', 'Zhang, J., et al. Genomic Landscape of Liver Cancers in China. Nature Genetics, 2019.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of papillary renal-cell carcinoma. New England Journal of Medicine, 2016.', 'Linehan WM, Spellman PT, Ricketts CJ, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. New England Journal of Medicine, 2016.'], ['Zhao, L., et al. (2016). Comprehensive characterization of somatic mutations in adrenal cortical carcinoma. Nature Communications.', 'Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports. 2018.', 'Cheng, L., et al. Molecular genetic pathology of testicular germ cell tumors. American Journal of Pathology. 2019.'], ['Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-1696.', 'Hodis E, et al. A landscape of driver mutations in melanoma. Cell. 2012 Jul 20;150(2):251-63.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA-CESC) dataset in the Genomic Data Commons'], ['The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Sanchez-Vega F, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018 Apr 5;173(2):321-337.e10.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Zhao, S., Bellone, S., Lopez, S., Thakral, D., Schwab, C. L., English, D. P., ... & Santin, A. D. (2013). Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proceedings of the National Academy of Sciences, 113(43), 12238-12243.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Kim YR, Kim IJ, Kang TW, Choi C, Kim KC, Kim JM, Rhee H, Lee JH, Kim HJ, Kim HS, Kim SY, Kim YW, Kim YS. FGFR2 amplifications in gastric cancer: prevalence, mechanism and clinical significance. Br J Cancer. 2013 Jan 15;108(2):440-4.'], ['Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-2498.', 'Ceccarelli M, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016;164(3):550-563.'], ['The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology. 2013 Mar;31(3):213-9.'], ['Campbell, J. D., et al. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics.', 'Cancer Genome Atlas Research Network. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature.'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008 Oct 23;455(7216):1061-8.', 'Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010 Jan 19;17(1):98-110.'], ['The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013 Oct;45(10):1127-33.', 'Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-UCS', 'https://portal.gdc.cancer.gov/projects/TCGA-UCS'], ['TCGA Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014.', 'Genomic Data Commons Data Portal: TCGA-BLCA project data.'], ['Publication 1: Comprehensive molecular characterization of the SRSF2 gene in various cancers, CPTAC-3 project.', 'Publication 2: Analysis of somatic mutations and copy number variants in the CPTAC-3 dataset.', 'Publication 3: Genomic alterations in cancer: Insights from the CPTAC-3 project.'], ['TCGA Research Network: Comprehensive molecular characterization of rectal adenocarcinoma. Nature, 2017.', 'Genomic Data Commons Data Portal: TCGA-READ project data.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM-2015', 'https://portal.gdc.cancer.gov/projects/TCGA-THYM'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons - TARGET-OS project data', \"Publication: 'Comprehensive Molecular Characterization of Osteosarcoma' in the TARGET initiative\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['TCGA Research Network: Comprehensive molecular portraits of human breast tumours. Nature. 2012.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Kandoth, C., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature, 502(7471), 333-339.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang H, et al. Genomic Landscape and Clinical Relevance of Somatic Mutations in Ovarian Cancer. Mol Cancer Res. 2017 Feb;15(2):246-250.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of esophageal carcinoma. Nature. 2017 Jan 12;541(7636):169-175.', 'Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, Wang J, Xu L, Zhang T, Wang B, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015 Nov 5;97(5):627-639.'], ['TCGA Research Network: Comprehensive genomic characterization of mesothelioma. Nature. 2018.', 'Genomic Data Commons Data Portal: TCGA-MESO project data.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-25.', 'Robinson D, Van Allen EM, Wu YM, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-28.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543550 (2014).', 'Campbell, J. D., et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics 48, 607616 (2016).'], ['https://gdc.cancer.gov/about-data/publications/TCGA-TGCT', 'https://portal.gdc.cancer.gov/'], ['TCGA-CESC project data from the Genomic Data Commons', 'Publication: Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 Mar 16;543(7645):378-384.'], ['TCGA Research Network: Comprehensive molecular characterization of diffuse large B-cell lymphoma. Cell, 2018.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], ['Publication 1: Smith, J. et al. (2022). Analysis of Somatic Mutations in Cancer Models. Journal of Cancer Research.', 'Publication 2: Doe, A. et al. (2023). Genomic Variants in Human Cancer Models. Cancer Genomics.', 'Publication 3: Lee, R. et al. (2023). Copy Number Variants in Cancer Development. Genomic Data Commons Reports.'], ['TCGA Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Ciriello G, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics. 2013.'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang, H., et al. (2019). Genomic landscape and analysis of prognostic molecular factors in bladder urothelial carcinoma. Oncotarget, 10(6), 648-660.', 'Liu, Y., et al. (2018). Comprehensive genomic profiling of bladder urothelial carcinoma reveals a distinct somatic mutation pattern. BMC Genomics, 19(1), 695.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, et al. International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['https://gdc.cancer.gov/about-data/publications/TCGA-THYM', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075687/'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov 30;171(4):950-965.e28.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons, TARGET-OS project data'], [\"Publication 1: Smith, J. et al. (2020). 'Genomic Alterations in Lung Cancer: Insights from the HIV+ Tumor Molecular Characterization Project.' Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2021). 'Somatic Mutations in Lung Cancer: A Study of HIV+ Patients.' Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2019). 'Copy Number Variants in Lung Cancer: Data from the CGCI-HTMCP-LC Project.' Genomic Data Commons Reports.\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor (MP2PRT-WT) project data'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.', 'Beroukhim R, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18;463(7283):899-905.'], ['Genomic Data Commons Data Portal - TCGA-BRCA', 'Publication: Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017.', 'Zhang, L., et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Invasive Esophageal Squamous Cell Carcinoma. Nature Genetics. 2018.'], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Cancer Genome Atlas Research Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012.'], ['TCGA Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 18;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic data commons: A comprehensive platform for exploring cancer genomics data. Nature Genetics, 2016.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['TCGA-DLBC project data from the Genomic Data Commons', 'Publication: Reddy, A., et al. (2017). Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell, 171(2), 481-494.e15.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Cancer Models', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Somatic Mutations in Cancer Development', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Copy Number Variants in Cancer Models', Genomic Data Commons Reports.\"], ['https://gdc.cancer.gov/about-data/publications/pancanatlas', 'https://gdc.cancer.gov/about-data/publications/TCGA-UCS'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['Genomic Data Commons Data Portal', 'CPTAC-3 Project Publications'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330337 (2012).', 'Zhang, J., et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford) 2011, bar026 (2011).'], ['TCGA Research Network: Comprehensive molecular characterization of thymoma. Nature, 2017.', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'Genomic Data Commons Data Portal. National Cancer Institute. https://gdc.cancer.gov/'], ['TCGA Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.', 'Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Genomic Data Commons Data Portal', 'TARGET Osteosarcoma Project Publications'], [\"Publication 1: 'Genomic Characterization of HIV-Associated Lung Cancer', Journal of Cancer Research, 2022.\", \"Publication 2: 'Somatic Mutations in Lung Cancer: Insights from the CGCI-HTMCP-LC Project', Cancer Genomics, 2023.\"], ['Genomic Data Commons - Molecular Profiling to Predict Response to Treatment - Wilms Tumor MP2PRT-WT project data'], ['Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29;517(7536):576-82.', 'Cibulskis K, Lawrence MS, Carter SL, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013 Mar;31(3):213-9.'], ['Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70.', 'Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506-519.'], ['Cancer Genome Atlas Research Network. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.', 'Ciriello, G., et al. (2013). Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 45(10), 1127-1133.'], ['Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 30;474(7353):609-15.', 'Zhang, H., et al. (2013). Integrated genomic analysis of ovarian cancer. Nature, 474(7353), 609-615.'], ['Genomic Data Commons Data Portal', 'TCGA Pancreatic Adenocarcinoma (PAAD) Study'], ['Genomic Data Commons Data Portal - Esophageal Carcinoma TCGA-ESCA project', \"Publication: 'Comprehensive molecular characterization of esophageal carcinoma' - Nature, 2017\"], ['TCGA Research Network: Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017.', 'The Genomic Data Commons Data Portal: https://portal.gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27;489(7417):519-25.', 'Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016 Jun;48(6):607-16.'], ['Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5;163(4):1011-1025.', 'Robinson D, et al. Integrative Clinical Genomics of Advanced Prostate Cancer. Cell. 2015 May 21;161(5):1215-1228.'], ['Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012 Jul 19;487(7407):330-7.', 'Zhang J, Baran J, Cros A, et al. International Cancer Genome Consortium Data Portala one-stop shop for cancer genomics data. Database (Oxford). 2011;2011:bar026.'], ['TCGA Research Network: https://www.cancer.gov/tcga', 'Genomic Data Commons Data Portal: https://gdc.cancer.gov/'], ['Cancer Genome Atlas Research Network. Comprehensive molecular characterization of testicular germ cell tumors. Cell Reports, 2018.', 'Wang, Y., et al. Genomic analysis of testicular germ cell tumors in the TCGA database. Nature Genetics, 2019.'], ['TCGA-CESC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of squamous cell carcinoma of the cervix' - Nature, 2017\", \"Publication: 'Integrated genomic and molecular characterization of cervical cancer' - Nature, 2018\"], ['TCGA-DLBC project data from the Genomic Data Commons', \"Publication: 'Comprehensive genomic characterization of diffuse large B-cell lymphoma' - Nature, 2015\"], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Cervical Cancer CGCI-HTMCP-CC project data', \"Publication: 'Comprehensive molecular characterization of cervical cancer' - Nature, 2017\"], [\"Publication 1: Smith, J. et al. (2022). 'Genomic Alterations in Cancer: A Comprehensive Analysis of the HCMI-CMDC Project'. Journal of Cancer Research.\", \"Publication 2: Doe, A. et al. (2023). 'Somatic Mutations and Copy Number Variants in Cancer: Insights from the Genomic Data Commons'. Cancer Genomics.\", \"Publication 3: Lee, R. et al. (2023). 'The Role of SRSF2 Mutations in Cancer: Data from the Human Cancer Model Initiative'. Oncogene.\"], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], ['Genomic Data Commons - HIV+ Tumor Molecular Characterization Project - Lung Cancer CGCI-HTMCP-LC project'], ['Smith, J. et al. (2022). Proteogenomic characterization of lung adenocarcinoma. Journal of Cancer Research.', 'Doe, A. et al. (2023). Genomic alterations in lung adenocarcinoma: Insights from the APOLLO-LUAD project. Cancer Genomics.'], [\"Publication 1: Smith et al., 2022, 'Genomic Alterations in Lung Adenocarcinoma: Insights from the CDDP_EAGLE-1 Project', Journal of Cancer Research.\", \"Publication 2: Johnson et al., 2023, 'Comprehensive Genomic Profiling of Lung Adenocarcinoma: Findings from the CDDP Integrative Analysis', Cancer Genomics.\", \"Publication 3: Lee et al., 2023, 'Somatic Mutations and Copy Number Variants in Lung Cancer: A Study from the Genomic Data Commons', Oncogene.\"]]\n"
     ]
    }
   ],
   "source": [
    "results = []\n",
    "references_list = []\n",
    "\n",
    "with open(\"/opt/gpudata/aartiv/qag/gpt-4o-2024-08-06/batch_gpt4o_latest.jsonl\", \"r\") as file:\n",
    "    for line in file:\n",
    "        record = json.loads(line)\n",
    "\n",
    "        try:\n",
    "            # step 1: get the assistant message content (which is a JSON string)\n",
    "            content_str = record[\"response\"][\"body\"][\"choices\"][0][\"message\"][\"content\"]\n",
    "\n",
    "            # step 2: parse that content string as JSON\n",
    "            content_json = json.loads(content_str)\n",
    "\n",
    "            # step 3: extract result and references\n",
    "            result = content_json.get(\"result\")\n",
    "            references = content_json.get(\"references\", [])\n",
    "\n",
    "            results.append(result)\n",
    "            references_list.append(references)\n",
    "\n",
    "        except (KeyError, json.JSONDecodeError) as e:\n",
    "            print(\"Error parsing line:\", e)\n",
    "            results.append(None)\n",
    "            references_list.append([])\n",
    "\n",
    "# Output examples\n",
    "print(\"Results:\\n\", results)\n",
    "print(\"\\nReferences:\\n\", references_list)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "8f07b0d2",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "questions = pd.read_csv(\n",
    "    '../csvs/questions.csv'\n",
    ")\n",
    "questions['gpt-4o-2024-08-06_base_output'] = results\n",
    "questions['gpt-4o-2024-08-06_references'] = references_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "707e7870",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>questions</th>\n",
       "      <th>gpt-4o-2024-08-06_base_output</th>\n",
       "      <th>gpt-4o-2024-08-06_references</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>What is the frequency of somatic JAK2 heterozy...</td>\n",
       "      <td>The final answer is: 3.5%</td>\n",
       "      <td>[Publication 1: Smith et al., 2022, 'Microsate...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>What is the frequency of somatic JAK2 heterozy...</td>\n",
       "      <td>The final answer is: 3.5%</td>\n",
       "      <td>[Genomic Data Commons, CS-MATCH-0007 Arm S1 MA...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                           questions  \\\n",
       "0  What is the frequency of somatic JAK2 heterozy...   \n",
       "1  What is the frequency of somatic JAK2 heterozy...   \n",
       "\n",
       "  gpt-4o-2024-08-06_base_output  \\\n",
       "0     The final answer is: 3.5%   \n",
       "1     The final answer is: 3.5%   \n",
       "\n",
       "                        gpt-4o-2024-08-06_references  \n",
       "0  [Publication 1: Smith et al., 2022, 'Microsate...  \n",
       "1  [Genomic Data Commons, CS-MATCH-0007 Arm S1 MA...  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "questions.head(n=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "19113356",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(6011, 3)"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "questions.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "54797940",
   "metadata": {},
   "outputs": [],
   "source": [
    "questions.to_csv('../csvs/gpt4o_base_results.csv', index=0)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python Poetry venv-3.10.13",
   "language": "python",
   "name": "venv-3.10.13"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
